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Acinetobacter baumannii is a Gram-negative, non-motile bacterium notorious for its 
ability to colonize and spread among hospitalized patients. The fact that A. baumannii is 
more frequently associated with colonization than infection, even in susceptible patients, 
emphasizes the relatively low virulence of this bacterium. However, severe A. baumannii 
infections, including pneumonia and bacteremia, do occur in critically ill patients. Given 
the accumulating numbers of A. baumannii strains resistant to the last resort antibiotics, 
today’s global nosocomial spread is a major cause of concern. It remains unclear which 
factors determine the clinical success of A. baumannii. The aim of the studies presented in 
this thesis was to obtain insight into the factors contributing to the epidemicity and 
pathogenicity of this bacterium. In this chapter, the current state of knowledge regarding 
Acinetobacter species, including their taxonomy, epidemiology, antibiotic resistance, 
clinical features and pathogenesis, is reviewed. 
 
 
Taxonomy, epidemiology and antibiotic resistance 
 
Bacteria belonging to the genus Acinetobacter have undergone significant taxonomic 
changes during the last decades. Until the mid 1980s, this genus comprised only a single 
species, A. calcoaceticus [1], although a second species, A. lwoffii, was included on the 
Approved Lists of Bacterial Names [2]. At the time, glucose-acidifying strains were also 
often referred to as ‘Bacterium anitratum’ [3]. With the recent description of A. pittii 
[genomic species (gen. sp.) 3], A. nosocomialis (gen. sp. 13TU) [4], A. rudis [5] and A. 
brisouii [6], the genus Acinetobacter currently comprises 27 validly named species. The 
species A. baumannii, A. calcoaceticus, A. pittii and A. nosocomialis are genotypically 
closely related and phenotypically difficult to distinguish, which has given rise to the 
proposal to group them in the A. calcoaceticus - A. baumannii (Acb) complex [7]. From a 
clinical perspective this is not appropriate as the complex combines three clinically 
relevant species (A. baumannii, A. pittii, and A. nosocomialis) [8–12] with an 
environmental species (A. calcoaceticus) that is occasionally encountered in clinical 
specimens, but to our knowledge not associated with infection [13]. It is noteworthy that 
due to the difficulty in separating these Acb complex species with commercial 
identification systems commonly used in diagnostic microbiology [13,14], the clinical role 
of A. pittii and A. nosocomialis may be underestimated.  
 The ecology of bacteria belonging to the genus Acinetobacter is diverse. These 
organisms have been recovered from soil, surface water, vegetables, animals, human 
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body lice, and humans [15–19]. Twenty-five to 44% of healthy individuals were found to 
carry Acinetobacter species on the skin, particularly at moist sites like the axillae and toe 
webs [16,19]. The majority of the Acinetobacter species isolated from the skin belong to A. 
lwoffii, A. johnsonii and A. junii, whereas A. baumannii skin carriage is rare in healthy 
individuals [19]. The natural reservoirs of A. baumannii remain to be discovered. Bacteria 
of this species have been isolated mainly from hospitalized patients, but also from the 
hospital environment, and from sick animals [20]. There are indications that skin and 
mucous membranes colonized by clinically relevant species is an important source of 
infections in hospitalized patients, thereby contributing to the development and 
persistence of outbreaks [7,21,22]. A. baumannii has the capacity to survive on inanimate 
surfaces, such as ventilation equipment and bedding materials [23–27], for up to five 
months [28,29], thereby creating an important secondary reservoir from which spread to 
patients may occur.  
 The incidence of A. baumannii infections varies widely: from less than 1% in 
different European hospitals [30,31] to e.g. 32% among ventilated patients in a Taiwanese 
hospital [32]. A. baumannii, A. pittii and A. nosocomialis are the species most frequently 
involved in these infections [11,33–35]. A. baumannii strains have become endemic in 
multiple centres [36–40] and outbreaks have been observed worldwide [13,41]. A 
systematic review of published nosocomial outbreaks in the intensive care units (ICU) 
setting from 2005 to 2010 has revealed that A. baumannii was responsible for almost 25% 
of ICU infection outbreaks [42]. Three major lineages of genetically highly related A. 
baumannii strains, designated European (EU) clone I, II and III, are frequently implicated in 
outbreaks [43,44]. A recent striking manifestation is the occurrence of A. baumannii 
infections in soldiers severely injured during the conflicts in Iraq and Afghanistan [45]. 
Although Acinetobacter is mainly associated with nosocomial infection, several cases of 
community-acquired pneumonia, mostly associated with underlying diseases, have been 
reported [46–48].  
 During the last three decades, clinicians are increasingly faced with infections of 
A. baumannii isolates resistant to almost all clinically applicable antibiotics [12,49,50]. By 
the late 1990s, carbapenems and polymyxins were the only remaining useful agents that 
could combat severe infections with this microorganism in certain hospitals. To date, 
however, carbapenem-resistant strains are accumulating worldwide [12,49,51], a worrying 
development given the paucity of alternative treatment agents [52]. The ability of A. 
baumannii to persist in the hospital environment and to colonize patients in addition to its 
multidrug-resistant (MDR) phenotype makes control of outbreaks caused by this organism 











Clinical manifestation and risk factors 
 
Acinetobacter is an opportunistic pathogen that almost exclusively affects predisposed 
individuals, i.e., critically ill patients, including intensive care unit (ICU) and heavy trauma 
patients, as well as hospitalized neonates [7,54–56]. It can cause various types of 
infection, including pneumonia, urinary tract infections, skin and wound infections, and 
bacteremia [7,41]. These infections are mainly caused by A. baumannii, although A. pittii 
and A. nosocomialis also play a role [33,35,57–62]. Hospital-acquired infections caused by 
other Acinetobacter species are rare and if they occur, the clinical course is usually mild.  
Prolonged hospital stay and previous antibiotic use have been identified as risk 
factors for A. baumannii infection [63–65]. In addition, invasive devices, such as tubes, 
catheters, and vascular devices may act as portes d’entrée for Acinetobacter species 
[64,65]. Consequently, A. baumannii has emerged as a particularly important organism in 
ICUs, responsible for increased length of hospital stay and consequently of healthcare 
costs [66,67]. 
 Mortality in patients with A. baumannii infection in the ICU fluctuates widely, 
depending on patient characteristics, such as age and immune status [68], but also on 
geographic region; in the USA, crude mortality rates of 2% to 34% have been described 
[69–71], whereas in Taiwan and Turkey, rates as high as 20-68% [72–75] and 60-81% 
[76,77] have been reported, respectively. A multicenter study of Acinetobacter outbreaks 
in the Netherlands from 1999 to 2001 showed that in 1% of cases, death was a direct 
consequence of A. baumannii infection, whereas it had possibly played a role in the death 
of 8% of the infected patients [26]. The impact of A. baumannii on mortality remains a 
matter of debate as it is often difficult to determine whether mortality is caused by the 
patient’s underlying illness or by the A. baumannii infection [7,78,79].  
 Altogether, MDR A. baumannii has a major clinical impact on the healthcare 
setting. In the next section, the factors that play a role in the pathogenesis of this 
troublesome pathogen will be discussed. 
 
 
Pathogenesis and host defenses 
 
The balance between on the one hand the host’s defense and on the other particular 
bacterial characteristics, so-called virulence factors [80], determines the outcome of 
infection. In the following paragraphs, we will discuss host defense mechanisms in general 
and the current knowledge of the virulence factors of A. baumannii (summarized in Figure 
1). 
General introduction and outline of the thesis 
 14 
Host defense mechanisms 
 
The first line of defense encountered by pathogens is the anatomical barrier presented by 
the skin and mucous membranes. Chemical features of these epithelia, including the 
presence of fatty acids, low pH, antimicrobial peptides and enzymes, help to prevent 
pathogen entry [81]. Moreover, a key component of mucosal secretions, lactoferrin, binds 
iron and thereby hinders bacterial growth. If pathogens do cross the protective epithelial 
barrier, humoral and cellular effectors of the host innate immune response come into 
play. The major humoral innate defense mechanism, the complement system, is activated 
in the presence of pathogens [82,83]. Activation leads to the deposition of C3b on the 
pathogen surface, initiating opsonisation for phagocytosis and the formation of the 
membrane-attack complex (MAC), which can cause direct lysis of the pathogen. The 
chemotactic activity of complement component C5a attracts immune cells from the 
circulation. Pathogens can also be recognized by specific pattern recognition receptors on 
host cells, including Toll-like receptor (TLR)2, TLR4, TLR5, and TLR9 and C-type lectins 
[84,85]. This results in the production and release of chemokines and cytokines and the 
subsequent recruitment of neutrophils and monocytes from the circulation. Neutrophils 
phagocytose and kill engulfed pathogens through the production of toxic reactive oxygen 
species (ROS) mediated by NADPH oxidase and myeloperoxidase as well as non-oxidative 
mechanisms. The recruited monocytes differentiate, depending on the local environment, 
into macrophages or dendritic cells that can phagocytose and kill the pathogen but are 
also involved in initiating an adaptive immune response. In response to bacteria, host cells 
can produce antimicrobial peptides, including the cathelicidin LL-37 and human defensins, 
that inhibit bacterial growth and modulate the host response [86]. Although these 
inflammatory reactions are essential to eradicate the pathogen, they can also contribute 
to a wide range of deleterious effects, such as tissue damage [87].  
Many bacteria have evolved different mechanisms to resist or evade these host 






The ability of bacteria to adhere to surfaces is the initial step in the colonization of various 
niches [88,89]. A. baumannii can adhere to different abiotic surfaces, such as glass and 
plastic [90–96], for prolonged periods [97,98], which may contribute to its persistence on 












Figure 1. Overview of the interaction of A. baumannii with its host. Bacteria can adhere to the host 
surface (1) via adhesins and aspecific factors. They multiply, form microcolonies and produce 
exopolysaccharides resulting in the formation of a biofilm (2). Quorum sensing, histidine metabolism, 
specific outer membrane proteins and pili play a role in this process. Once adhered, bacteria can invade 
the host via a zipper-like mechanism or secrete several enzymes that degrade host cell molecules 
enabling them to enter the underlying tissues (3). Such toxic agents produced by the bacteria can, 
either directly or via outer membrane vesicles, be transferred to the host cells leading to apoptosis (5). 
The host cells can sense the bacteria via specific pattern recognition receptors, which triggers an innate 
immune response (4). Once inside the host, bacteria activate dendritic cells (7), which subsequently 
activate the adaptive immune response. Neutrophils and macrophages residing in the tissues or 
bloodstream can phagocytose and kill the invaded bacteria (8). However, bacteria can also prevent 
killing by these cells either by inducing apoptosis of the host cells or by preventing ROS-induced DNA 
damage. The ability of bacteria to evade the killing actions of the complement system, e.g., by binding 
complement inhibitors to their surface, and the ability to acquire iron via siderophores enables them to 
survive and multiplicate inside the host (6).  
AHL, acylated homoserine lactones; AIF, apoptosis inducing factor; Bap, biofilm-associated protein; DC, 
dendritic cell; hBD, human beta defensin; IL, interleukin; iNOS, inducible nitric oxide synthase; LPS, 
lipopolysaccharide; MAPK, mitogen-activated protein kinases; NFкB, nuclear factor кB; Omp, outer 
membrane protein; OMV, outer membrane vesicle; PNAG, poly-β-(1-6)-N-acetyl glucosamine; ROS, 
reactive oxygen species; TLR, Toll-like receptor. 
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Acinetobacter is also able to colonize biotic surfaces, including human skin and mucosal 
surfaces [16,19], which was corroborated by laboratory studies demonstrating that 
Acinetobacter strains could adhere to human epithelial cells in vitro [91,94,99,100].  
 Specific factors, such as adhesins, and aspecific factors like surface 
hydrophobicity play an integral role in bacterial adherence [81,94,101]. Adhesins are 
bacterial components capable of binding to a large variety of surfaces, thereby mediating 
interactions between the bacterium and a surface. They can broadly be divided into 
fimbrial and afimbrial adhesins [102,103]. Fimbriae are short, hair-like bacterial 
appendages [104] that can be assembled by various pathways, including the chaperone-
usher pathway. Via this pathway two proteins are produced, a periplasmic chaperone, 
which facilitates the folding of pilus subunits and an outer membrane usher that facilitates 
the dissociation of the subunits of the chaperone, exposing the subunit´s interactive 
surface and driving its assembly into the pilus [103]. Genome analyses revealed the 
existence of different fimbrial genes in A. baumannii [105–107]. In agreement with these 
findings, various types of fimbrial adhesins have been identified in Acinetobacter species, 
including bundle forming thin pili, which are associated with adherence to abiotic and 
biotic surfaces, and individual thick pili that are associated with twichting motility, i.e., the 
ability to move on solid surfaces [108], enabling colonization of adjacent surface areas 
[92,93,95]. Pili mediated by the CsuA/BABCDE chaperone-usher system have been 
identified as important structures to enable adherence to glass and plastic surfaces [95]. 
Another chaperone-usher system with a similarly organised pilus gene cluster, the acuA 
cluster, was identified in the environmental species A. baylyi [92]. Altogether, these 
studies indicate that Acinetobacter species express different pili that are associated with 
the adherence to abiotic and biotic surfaces. 
In addition to fimbrial adhesins, many bacterial species express a family of cell-
surface adhesins that specifically recognize and bind components of the extracellular 
matrix [109]. Koljalg et al demonstrated that different clinical A. baumannii isolates could 
adhere to the extracellular matrix constituents collagen, fibronectin, fibrinogen and 
vitronectin [110], but the microbial surface components recognizing these adhesive matrix 
molecules have not been identified yet. Outer membrane protein A (OmpA) is the most 
abundant surface protein of A. baumannii and has been shown to be required for 
adherence of A. baumannii ATCC19606
T
 to fungal filaments and alveolar epithelial cells 
[111]. Other factors like surface hydrophobicity play a role in the adherence of 
Acinetobacter to abiotic [91,94] and cellular surfaces [92]. Clinical A. baumannii strains 
were found to constitute higher hydrophobicity as compared to A. baumannii strains 
isolated from skin of healthy individuals [112]. Thus, in addition to pili, other cell surface 










their adherence to host surfaces. 
   
Biofilm formation 
Once bacteria have adhered to a surface, they can multiply and form microcolonies, 
followed by the production of exopolysaccharides, resulting in a highly structured 
microbial community: the biofilm [113,114]. The biofilm confers several advantages to 
bacteria within this structure as compared to their free-living counterparts: (i) the biofilm 
is an efficient scavenging system for trapping and concentrating essential minerals and 
nutrients from the environment [115]; (ii) sessile bacteria are more resistant to the effects 
of antibiotics and to effector cells and molecules of the host defense system than 
organisms in suspension [113]; and (iii) the proximity of bacteria within the biofilm 
provides an ideal environment for the horizontal transfer of genes, including antibiotic 
resistance genes [116]. 
 The ability of A. baumannii to form biofilms on glass and plastic surfaces 
[95,96,117] has been shown to depend on CsuA/BABCDE-mediated pili [95]. The 
expression of these pili is regulated by a two-component regulatory system comprised of a 
sensor kinase encoded by bfmS and a response regulator encoded by bfmR [118]. In 
addition, OmpA is needed for the formation of robust biofilms on abiotic surfaces [111]. 
Outer membrane proteins NlpE [106], Omp33 and the peptidoglycan-binding protein LysM 
as well as the putative porins CarO, OprD-like and DcaP-like proteins are also involved in 
A. baumannii biofilm formation on plastic, although their precise role in this process 
remains to be determined [119]. Choi et al described that the pgaABCD genes encode 
enzymes that synthesize the extracellular polysaccharide poly-β-(1-6)-N-acetyl 
glucosamine in A. baumannii [120], which is an important component of the biofilm. A 
homologue of the staphylococcal biofilm-associated protein (Bap) is involved in inter-
bacterial adhesion in mature biofilms and is needed for the stabilization of A. baumannii 
biofilms formed on glass [121].  
 Biofilm formation is influenced by environmental factors, such as the 
concentration of free calcium and iron, both of which enhance A. baumannii biofilm 
formation on plastic [95,122]. Two recent studies described the involvement of proteins 
participating in histidine metabolism in biofilm formation by A. baumannii, although the 
precise role still needs to be identified [119,123]. In this connection, it was suggested that 
A. baumannii reprograms bacterial gene expression by using certain aminoacids like 
histidine, leading to biofilm formation as described for Pseudomonas putida [124]. 
 The association between A. baumannii biofilm formation, antibiotic resistance 
and clinical success is ambiguous. Rodriguez-Bano et al [125] and King et al [126] did not 
find that MDR resistant A. baumannii isolates were more frequently biofilm-formers on 
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abiotic surfaces as compared to susceptible isolates, in contrast to several other studies 
[127,128]. It is of note that all these studies only examined an indirect association by 
comparing antibiotic resistant and susceptible strains for their ability to form a biofilm. 
Shin et al reported that the extended-spectrum β-lactamase PER-1 was up-regulated in A. 
baumannii cultured under biofilm conditions [123]. Another study has demonstrated a 
positive association between the expression of blaPER-1 and the ability of A. baumannii to 
form a biofilm [122]. Furthermore, a putative resistance nodulation cell division type 
efflux pump (RND pump) is increased in bacteria residing in biofilms. Overexpression of 
this type of efflux pump in A. baumannii confers resistance to different antibiotics 
[129,130], suggesting that changes in the A. baumannii proteome during biofilm formation 
play a role in the resistance to antibiotics. 
  Altogether, A. baumannii in biofilm structures are protected against 
environmental stresses, such as desiccation [131] and exposure to antibiotics, which may 




In order to build a highly structured and complex biofilm community, bacteria are thought 
to communicate with one another through a process called quorum sensing [132]. The 
term ‘quorum sensing’ describes the ability of bacteria to monitor the microbial 
population density, which is reflected by levels of specific signal molecules, autoinducers 
[132]. In Gram-negative bacteria, quorum sensing is typically mediated by autoinducers 
belonging to the group of acylated homoserine lactone derivatives (AHLs) [133]. These 
signal molecules are synthesized at a low basal level and diffuse from the bacterium 
according to their concentration gradient. Increased population density results in the 
accumulation of AHLs, which interact with transcription factors that control the expression 
of, among others, virulence genes [134,135]. Smith et al recently described the existence 
of genes encoding autoinducer processing in a clinical A. baumannii strain [107]. This is 
supported by the finding of three different quorum sensing signal molecules among 
Acinetobacter species, including A. baumannii, A. pittii and A. nosocomialis [136,137] and 
several studies that described an association between autoinducer production and biofilm 
formation by Acinetobacter [138–140]. 
 
Invasion 
Once adhered to the host surface, pathogens may gain access into the host by a process 
called invasion [141]. For this purpose, pathogens can secrete several enzymes that 










uptake by host cells, so-called extracellular invasion. Intracellular invasion occurs when a 
pathogen actually penetrates host cells, which can occur via two mechanisms: a zipper-
like mechanism, which requires the direct interaction of bacterial ligands to host’s cell 
surface receptors; and a trigger mechanism, which is initiated by injection of bacterial 
effector proteins into host cells by a type III secretion system. In both cases, the host’s 
cytoskeleton is rearranged to promote bacterial invasion. 
 A. baumannii can invade different respiratory epithelial cells [111,142] via a 
zipper-like mechanism [142]. OmpA plays a role in the invasion of these cells by A. 
baumannii ATCC19606
T
 [111,142] and was involved in the dissemination of this strain into 
the bloodstream in a mouse pneumonia model [142]. A. baumannii secretes enzymes that 
can potentially degrade host cell molecules, including lipases and hemolysins [97], by 
which this pathogen may invade the host. Moreover, Jacobs et al reported a role for 
phospholipase D of A. baumannii in bronchial epithelial cell invasion in vitro and 
dissemination in vivo [143]. These so-called invasins can, in addition to promoting 
bacterial invasion, also induce cytotoxicity as described below. 
 
Induction inflammatory responses 
The bacterial cell envelope-associated lipopolysaccharide (LPS) is considered to be the 
principal component of Gram-negative bacteria that is responsible for the induction of the 
host’s immune response. The lipid A part of LPS of different A. baumannii isolates is a 
bisphosphorylated diglucosamine with at least six saturated fatty acyl chains with lengths 
of 12 or 14 carbons [163], a structure that is associated with a high cytokine-inducing 
capacity [164]. This notion is supported by different studies showing that LPS of A. 
baumannii and A. hemolyticus induced an inflammatory response in vivo [163,165,166]. 
TLR4 plays a key role in innate sensing of A. baumannii via the LPS moiety, in initiating an 
adequate inflammatory response and, hence, in effective elimination of bacteria from e.g. 
the lung and in prevention of systemic bacterial spread. TLR2, however, reduced 
inflammatory innate responses and delayed eradication of A. baumannii in a murine 
model of pneumonia [166]. In vitro, both TLR2 and TLR4 have been shown to engage with 
A. baumannii [163,167], triggering activation of NF-κB and mitogen-activated protein 
kinases (MAPKs) pathways and the subsequent production of IL-8 in alveolar epithelial 
cells [163]. OmpA is another immunomodulatory factor of A. baumannii [168]. It was 
found to be associated with the activation and maturation of dendritic cells that drive T 
cell differentiation towards a T helper cell type 1 response [168].  
 Only a few studies have investigated host’s immune responses to A. baumannii. It 
was shown that C57BL/6 mice were capable of clearing A. baumannii within 72 h after 
intranasal inoculation with relatively high doses [166,169–171]. These results suggest that 
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innate immune defenses in the lungs can effectively control A. baumannii infection and 
prevent development of severe disease. In mice, A. baumannii induces the production of 
moderate amounts of the pro-inflammatory cytokines and chemokines tumor necrosis 
factor (TNF)α, interleukin (IL)-1β, IL-6, IL-17, monocyte chemotactic protein (MCP)-1, 
macrophage inflammatory protein (MIP)-2 and keratinocyte chemoattractant (KC) 
[166,169–173], resulting in the recruitment of neutrophils. Early recruitment of 
neutrophils into the lung has been shown to be important for initiating an efficient host 
defense against respiratory A. baumannii infection in mice [169,171,172]. 
 Neutrophils can engulf microbes into a phagosome that fuses with intracellular 
granules to form a phagolysosome, in which bacteria are killed through the action of 
reactive oxygen species (ROS) and oxygen-independent mechanisms such as antimicrobial 
peptides [174]. Qiu et al demonstrated a crucial role for NADPH oxidase-dependent ROS in 
the neutrophil-mediated killing of A. baumannii ATCC17961 in a mouse model of 
pneumonia [175]. However, A. baumannii may also evade killing after phagocytosis as has 
been described for a strain that induced the expression of several oxidative-stress 
responsive proteins during the late stationary phase of growth in vitro, which may 
function in ROS detoxification [176]. Furthermore, another study described the role of the 
enzyme RecA in protection of A. baumannii from DNA damaging agents, including ROS 
produced by macrophages in vitro [177]. In addition to the oxidative-dependent killing 
mechanisms, Acinetobacter has also been shown to be susceptible to the antimicrobial 
peptides present in neutrophils [178,179]. Different A. baumannii strains are susceptible 
to the antimicrobial action of human beta defensin 2, which is produced by alveolar 
epithelial cells in response to this pathogen, showing that epithelial cells are capable of 
producing mediators necessary for the clearance of A. baumannii [163]. 
 
Cytotoxicity 
The ability to produce toxins plays a crucial role in the pathogenesis of many bacteria 
[144]. Toxic agents can be secreted by the pathogen into the surrounding environment or 
directly injected into the host cell via e.g. a type III secretion system. Although A. 
baumannii has not been documented to produce specific toxins, strains of this species 
have been shown to be toxic to human respiratory epithelial cells and macrophages 
[142,145–147]. OmpA was involved in the induction of cell death in these cells [145] as 
well as in fungal filaments [111] by activating caspase-dependent and apoptosis inducing 
factor (AIF)-dependent pathways [145]. In addition, OmpA was shown to be present in 
outer membrane vesicles (OMVs) produced by a clinical A. baumannii isolate [148] that 
bound to host cells [149]. It was postulated that OMVs from A. baumannii were thus a 










Iron acquisition  
Iron is a vital nutrient for virtually all forms of life as it has an essential role in many 
cellular processes. The vast majority of iron in the vertebrate host is bound to the iron 
storage proteins ferritin, transferrin and lactoferrin or complexed within the porphyrin 
ring of heme, making the levels of free iron in the tissues and bloodstream very low [150]. 
One of the most commonly found strategies evolved by microorganisms to survive in 
these iron-limited conditions of the host is the synthesis and excretion of low molecular 
weight compounds with a very high affinity for iron, called siderophores [151–153]. These 
siderophores may compete directly with host proteins for bound iron in order to make it 
available for the microbial cell [152]. Bacteria may also access iron through Omp receptors 
that recognize the whole complex of host proteins and iron, allowing the internalization of 
iron without the intermediacy of a siderophore [151]. 
 Several studies have shown that A. baumannii isolates have the ability to grow 
under iron-limiting conditions in vitro [97,154–156] and different siderophores, heme-
acquisition and ferrous iron-uptake systems, have been described [97,154,155,157–160]. 
Furthermore, inner and outer membrane proteins related to FatA, which is part of an 
outer membrane receptor that recognizes and internalizes iron-siderophore complexes in 
the fish pathogen Vibrio anguillarum [161], were detected in a clinical isolate of A. 
baumannii [157]. The wide distribution of multiple iron-acquisition systems among 
different A. baumannii isolates suggests that iron-acquisition is an indispensible attribute, 
and hence, an important virulence factor. 
 
Serum multiplication 
When invading the tissues and the bloodstream, bacteria have to evade the killing actions 
of the complement system in order to survive. Some A. baumannii strains are shown to be 
resistant to the killing action of human serum [97,126,143,162]. OmpA plays a role in 
serum resistance of A. baumannii by binding complement factor H, thereby inhibiting the 
alternative complement pathway [162]. It was also found that the production of 
phospholipase D is associated with serum resistance of A. baumannii [143], although the 
mechanism involved has not been characterized yet. The resistance of A. baumannii to the 
killing actions of complement likely plays an important role in the ability of the organism 
to survive in the host’s tissues and bloodstream. 
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Outline of the thesis 
 
Altogether, a variety of virulence factors have been identified in A. baumannii. However, 
in most studies only one or a few strains have been used and it is not known whether 
these findings can be extrapolated to other strains of this species. Moreover, not all 
studies have used well-validated genotypic species identification methods, making it 
difficult to extrapolate findings to particular species. Whether these factors explain the 
clinical success of A. baumannii relative to other Acinetobacter species remains to be 
determined. The studies presented in this thesis aimed to improve insight into the 
bacterial and host factors associated with the pathogenesis of A. baumannii as a first step 
towards an explanation for the success of A. baumannii as a human pathogen.  
 
The three main questions underlying the studies presented in this thesis were: 
(i) Can adherence to and biofilm formation on (a)biotic surfaces explain the clinical 
success of A. baumannii relative to other Acinetobacter species? 
(ii) What is the role of the host innate immune response in the clinical success of A. 
baumannii relative to other Acinetobacter species?  
(iii) Which virulence attributes are expressed by A. baumannii? 
 
To answer these questions, we made use of a large collection of epidemiologically well-
described strains that has been set up during an ongoing project at the Leiden University 
Medical Centre. This project was started up in the early 1980s at the Dijkzigt Rotterdam 
University Hospital (currently the Erasmus University Hospital Rotterdam) and focuses on 
the epidemiology and taxonomy of Acinetobacter. We selected strains that differ in their 
behaviour in the clinical setting, i.e., MDR A. baumannii strains known to be involved in 
outbreaks of infection, susceptible sporadic A. baumannii strains and strains of other, 
clinically less-relevant Acinetobacter species. In chapter 2, we compared these strains and 
species for their ability to form biofilms on abiotic surfaces, to adhere to human cells and 
to induce an innate immune response in these cells. In chapter 3, we studied the role of 
CsuA/BABCDE-dependent pili, which have been described to be involved in biofilm 
formation on abiotic surfaces [95] in the adherence to human cells and in the induction of 
an inflammatory response in these cells. To investigate the role of the host response in 
more detail, we compared the persistence of and host response to different well-
characterized A. baumannii strains and an A. junii strain in a mouse pneumonia model 
(chapter 4). We used a systems biology approach involving genomics, phenomic and 
virulence studies in order to investigate the genetic basis of the different virulence 










species are successful as human pathogens and others are not (chapter 5). Several papers 
have suggested that membrane vesicles play a role in the delivery of virulence factors to 
host cells [148,149] but it is not clear how and when in the life cycle of the bacterium 
these vesicles are produced. Moreover, it is not known whether laboratory procedures 
influenced the generation of particular vesicles. We used advanced electron microscopy 
techniques in combination with a lenient vesicle purification method to investigate the 
formation and structure of membrane vesicles produced by A. baumannii in different 
growth phases (chapter 6). As a novel model to study virulence attributes, we developed a 
three-dimensional human epidermal skin model of Acinetobacter colonization (chapter 7). 
Finally, the main findings from our studies are summarized and discussed in chapter 8 and 
a summary in Dutch can be found in chapter 9. 
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The dramatic increase in antibiotic resistance and the recent manifestation in war trauma 
patients underscore the threat of Acinetobacter baumannii as a nosocomial pathogen. 
Despite numerous reports documenting its epidemicity, little is known about the 
pathogenicity of A. baumannii. The aim of this study was to obtain insight into the factors 
that might explain the clinical success of A. baumannii. 
We compared biofilm formation, adherence to and inflammatory cytokine 
induction by human cells for a large panel of well-described strains of A. baumannii and 
compared these features to that of other, clinically less relevant Acinetobacter species. 
Results revealed that biofilm formation and adherence to airway epithelial cells varied 
widely within the various species, but did not differ among the species. However, airway 
epithelial cells and cultured human macrophages produced significantly less inflammatory 
cytokines upon exposure to A. baumannii strains than to strains of A. junii, a species 
infrequently causing infection. 
The induction of a weak inflammatory response may provide a clue to the 












With the recent description of Acinetobacter bereziniae (genomic species (gen. sp.) 10), A. 
guillouiae (gen. sp. 11) [1], A. venetianus [2] and A. soli [3], the genus Acinetobacter 
comprises 23 named species and 11 species with provisional designations. Of these, A. 
baumannii and the closely related A. gen. sp. 3 and 13TU are clinically the most relevant. 
Strains of these species have the ability to colonize and spread among critically ill 
hospitalized patients. Outbreaks of multidrug resistant A. baumannii strains have been 
observed worldwide [4], [5]. A striking manifestation is the dramatic increase in the 
frequency of imipenem resistant Acinetobacter isolates in US hospitals [6] and the recent 
occurrence of infection in severely injured soldiers during the conflicts in Iraq and 
Afghanistan [7]. Three major lineages of genetically highly related A. baumannii strains, 
designated European clone I, II and III, have been found to be frequently implicated in 
outbreaks [8], [9]. Other Acinetobacter species, such as A. junii, A. johnsonii and A. lwoffii 
that can frequently be found on the human skin are only incidentally involved in infection, 
which usually has a mild course [4]. This suggests differences in the pathogenic potential 
among Acinetobacter species. 
The high prevalence of A. baumannii strains in the hospital in epidemic and 
endemic situations might be explained by several factors, including their resistance to 
antibiotics [10] and desiccation [11], their ability to form biofilms on medical devices [12], 
and to colonize skin and mucosal surfaces of vulnerable hosts [13], [14]. Adherence of 
bacteria to host cells is generally considered to be an essential initial step in the 
colonization process [15]. Once the primary colonizing bacteria have attached to a surface, 
microcolonies are formed after which bacteria may secrete exopolysaccharides resulting 
in a highly structured sessile microbial community, the biofilm [16]. Several studies have 
documented the ability of A. baumannii to adhere to epithelial cells and to form biofilms 
on glass and plastic surfaces [12], [17], [18]. Adherent bacteria can interact with cells of 
the host defense systems resulting in the release of cellular mediators and effector 
molecules, such as interleukin (IL)-6 and IL-8 and antimicrobial peptides, which help to 
eradicate the pathogen [19]. 
Little is known about the pathogenicity of A. baumannii. Moreover, the scarce 
reports on the virulence of A. baumannii are focused on one or a few strains only. The 
purpose of the present study was to obtain insight into the factors that might explain the 
clinical success of A. baumannii. To this aim, biofilm formation was investigated for a large 
set of well-described A. baumannii strains that differed in epidemicity and clonality. Next, 
biofilm formation by A. baumannii was compared to that of other Acinetobacter species, 
including A. gen. sp. 3 and 13TU, A. calcoaceticus and A. junii. For a subset of A. baumannii 
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and A. junii strains, adherence to airway epithelial cells and induction of inflammatory 
cytokine production by these cells and cultured human macrophages was quantitated. 
Furthermore, the presence of pilus-like structures that may play a role in adherence and 
biofilm formation was assessed with scanning electron microscopy (SEM). 
 
 
Materials and Methods 
 
Bacterial strains, culture conditions and antimicrobial susceptibility testing 
Forty-five A. baumannii, 3 A. gen. sp. 3, 3 A. gen. sp. 13TU, 3 A. calcoaceticus, and 7 A. junii 
isolates, were selected from the Leiden University Hospital Acinetobacter collection for 
this study. Of the A. baumannii strains, 18 were from outbreaks, 16 presumably not from 
outbreaks on basis of time-space-origin, and 11 of which the association with an outbreak 
was unknown. Eight of the A. baumannii strains belonged to European clone I, 11 to clone 
II, and 3 to clone III. All isolates had previously been identified to species by one or more 
validated genotypic identification methods [27], [28], [29]. Bacteria were preserved for 
prolonged periods in nutrient broth supplemented with 20% (v/v) glycerol at -80°C. Prior 
to each experiment, inocula from frozen cultures were grown overnight at 30°C [30] on 
sheep blood agar plates (BioMerieux, Boxtel, the Netherlands). For experiments, fresh 
subcultures were made either under these conditions or in Luria-Bertani (LB) medium. 
Susceptibility to antimicrobial agents was determined by disc diffusion according to CLSI 
recommendations [31]. Strains resistant to more than two of the following drug classes 




Biofilm formation in 96-wells polyvinylchloride microtiter plates (Falcon, BD, Breda, the 
Netherlands) was assayed as described [32]. Briefly, bacteria from an overnight culture in 
LB medium were suspended to 1×10
6
 colony forming units (CFU)/ml as calculated from 
the absorbance of a suspension at 600 nm. Five µl of this suspension was inoculated in 
100 µl of M63 medium consisting of KH2PO4 (12 g/l), K2HPO4 (7 g/l), (NH4)2SO4 (2 g/l), 
glucose (0.2% w/v), MgSO4 (1 mM) and casaminoacids (0.5% w/v). After 24 h incubation at 
28°C and 37°C, wells were washed and biofilms attached to the wells were stained with 
crystal violet (1% w/v). The optical density at 590 nm, expressed in arbitrary units (a.u.), 
was taken as a quantitative measure of biofilm mass. To determine the bacterial 
concentration after 24 h, serial dilutions of the supernatants were made in phosphate 










Adherence to human airway epithelial cells 
Adherence of bacteria to human bronchial epithelial H292 cells (ATCC CRL-1848, Manassas, 
VA, USA) was determined as described [18]. Briefly, H292 cells were cultured in RPMI-1640 
medium supplemented with 2 mM L-glutamine, 50 µg/ml streptomycin, 1000 U sodium 
penicillin G, and 10% (v/v) heat-inactivated foetal calf serum (FCSi) (all from Gibco, 
Invitrogen, Breda, The Netherlands), further referred to as culture medium, in 25 cm
2
 
tissue culture flasks (Greiner Bio-One, Frickenhausen, Germany) at 37°C/5% CO2. At 
confluency, cells were trypsinized and 2x10
5
 cells were cultured on plastic coverslips 
(Thermanox, Nunc, Amsterdam, the Netherlands) placed in 24-wells plates. At 85-90% 
confluency, H292 cells were washed with PBS and incubated at 37°C/5% CO2 in culture 
medium without antibiotics for 24 h. Subsequently, cells were washed with PBS and 






) CFU of an overnight culture on 
blood agar. Bacterial adherence to H292 cells was quantified by light microscopy using two 
parameters: (i) percentage of epithelial cells associated with at least one bacterium; and 
(ii) average number of bacteria per epithelial cell [18]. 
 
Cytokine induction in human airway epithelial cells 
Cytokine production by airway epithelial cells in response to bacteria was determined as 
described [33] with minor modifications. In short, bacteria were cultured overnight at 
30°C on blood agar and suspended in RPMI-1640 to a concentration of 5×10
8
 CFU/ml as 
assessed spectrophotometrically. Approximately 2×10
5
 H292 cells, cultured in 24-wells 
plates as descrived above, were incubated in culture medium without antibiotics and FCSi 







 CFU live or heat-inactivated (by 1 h incubation at 100°C) bacteria. 
H292 cells were washed five times with PBS to remove non-adherent bacteria and RPMI-
1640 with 2 mM L-glutamine was added. After additional 5 or 23 h incubation at 37°C, 
supernatants were collected and stored at −20°C. A]er 24 h, bacterial CFU count in the 
supernatants was determined. In each experiment, RPMI-1640 with 2 mM L-glutamine 
alone was added to the cells to determine background values. A mixture of cytokines (100 
ng/ml TNFα, 20 ng/ml IL-1β and 10 ng/ml IFNγ; all from Biosource, Nivelles, Belgium) with 
10 ng/ml rough type lipopolysaccharide (LPS, Escherichia coli J5, Sigma-Aldrich, 
Zwijndrecht, the Netherlands), further referred to as cytomix, was added to the cells as a 
positive control. 
 
Cytokine induction in cultured human macrophages 
Buffy coats from healthy human donors were purchased from Sanquin bloodbank, 
Amsterdam, the Netherlands, upon written consent with regard to scientific use. The 
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current study did not require approval from an ethics committee according to the Dutch 
Medical Research Involving Human Subjects Act. Monocytes were isolated from 
buffycoats by Ficoll amidotrizoate density centrifugation and magnetic sorting using anti-
CD14-coated beads (Miltenyi Biotec, Auburn, CA, USA) according to the manufacturer's 
instructions. Monocytes were resuspended in culture medium and cultured at a 
concentration of 2×10
5
 cells/ml in wells of a 24-wells plate at 37°C/5% CO2 in the presence 
of either 5 ng/ml recombinant human granulocyte–macrophage colony-stimulating factor 
(Biosource International, Camarillo, CA, USA) to induce differentiation of monocytes into 
macrophage type 1 or in the presence of 50 ng/ml recombinant human macrophage 
colony-stimulating factor (R&D Systems, Minneapolis, MN, USA) for type 2 macrophages 
[20]. After three days, 0.5 ml of fresh culture medium was added. On the sixth day 
following isolation, cells were washed once in PBS and 0.5 ml RPMI-1640 with 2 mM L-
glutamine was added. Bacteria were cultured overnight at 30°C on blood agar and 
suspended in PBS to a concentration of 5×10
7
 CFU/ml as assessed spectrophotometrically. 
Cells were stimulated with 1×10
7
 CFU of live bacteria for 24 h, after which supernatants 
were collected and stored at −20°C. In each experiment, PBS and LPS (100 ng/ml) were 
added to the cells as negative and positive control, respectively. 
 
Determination of levels of inflammatory mediators 
The levels of IL-6, IL-8, TNFα, IL-12p40 and IL-10 in culture supernatants were determined 
by ELISA (Biosource) according to the manufacturer's instructions. The lower limit of 
detection was 15 pg/ml for IL-6, 7 pg/ml for IL-8, and 25 pg/ml for TNFα, IL-12p40 and IL-
10. 
 
Electron microscopy analysis of bacterial surface structures 
Bacteria from an overnight culture on blood agar at 30°C were suspended in PBS and fixed 
for 1 h at room temperature with 1.5% (w/v) glutaraldehyde in 0.1 M sodium cacodylate 
buffer (1:1). Fixed bacteria were transferred to poly-L-lysine-coated glass slides. After 1 h 
incubation at room temperature, bacteria were fixed to the slides with 1.5% 
glutaraldehyde for 30 min at room temperature. Thereafter, slides were washed twice in 
PBS, dehydrated through a series of graded ethanol, critical-point-dried, and coated with a 
layer of palladium-gold. Bacteria were examined using a JEOL JSM-6700F field emission 
scanning electron microscope. 
 
Statistical analysis 
Results are expressed as medians and ranges unless stated otherwise. The Kruskal-Wallis 










differences in distribution. Spearman rank correlation coefficients were calculated to 
evaluate possible associations between epidemicity and adherence to epithelial cells and 






Biofilm formation on plastic at 28°C and 37°C was first investigated for a comprehensive 
set of A. baumannii strains. The results revealed a large variation in biofilm formation 
among A. baumannii isolates; the results at 28°C and 37°C did not differ (Fig. 1). There was 
no difference in the median biofilm size between strains from outbreaks (0.9; 0–1.8 a.u.) 
and those not assumed to be from outbreaks (0.8; 0.1–2.8 a.u.). Strains of European clone 
II (1.1; 0.6–1.8 a.u.) formed larger (p≤0.05) biofilms than strains of clone I (0.8; 0–1.0 a.u.), 
but not larger than strains of clone III (1.0; 0.6–1.3 a.u.). Multidrug resistant strains (0.8; 
0–1.8 a.u.) did not form larger biofilms than susceptible strains (0.8; 0.1–2.8 a.u.). 
Furthermore, no association between biofilm formation and body site of isolation was 
found (data not shown). 
 
 
Figure 1. Biofilm formation by Acinetobacter. Biofilm formation after 24 h at 28°C for the clinically 
relevant A. baumannii (n=45), A. gen. sp. 3 (n=3) and A. gen. sp. 13TU (n=3) and for the clinically less-
relevant A. calcoaceticus (n=3) and A. junii (n=7). Data are expressed as mean biofilm mass (in 
arbitrary units (a.u.)) of three independent experiments; each performed in sixplicate. Outbreak-
associated (+) or non-outbreak-associated (−) isolate. European clone I (I), II (II) or III (III) isolate. 
Multidrug resistant (MDR; +) or susceptible (−) isolate. 
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Next, biofilm formation by A. baumannii strains was compared to that by strains of other 
Acinetobacter species. No significant differences in the median size of the biofilms at 28°C 
were found between clinically relevant species, i.e., A. baumannii (0.8; 0–2.8 a.u.), A. gen. 
sp. 3 (1.4; 1.3–1.5 a.u.) and A. gen. sp. 13TU (0.4; 0.2–0.7 a.u.), and the other 
Acinetobacter species, i.e., A. calcoaceticus (1.1; 1.0–1.1 a.u.) and A. junii (1.6; 0.5–3.0 
a.u.). Similar results were obtained at 37°C except for strains of A. gen. sp. 13TU that 
formed smaller (p≤0.05) biofilms than all other species. Of note, the number of bacteria in 
the supernatants at the end of each experiment did not differ much between the different 
strains (data not shown). 
 
Adherence to human airway epithelial cells 
For further comparison of clinically relevant to less-relevant Acinetobacter strains and 
species, experiments exploring the ability of strains to adhere to and induce cytokines by 
human cells were conducted with a subset of strains (further referred to as subset), 
including six strains of A. baumannii and six strains of A. junii, a species infrequently 
causing infections (Table 1A). All selected strains were epidemiologically unrelated and 
were genotypically diverse as assessed by AFLP genomic fingerprinting.  
 
Table 1A. Characteristics of subset of Acinetobacter strains 
Origin Year Specimen Clone Outbreak‡
LUH1398 St. Zagora (BG) 1993 Throat secr. II
LUH7312 Leiden (NL) 2001 Sputum +
LUH7493 Leiden (NL) 2001 Sputum
RUH875 Dordrecht (NL) 1984 Urine I +
RUH3023T 
(ATCC19606)
Atlanta (USA) 1965 Urine
RUH3239 London (UK) 1985 Urine I +
LUH3283 Leiden (NL) 1995 Blood
LUH5851 Leiden (NL) 1999 Ear
LUH6931 Nottingham (UK) 2000 Faeces
LUH6981 Leiden (NL) 2000 Faeces
LUH8161 Leiden (NL) 2002 Blood
RUH2228T 
(ATCC17908)





‡Outbreak-associated (+) strain, (i.e. common AFLP profile in >2 patients and 
with same time-space-origin). 
 
Adherence to human airway epithelial H292 cells varied widely among the Acinetobacter 
strains (Table 1B). No significant difference in the percentage of H292 cells associated with 
bacteria was observed between A. baumannii (30; 7–55%) and A. junii (23; 11–70%). In 
addition, no difference in the number of A. baumannii and A. junii per positive H292 cell 














) between the various 
experiments did not influence the outcome of the adherence assay. Furthermore, cell 
monolayers remained intact and the morphology of the cells was not affected by the 
bacteria (data not shown). 
 
Table 1B. Biofilm formation, adherence and cytokine induction by Acinetobacter 
LUH1398 0.8 (0.5-1.1) 38 (32-65) 3 (3-3) 0.9 (0.0-3.9) 1.5 (0.4-4.8)
LUH7312 0.3 (0.3-0.4) 53 (38-76) 5 (3-6) 2.1 (0.1-14.5) 3.5 (0.8-12.8)
LUH7493 0.4 (0.3-0.5) 35 (16-46) 2 (2-3) 1.1 (0.0-3.6) 2.3 (0.1-4.8)
RUH875 1.0 (0.8-1.1) 24 (17-45) 3 (2-3) 1.2 (0.0-5.6) 2.0 (0.3-4.6)
RUH3023T 
(ATCC19606)
1.9 (0.9-2.2) 19 (9-21) 2 (1-2) 0.6 (0.0-2.7) 1.0 (0.1-3.5)
RUH3239 0 (0.0-0.0) 6 (3-14) 1 (1-2) 1.0 (0.0-4.4) 1.5 (0.1-3.5)
LUH3283 0.7 (0.0-0.8) 70 (62-83) 3 (3-4) 2.0 (0.1-11.9) 2.5 (0.8-10.0)
LUH5851 1.6 (1.4-1.8) 31 (15-41) 2 (2-3) 2.0 (0.2-11.8) 3.3 (1.6-8.1)
LUH6931 0.6 (0.6-0.6) 12 (9-13) 2 (2-2) 1.4 (0.0-7.4) 2.1 (0.4-8.7)
LUH6981 2.7 (2.6-3.0) 9 (5-29) 2 (1-2) 1.7 (0.1-12.3) 4.9 (1.5-11.5)
LUH8161 3.0 (3.0-3.0) 15 (8-25) 3 (3-3) 3.1 (0.1-8.7) 3.8 (0.7-9.9)
RUH2228T 
(ATCC17908)





Biofilm formaIon† % Bacterial-associated 
cells‡




†Biofilm formation on plastic after 24 h at 28°C. Results are expressed as median optical density values at 
590 nm (ranges) of three independent experiments; each performed in sixplicate. ‡Adherence to human 
bronchial epithelial H292 cells after 1h. Results are expressed as median percentage of H292 cells that is 
associated with bacteria and median number of bacteria per H292 cells (range) of two independent 
experiments; each performed in duplicate. ¶IL-6 and IL-8 levels in the culture supernatants of H292 cells, 24 
h after exposure to bacterial strains. Results are expressed as median values (range) in ng/ml of three 
independent experiments; each performed in triplicate. 
 
Cytokine production by human airway epithelial cells in response to Acinetobacter 
Pilot experiments demonstrated that 1×10
8
 CFU bacteria induced higher (p≤0.05) levels of 




 CFU did. Furthermore, 
stimulation with live bacteria resulted in higher (p≤0.05) IL-6 and IL-8 production by H292 
cells than heat-inactivated bacteria did. Time-course experiments demonstrated that the 
levels of IL-6 and IL-8 were higher (p≤0.05) after 24 h than after 6 h stimulation. Therefore, 
further stimulation experiments were performed for 24 h with 1×10
8
 CFU live bacteria. 
Results revealed that H292 cells produced less (p≤0.05) IL-8 in response to A. 
baumannii strains (1.8; 1.0–3.5 ng/ml) than to A. junii strains (3.2; 2.1–4.9 ng/ml; Fig. 2). 
Interleukin-6 production was lower in response to A. baumannii strains (1.1; 0.6–2.1 
ng/ml) than to strains of A. junii (2.0; 1.4–3.1 ng/ml; Fig. 2), without reaching statistical 
significance (p=0.055). Of note, H292 cells stimulated with cytomix produced 2.3 (0.6–3.0) 
ng/ml IL-6 and 3.4 (1.4–4.1) ng/ml IL-8 and unstimulated cells produced 0.1 (0–0.1) ng/ml 
IL-6 and 0.2 (0.1–0.2) ng/ml IL-8. Cytokine induction did not vary widely among strains of 
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each species, except for A. baumannii strain LUH7312 that induced significantly higher 
levels of IL-6 and IL-8 than the other A. baumannii strains. Stimulation of H292 cells with 7 
additional A. baumannii strains that were epidemiologically unrelated and genotypically 
diverse also resulted in low IL-8 (1.3; 0.3–1.7 ng/ml) and IL-6 production (0.1; 0–0.2 
ng/ml), demonstrating that, with the exception of strain LUH7312, A. baumannii strains 
induced significantly (p≤0.01) less IL-6 and IL-8 than A. junii strains. 
Since live bacteria were used in this assay, there was a possibility of outgrowth 
that may have caused the difference in cytokine induction. However, the number of 
bacteria in the supernatants at the end of each experiment did not differ much between 




 CFU/ml). Of note, cell monolayers remained 




Figure 2. Cytokine production by human airway epithelial cells in response to Acinetobacter. Boxplots 
showing IL-6 and IL-8 production in ng/ml by H292 airway epithelial cells 24 h after stimulation with 
strains of A. baumannii (n=6) and A. junii (n=6). Boxes represent medians and second and third 
interquartiles, whiskers represent range of 6 strains. *significant (p≤0.05) difference between A. 
baumannii and A. junii. 
 
 
Finally, preliminary experiments demonstrated that exposure of primary human bronchial 
epithelial cells of a single donor to six A. baumannii strains (in triplicate) resulted in lower 
(p≤0.05) levels of IL-8 (0.9; 0.5–3.6 ng/ml) than to six A. junii strains (4.5; 0.9–30.7 ng/ml). 
Cytomix induced 8.6 (7.4–11.5) ng/ml IL-8 in these cells. Of note, no IL-6 was produced by 
these primary cells upon exposure to these two Acinetobacter species or to cytomix. 
 
Cytokine production by cultured human macrophages in response to Acinetobacter 
In tissues, macrophages trigger an adequate innate immune response upon encountering 










contribute to the elimination of pathogens and the elicitation of an inflammatory reaction. 
When the infection recedes due to removal of the pathogens, their function may shift 
toward resolution of inflammation and tissue repair. In line with this notion, we 
investigated cytokine production by two clearly distinct types of macrophages, i.e., pro-
inflammatory macrophages (further referred to as type 1 macrophages), and 
macrophages with an anti-inflammatory/pro-angiogenic phenotype (type 2 macrophages) 
[20], upon exposure to A. baumannii and A. junii strains. Results revealed that 
macrophage type 1 produced significantly (p≤0.05) less tumor necrosis factor (TNF)α, IL-
12p40, IL-10 and IL-8 in response to strains of A. baumannii [195 (108–244) ng/ml TNFα, 7  
(2-11) ng/ml IL-12p40, 22 (0-149) pg/ml IL-10 and 49 (27-66) ng/ml IL-8] than to strains of 
A. junii [650 (458–812) ng/ml TNFα, 130 (111–155) ng/ml IL-12p40, 764 (126–1587) pg/ml 
IL-10 and 111 (48–208) ng/ml IL-8; Fig. 3]. A. baumannii strains also induced less (p≤0.05) 
inflammatory cytokines in macrophage type 2 than A. junii strains (Fig. 3). Of note, cell 
monolayers remained intact and the morphology of the cells was not affected by the 
bacteria (data not shown). 
 
Electron microscopy analysis of bacterial surface structures 
Pili have been described to be involved in biofilm formation, adherence and the induction 
of an immune response [21]. Therefore, we performed SEM to assess the presence of such 
surface structures on four A. baumannii strains that differed in their ability to form biofilm 
and adhere to human cells. SEM of bacteria cultured for 16 h at 37°C on blood agar plates 
revealed two types of cell appendages: short pilus-like structures and long extensions (Fig. 
4). The latter varied in length, were irregularly distributed over the cell surface, and 
sometimes connected bacteria. The pilus-like structures were detected in A. baumannii 
strain LUH1398, a large biofilm former and highly adherent, in LUH7312, a small biofilm 
former and highly adherent, and RUH3023
T
, a large biofilm former but poorly adherent 
(Fig. 4, white arrows). Long cell extensions were seen in A. baumannii strain RUH3023
T
 
and RUH3239, a small biofilm former and poorly adherent (Fig. 4, black arrows). In 
addition to these structures, there was a marked surface heterogeneity, from smooth 
(LUH7312) to pockmarked (LUH1398). 
In contrast to A. baumannii strain RUH3023
T
 and RUH3239, strain LUH1398 and 
LUH7312 formed only a few cell clusters with no more than four cells grouped together on 
the glass slides (data not shown). No difference in structural features was observed 
between strains cultured at 37°C and 30°C. 
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Figure 3. Cytokine production by human macrophages in response to Acinetobacter. Boxplots showing 
TNFα (A), IL-12p40 (B), IL-8 (C) and IL-10 (D) production by cultured human macrophages type 1 (white 
boxes) and 2 (gray boxes) 24 h after stimulation with strains of A. baumannii (n=6), A. junii (n=6), LPS 
and without stimulation (none). Boxes represent medians and second and third interquartiles, 
whiskers represent range of 6 strains (for A. baumannii and A. junii) or range of experiments with 4 














This study was undertaken to obtain some insight into the mechanisms underlying the 
clinical success of A. baumannii. The main conclusion from the present study is that strains 
of A. baumannii induced a poor inflammatory response in human cells, despite the finding 




Figure 4. Scanning electron micrographs of A. baumannii. Scanning electron micrographs of A. 
baumannii strain LUH1398, LUH7312, RUH3023, and RUH3239. Black arrows indicate long cell 
extensions; white arrows indicate short pili-like structures. Magnification: 30,000x. Bars: 100 nm. 
 
First, airway epithelial H292 cells in vitro produced less IL-6 and IL-8 in response to A. 
baumannii strains than to A. junii strains. Furthermore, cultured human macrophages 
produced less TNFα, IL-12p40, IL-8 and IL-10 in response to A. baumannii strains than to A. 
junii strains. In agreement with our in vitro data, Qiu et al documented that the high 
susceptibility of A/J mice to A. baumannii ATCC17961 infection was associated with a 
reduced local pro-inflammatory response and reduced elimination of bacteria from the 
lungs [22]. Knapp et al showed in an in vivo model that A. baumannii strain RUH2037 
induced the release of pro-inflammatory cytokines and chemokines resulting in clearance 
of bacteria from the lungs of experimentally infected mice [23]. Although study-design and 
outcome were distinct from our study, the findings emphasize the importance of 
inflammatory cytokines for clearing of A. baumannii. It is furthermore of note that our 
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finding that clinically relevant strains induced a weak immune response in vitro has also 
been reported for Haemophilus influenzae [24]. 
There was a wide variation in biofilm formation among a large set of well-
described A. baumannii strains. Although epidemic strains did not form larger biofilms 
than sporadic strains, it appeared that strains of European clone II formed larger biofilms 
than strains of clone I. It is of note that clone II, which was less frequently involved in 
outbreaks during the 1990s than clone I, is now emerging in several European countries 
with many strains being carbapenem resistant [25], [26]. Further to A. baumannii, the 
intra-strain variation in biofilm formation of A. gen. sp. 3 and 13TU and of the clinically 
less-relevant species A. calcoaceticus and A. junii was also considerable. Interestingly, 
there was no difference between these species, except for A. gen. sp. 13TU that formed 
small biofilms. 
Many of the strains used for the current biofilm experiments had previously been 
used to investigate adherence to H292 airway epithelial cells [18]. In that study, it was 
shown that adherence to airway epithelial cells varied considerably among strains of A. 
baumannii, while strains of clone II had higher adherence values than those of clone I [18]. 
Likewise, the present study showed a considerable intra-species variation in adherence to 
human airway epithelial cells but no difference between A. baumannii and A. junii strains. 
Biofilm formation on plastic was not correlated to adherence to human cells, indicating 
that different mechanisms are involved in these colonization processes. Furthermore, the 
ability to form biofilm on plastic and the capacity to adhere to human cells was not always 
accompanied by the presence of pilus-like cell surface structures and long cell extensions. 
Taken together, it seems that biofilm formation and adherence to human cells is strain- 
and not species-specific. Thus, these features do not solely explain the success of A. 
baumannii in the susceptible host. 
In summary, biofilm formation and adherence to airway epithelial cells did not 
differ between clinically relevant and less-relevant Acinetobacter strains and species. 
However, there was a difference in the production of inflammatory cytokines by airway 
epithelial cells and macrophages between A. baumannii and A. junii. This may be a first 
clue to explain the difference in clinical behavior between A. baumannii and A. junii. We 
hypothesize that A. baumannii may survive and persist in the airways of patients and 
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Acinetobacter baumannii is a nosocomial pathogen responsible for outbreaks of infection 
worldwide. The factors associated with its ability to colonize/infect human hosts are 
largely unknown. Adherence to host cells is the first step in colonization/infection, which 
can be followed by biofilm formation. A. baumannii ATCC19606
T
 biofilm formation on 
abiotic surfaces depends on expression of the CsuA/BABCDE chaperone–usher pili 
assembly system. The present study focused on the involvement of CsuA/BABCDE-
dependent pili in the interactions between A. baumannii 19606
T
 and human bronchial 
epithelial cells and sheep erythrocytes. Light microscopy analysis revealed that CsuE-
mutant #144 adhered to more bronchial epithelial cells than the parental strain. Similar 
amounts of interleukin (IL)-6 and IL-8 were produced by bronchial epithelial cells in 
response to these two bacterial strains. Scanning electron microscopy revealed the 
presence of two types of surface extensions on ATCC19606
T
, i.e., short (29 nm; 5–140 nm) 
pili and long (260 nm; 143–1008 nm) extensions. The latter were not observed on the 
CsuE-mutant and therefore are likely the previously described CsuA/BABCDE-encoded 
extensions. We conclude that CsuA/BABCDE-dependent pili are not involved in adherence 
of A. baumannii ATCC19606
T
 to bronchial epithelial cells. The structure of the short pili 












During the last decades, Acinetobacter baumannii has emerged globally as an important 
nosocomial pathogen that gives rise to outbreaks of colonization and infection of critically 
ill, hospitalized patients [3], [6], [12] and [16]. The strains involved are frequently 
multidrug-resistant (MDR) and have the ability to spread epidemically among patients and 
survive in the hospital environment [25]. The recent appearance of carbapenem resistance 
in these strains is a major source of concern [17]. 
Despite the widely documented problems regarding nosocomial A. baumannii 
infections, little is known about the mechanisms that contribute to the epidemicity and 
pathogenicity of this species. It is generally thought that the intimate interaction between 
bacteria and their host begins with the adherence of the microorganism to host tissues 
followed by colonization of the host [2]. During colonization, bacteria may form 
microcolonies and produce exopolysaccharides resulting in a highly structured microbial 
community called biofilm [5]. Bacteria within a biofilm exhibit increased resistance to 
antimicrobial compounds, including those elicited by the host's immune response [5]. The 
progression from colonization to infection of the host depends on the balance between 
the host's immune response and the virulence of the bacterium. 
Several in vitro studies have shown that particular strains of A. baumannii can 
adhere to human cells [13] and form biofilms on abiotic surfaces [18], [22], [26] and [27]. 
Tomaras et al. have demonstrated that the ability of A. baumannii strain ATCC19606
T
 to 
form pili, adhere to and form biofilms on abiotic surfaces depends on the expression of 
csuE, which is part of the CsuA/BABCDE chaperone–usher pili assembly system [22]. Pili 
may not only promote adherence and biofilm formation, but the coupling of pili to host 
cell receptors may also induce inflammation through the production of inflammatory 
mediators, including chemokines and cytokines [21]. 
The aim of the present study was to investigate the involvement of A. baumannii 
CsuA/BABCDE-mediated pili in adherence to vertebrate cells and the inflammatory 
response of human bronchial epithelial cells. 
 
 
Materials and Methods 
 
Bacterial strains and culture conditions 
A. baumannii type strain ATCC19606
T
 and the csuE isogenic insertion mutant ATCC19606 
#144 [22] were used. High-resolution fingerprinting by AFLP analysis confirmed that both 
isolates belong to the same strain (similarity of 99.4% as calculated by the Pearson 
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correlation coefficient). Upon verification, CsuE-mutant #144 did not form a biofilm on 
polystyrene after 24 h incubation at 28°C and 37°C. Of note, biofilm formation on abiotic 
surfaces was tested as described before [22]. 
Bacteria were preserved for prolonged periods in nutrient broth supplemented 
with 20% (v/v) glycerol at −80°C. Prior to each experiment, inocula from frozen cultures 
were grown overnight at 30°C on sheep blood agar plates (BioMerieux, Boxtel, The 
Netherlands) or trypticase soy agar (BD, Sparks, MD, USA) containing 5% sheep 
erythrocytes. For experiments, subcultures were made under these conditions. 
 
Bronchial epithelial cell culture 
Human bronchial epithelial H292 cells (ATCC CRL-1848, Mansas, VA, USA) were cultured as 
described previously [13]. Briefly, H292 cells were cultured in RPMI-1640 medium 
supplemented with 2 mM L-glutamine, 50 μg/ml streptomycin, 1 mg/ml sodium penicillin 
G, and 10% heat-inactivated fetal calf serum (FCS) (all from Gibco, Invitrogen, Breda, The 
Netherlands), further referred to as culture medium, at 37°C/5% CO2 in 25 cm
2
 tissue 
culture flasks (Greiner Bio-One, Frickenhausen, Germany). At confluency, cells were 
trypsinized and 2x10
5
 H292 cells were resuspended in 0.5 ml of RPMI-1640 supplemented 
with 2 mM l-glutamine and 10% FCS, further referred to as RPMI medium, in 24-wells 
plates. 
 
Bacterial adherence to bronchial epithelial cells 
The adherence of bacteria to human bronchial epithelial cells was determined as 
described [13]. Briefly, 2x10
5
 H292 cells were cultured for 24 h in RPMI medium on 13-mm 
diameter plastic coverslips (Thermanox, Nunc, Rochester, NY, USA) placed in 24-well 
plates. Bacteria were cultured overnight at 30°C on blood agar plates and suspended in 
RPMI medium to an optical density at 600 nm of 0.6 (SmartSpec 3000, BioRad), 
corresponding to a concentration of ~1x10
8
 colony forming units (CFU)/ml, which was 







) bacteria. Next, each coverslip was removed and washed 
five times with prewarmed PBS. The cells on the coverslip were fixed with methanol and 
stained with Giemsa, after which the coverslips were mounted onto microscope slides. 
Bacterial adherence was quantitated by light microscopy examination. For each coverslip, 
a minimum of 800 H292 cells were inspected and the percentage of epithelial cells 
associated with at least one bacterium was determined. In addition, 100 H292 cells with 
attached bacteria were analyzed to assess the number of bacteria associated with human 
bronchial epithelial cells. Each bacterial strain was examined in duplicate in four 










Stimulation of bronchial epithelial cells 
Cytokine production in bronchial epithelial cells in response to the presence of bacteria 
was determined using a stimulation assay. Bacteria were cultured overnight at 30°C in 
Luria–Bertani (LB) medium (10 g bactotryptone, 5 g yeast extract (both from BD, Sparks, 
MD, USA), 5 g sodium chloride (Merck, Darmstadt, Germany) in 1000 ml distilled water), 
washed twice with PBS and suspended in RPMI medium to a concentration of 1x10
8
 
CFU/ml as calculated from the absorbance of a suspension at 600 nm. Approximately 
2x10
5
 H292 cells were cultured in 0.5 ml of RPMI medium in 24-well plates. At 85–90% 
confluency, H292 cells were washed once with prewarmed PBS and incubated at 37°C/5% 
CO2 with 1x10
7
 bacteria. After 1 h, H292 cells were washed five times with prewarmed PBS 
to remove non-adherent bacteria and incubated again in fresh RPMI medium. After 23 h 
incubation at 37°C, supernatants were collected and stored at −20°C, unkl determinakon 
of the levels of the inflammatory mediators interleukin (IL)-6 and IL-8 by ELISA. In each 
experiment, RPMI medium alone was added to the cells in order to obtain background 
values. Five independent experiments were performed in triplicate. 
 
Determination of inflammatory mediators 
The levels of IL-6 and IL-8 in culture supernatants were determined by enzyme-linked 
immunosorbent assays (ELISA, Biosource, Camarillo, CA, USA) according to the 
manufacturer's instructions. The lower limit of detection was 15 pg/ml for IL-6 and 7 
pg/ml for IL-8. 
 
Scanning electron microscopy 
For scanning electron microscopy (SEM), bacteria from an overnight culture on blood agar 
were suspended in PBS and subsequently fixed for 1 h at room temperature with 1.5% 
glutaraldehyde in 0.1 M sodium cacodylate buffer (1:1). Fixed bacteria were washed twice 
in PBS and transferred to poly-l-lysine-coated glass slides. After 1 h incubation at room 
temperature, bacteria were fixed to the slides with 1.5% glutaraldehyde for 30 min at 
room temperature. Thereafter, slides were washed twice in PBS, dehydrated through a 
series of graded ethanol, critical-point-dried, and finally coated with a layer of palladium-
gold. The bacteria were examined using either a JEOL JSM-6700F or a Zeiss Supra 35VP 
field emission scanning electron microscope. 
 
Detection of CsuA/B protein 
For detection of the CsuA/B protein, bacteria from an overnight culture on blood agar 
were used to prepare whole-cell lysates as described before [7]. Proteins were size-
fractionated on 12.5% polyacrylamide gels [1], transferred to nitrocellulose [24], and 
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incubated with polyclonal anti-CsuA/B antiserum raised in rabbits using recombinant 
CsuA/B (overexpressed and purified by Ni-affinity column chromatography) as antigen 
[23]. The immunocomplexes were detected by chemiluminescence using horse radish 
peroxidase (HRP)-labeled protein A. Protein concentrations were determined as described 
previously [4]. 
 
Detection of acuA gene 
The presence of the acuA gene, a pilus-encoding gene identified in another Acinetobacter 
species, A. baylyi, was determined using a PCR that amplified part of the acuA gene (289 
bp of 582 bp). Total DNA was extracted from bacteria grown overnight on Iso-Sensitest 
plates (Oxoid Ltd, Basingstoke, Hampshire, UK) at 30°C. Five bacterial colonies were 
suspended in 20 μl of lysis buffer (0.25% sodium dodecyl sulfate (SDS), 0.05 N NaOH). The 
suspension was heated for 15 min at 95°C. After addition of 180 μl of sterile H2O and 
centrifugation, supernatants were used for PCR experiments. Amplification reactions were 
carried out in a total volume of 25 μl containing 5 μl of total DNA, 25 pmol of each primer 
and 3 U of Taq DNA polymerase (Qiagen, Hilden, Germany). Primers for amplification of 
the acuA gene were acuAforward (5′-CAA CGC TAT GTG CTG CTG G-3′, located at position 32–
50 of the acuA gene) and acuAreverse (5′-GGC CCA CCC AAA GTA ATC C-3′, located at 
position 320–302 of the acuA gene). Amplification conditions consisted of an initial cycle 
at 94°C for 1 min followed by 35 cycles of 30 s at 94°C, 40 s at 48°C, 1 min at 72°C, and a 
final cycle at 72°C for 6 min. PCR products were visualized by electrophoresis and staining 
with ethidium bromide on 1.5% agarose gels. 
 
Statistical analysis 
Results are means ± standard deviations unless indicated otherwise. Data were analyzed 






Adhesion to human bronchial epithelial cells and sheep erythrocytes 
To investigate whether CsuE-mediated pili are involved in the initial colonization process, 
adherence of A. baumannii 19606
T
 and its isogenic CsuE-mutant #144 to human bronchial 
epithelial cells was compared in vitro. Light microscopy analysis of Giemsa-stained cells 
showed that the CsuE-mutant adhered to a significantly (p < 0.05) higher percentage of 
epithelial cells (29 ± 6.8%) than strain 19606
T










infected cell was not significantly higher for the mutant (1.9±0.2 bacteria/infected cell) 
than for the parental strain (1.4±0.1 bacteria/infected cell). Of note, the monolayers and 
morphology of the bronchial epithelial cells remained intact after 1 h incubation with 
either of the two A. baumannii strains. Differences in inoculum size between experiments 
did not influence the outcome of the adherence assays (data not shown). 
SEM analysis revealed that strain 19606
T
 and the CsuE-mutant were able to 
adhere to sheep erythrocytes (Fig. 1), showing that both strains can attach to at least two 




Figure 1. Scanning electron micrographs of A. baumannii strain 19606
T
 (A) and its CsuE-mutant (B) in 
the presence of sheep erythrocytes. Bars: 1 μm. 
 
 
Cytokine induction in human bronchial epithelial cells 
To investigate whether CsuA/BABCDE-mediated pili contribute to the ability of A. 
baumannii to induce cytokine production by human cells, bronchial epithelial H292 cells 
were exposed to strain 19606
T
 and its CsuE-mutant in vitro and the levels of IL-6 and IL-8 
in the culture supernatant were determined after 24 h. The results revealed that bronchial 
epithelial cells co-incubated with strain 19606
T
 or its CsuE-mutant produced significantly 
(p<0.05) higher levels of the cytokine IL-6 (875±398 pg/ml and 823±441 pg/ml, 
respectively) and the chemokine IL-8 (1751±608 pg/ml and 1930±705 pg/ml, respectively) 
than unstimulated cells (274±159 pg/ml IL-6 and 428±105 pg/ml IL-8). However, there was 
no significant difference between the ability of strain 19606
T
 and the mutant to elicit IL-6 
and IL-8 production by bronchial epithelial cells. 
 
Electron microscopy analysis of bacterial surface structures 
SEM analysis of bacteria cultured for 16 h at 30°C on blood agar plates revealed the 
existence of two types of cell appendages in strain 19606
T
: thin and short (median 29 nm; 
range 5–140 nm, n = 20 bacteria) pili-like structures and long cell extensions (Fig. 2A,B). 
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The latter (median 260 nm, n = 20 bacteria) varied in length from 143 nm to 1008 nm and 
were irregularly distributed over the cell surface. The CsuE-mutant, which was grown 
under similar conditions, lacked the long cell extensions and had a more dense 
distribution of the short pili at its surface than strain 19606
T
 (Fig. 2D). Of note, short pili 
could not be observed on all mutant cells. The CsuE-mutant adhered poorly to the poly-l-
lysine-coated glass slides used for SEM and bacteria of this strain were mainly found 
adhering to debris on the glass slide. Interestingly, the short pili were seen mainly at the 
interface between the bacterial surface and the debris, suggestive of their involvement in 
adherence. Furthermore, the mutant strain showed, in contrast to the parental strain, 
only a few cell clusters with no more than two cells grouped together on the surface of 




Figure 2. Scanning electron micrographs of A. baumannii 19606
T
 (A and B) and CsuE-mutant (C and D) 
cells suspended from blood agar plates. Black arrows indicate long cell extensions; white arrows 
indicate thin and short pili. Bars: 1 μm (A and C) and 100 nm (B and D). 
 
 
Detection of CsuA/B protein 
Since secretion of CsuE, which is the tip adhesion on the pilus, is thought to precede the 
secretion of the CsuA/B subunit for pilus biogenesis [20], we reasoned that bacteria 










feedback inhibition or degradation of CsuA/B. We assessed the production of CsuA/B by A. 
baumannii 19606
T
 and its CsuE-mutant by immunoblot analysis of whole lysates with anti-
CsuA/B serum. The results demonstrated that the 18-kDa CsuA/B protein is expressed by 
the parental strain 19606
T
. In contrast, the isogenic CsuE-mutant did not express 
detectable levels of CsuA/B protein (Fig. 3), indicating that the pili produced by the CsuE-






Figure 3. Detection of the CsuA/B protein in A. baumannii 19606
T
 (lane 1) and the CsuE-mutant (lane 
2). M, molecular weight markers. 
 
 
Detection of acuA gene 
A. baylyi strain ADP1 expresses a chaperone usher system, named Acu, which is required 
for formation of thin pili in this environmental isolate [8]. To determine whether this 
system might be involved in formation of CsuA/BABCDE-independent short pili in A. 
baumannii, the presence of acuA, which encodes the structural subunit of thin pili in A. 
baylyi [8], was determined using PCR. Although not shown, this approach showed that a 
289-bp acuA amplicon could be produced when total DNA from A. baylyi strain ADP1 was 
used as a template. In contrast, no amplicon was produced when total DNA from A. 
baumannii strain 19606
T
 and the CsuE-mutant were used as a template. These 
observations suggest that the short pili produced by the parental strain 19606
T
 and the 





In this study, we demonstrated that production of the CsuA/BABCDE-mediated pilus, 
which is essential for biofilm formation on abiotic surfaces [22], is not required for the 
adherence of A. baumannii ATCC19606
T
 to H292 cells and induction of inflammatory 
cytokine production by these bronchial epithelial cells. Interestingly, in addition to the 
CsuA/BABCDE-mediated pili, strain 19606
T
 was found to produce CsuA/BABCDE-
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independent short pili, which to our knowledge have not been reported before in A. 
baumannii. 
Our conclusion is based on the following findings. First, light and scanning 
electron microscopy showed that A. baumannii type strain 19606
T
 and its isogenic CsuE-
mutant adhered to human bronchial epithelial cells and sheep erythrocytes in vitro, 
indicating that CsuA/BABCDE-mediated pili are not essential for adherence to vertebrate 
cells. The finding that the CsuE-mutant strain adhered to a significantly larger number of 
epithelial cells than the parental strain might be attributed to increased expression of 
another type of pilus on the surface of the latter strain, as has been described for 
Escherichia coli [15]. Secondly, we found that A. baumannii type strain 19606
T
 and its 
CsuE-mutant induced similar levels of inflammatory cytokines IL-6 and IL-8 in bronchial 
epithelial cells, suggesting that CsuA/BABCDE-mediated pili are not involved in induction 
of inflammatory responses in human bronchial epithelial cells interacting with this 
bacterial pathogen. 
The presence of pili on the surface of Acinetobacter strains was first described by 
Henrichsen and Blom in 1975 in A. baylyi BD4 (formerly A. calcoaceticus BD4) [9]. This 
strain was found to produce bundle-forming thin pili (2–3 nm in diameter) associated with 
adherence to abiotic and biotic surfaces [8] and individual thick pili (6 nm in diameter) 
involved in twitching motility [9], i.e., the ability to move on solid surfaces [14] enabling 
colonization of adjacent surface areas. The involvement of thin pili in adherence to abiotic 
surfaces was also demonstrated for A. venetianus strain RAG-1 [19]. Recently, Ishii et al. 
described two types of appendages in the highly adhesive Acinetobacter sp. strain Tol 5, 
an anchor-like appendage that tethers the bacterium to the substratum over distances of 
several hundreds of nanometers, and a peritrichate fibril-type appendage that attaches to 
the substratum at multiple places fixing the cell at shorter distances [10]. We have 
extended these findings by describing the existence of two types of cell appendages in the 
A. baumannii type strain 19606
T
: (i) irregular long cell extensions connecting bacteria that 
are assumed to represent the CsuA/BABCDE-mediated pili described by Tomaras et al. [22] 
and; (ii) thin and short pili-like structures that contact the surface areas adjacent to 
bacterial cells. The latter pili were not observed by Tomaras et al. [22], possibly because of 
the use of different experimental conditions and techniques, i.e., Luria–Bertani media and 
transmission electron microscopy versus blood agar and scanning electron microscopy, 
which were used to culture bacteria and visualize surface structures, respectively. 
Interestingly, the short pili were mainly seen at the site where the bacterium adhered to a 
surface area. Lee et al. [13] also described the presence of thin pili-like extensions on the 
surface of an A. baumannii strain that anchored the bacterium to the membrane surface 










whether the presence of a particular surface area triggers the production of short pili by A. 
baumannii, as has been described for Acinetobacter sp. strain Tol 5 [11]. 
It should be noted that although no PCR product could be amplified, acuA, which 
encodes pili in A. baylyi that are related to F17 pili of Escherichia coli [8], still could be 
present in A. baumannii 19606
T
. This is supported by the finding that a genome search of 
the A. baumannii AB307-0294 genome using acuA from A. baylyi leads to detection of 
genes encoding subunits of F17-related pili. 
In summary, in addition to the already described CsuA/BABCDE-mediated pilus 
that plays a role in biofilm formation on abiotic surfaces, A. baumannii ATCC19606
T
 
produces a CsuA/BABCDE-independent thin and short pilus, which may be involved in 
adherence of the bacterium to biotic surfaces such as those of human respiratory cells. 
Further genetic, structural and physiological studies are necessary to elucidate the role of 
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Despite many reports documenting its epidemicity, little is known on the interaction of 
Acinetobacter baumannii with its host. To deepen our insight into this relationship, we 
studied persistence of and host response to different A. baumannii strains including 
representatives of the European (EU) clones I-III in a mouse pneumonia model. 
Neutropenic mice were inoculated intratracheally with five A. baumannii strains and an A. 
junii strain and at several days morbidity, mortality, bacterial counts, airway inflammation, 
and chemo- and cytokine production in lungs and blood were determined. A. baumannii 
RUH875 and RUH134 (EU clone I and II, respectively) and sporadic strain LUH8326 resulted 
in high morbidity/mortality, whereas A. baumannii LUH5875 (EU clone III, which is less 
widespread than clone I and II) caused less symptoms. A. baumannii type strain RUH3023
T
 
and A. junii LUH5851 did not cause disease. All strains, except A. baumannii RUH3023
T
 and 
A. junii LUH5851, survived and multiplied in the lungs for several days. Morbidity and 
mortality were associated with the severity of lung pathology and a specific immune 
response characterized by low levels of anti-inflammatory (IL-10) and specific pro-
inflammatory (IL-12p40 and IL-23) cytokines at the first day of infection. Altogether, a 
striking difference in behavior among the A. baumannii strains was observed with the 
clone I and II strains being most virulent, whereas the A. baumannii type strain, which is 













Multidrug-resistant Acinetobacter baumannii is a cause of severe infections in critically ill 
patients and notorious for its ability to spread epidemically. Three clonal lineages of A. 
baumannii, European (EU) clone I, II and III, are implicated in outbreaks worldwide [1,2]. 
Other Acinetobacter species, including the skin colonizer A. junii [3], are only incidentally 
involved in infection [4].  
 Various factors are assumed to contribute to the ability of A. baumannii to 
colonize the hospital environment and patients [5–11]. However, knowledge on the host’s 
response to A. baumannii is limited. Recognition by Toll-like receptor 4 and CD14 [12] and 
early recruitment of neutrophils [13,14] are important factors in the host innate defence 
against respiratory A. baumannii infection in mice. Others demonstrated the differential 
ability of clinical A. baumannii isolates to induce severe infections in neutropenic mice 
[15]. We previously showed in vitro that A. baumannii strains induce significantly less 
inflammatory cytokine production in human airway epithelial cells and cultured human 
macrophages than A. junii strains do [5], emphasizing the role of the innate immune 
system in A. baumannii infections.  
The aim of the present study was to investigate the virulence of and host innate 
immune response to well-characterized A. baumannii strains, including representatives of 
clones I-III, and an A. junii strain in a mouse pneumonia model.  
 
 
Materials and Methods 
 
Bacteria 





) and a sporadic isolate (LUH8326), and one A. junii strain were 
investigated (Table 1). Bacteria were preserved in glycerolbroth at -80°C. Prior to 
experiments, strains were rendered virulent by a single passage in mice.  
 
Animals  
Specific pathogen-free female C3H/HeN mice weighing 18-20 g were housed fifteen per 
cage and had ad libitum access to chow and water throughout the experiments. Animal 
studies were approved by the Animal Experimental Committee of the Angers University 
Hospital (permit C49007002) and complied with relevant laws related to the conduct of 
animal experiments. 
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Table 1. Strain characteristics 
Year Specimen EU Clone* Outbreak† MDR‡
RUH875 Dordrecht (NL) 1984 urine I + +
RUH134 Rotterdam (NL) 1982 urine II + +
LUH5875 Utrecht (NL) 1997 blood III + +
LUH8326 Leiden (NL) 2002 wound  - -  -
RUH3023T Atlanta (USA) 1965 urine - -  -
(ATCC19606T)





*Strain belonging to European clones I-III (+) or not belonging to these clones (-). All 
isolates have been identified to species by one or more genotypic methods [1,33,34]. 
†Outbreak-associated (+) strain (i.e., common AFLP profile in >2 patients and with same 
time-space-origin) or (-) sporadic strain. ‡Mulkdrug-resistant (+) strain (i.e., resistant to 
more than two of the following drug classes or combinations: cephalosporins, 




The survival of Acinetobacter strains after intratracheal infection of mice was assessed 
according to Eveillard et al [15]. To favour the onset of infection, mice were rendered 
transiently neutropenic by intraperitoneal injection with 150 mg of cyclophosphamide per 
kg of body weight (in 100 μl of saline) at days 4 and 3 prior to infection. Bacteria from an 
overnight culture on blood agar were suspended into saline to an optical density of 0.5 
McFarland, corresponding to a concentration of approximately 10
8
 colony forming units 
(CFU)/ml. Mice were anesthesized by isoflurane in conjunction with oxygen and 50 μl of 
the bacterial suspension were injected intratracheally via a cannula. Immediately after 
inoculation, two animals were sacrificed, lungs were homogenized and vital count was 




 CFU/g lung tissue). At 
1, 2, 3 and 4 days after infection, if possible 8 mice per strain were anesthesized and blood 
was collected by intracardiac puncture, after which mice were sacrificed by cervical 
dislocation. Serum was obtained by centrifugation of blood samples and stored at -80°C 
for cytokine analysis. Spleens and part of the lungs were removed, weighed and 
homogenized in 3 ml of phosphate buffered saline (pH 7.4) using the GentleMACS 
Dissociator (Miltenyi Biotec, Germany). Vital counts in blood, lung and spleen 
homogenates were performed to assess the number of viable bacteria (lowest limit of 
detection: 20 CFU/ml). Lung homogenates were stored at -80°C for cytokine analysis. 
 A semi-quantitative analysis of mice morbidity was performed using a clinical 
score ranging from 0 for no clinical symptoms to 4 for maximal symptoms based on the 
following criteria: mice mobility (0, spontaneous; 1, only after stimulation; 2, absent), the 










normal; 1 ruffled). Mortality was assessed daily and analyzed by Kaplan-Meier survival 
curve. 
 
Histological analysis of lung inflammation 
Lungs of mice at day 1-4 after inoculation were analyzed by histological examination as 
described [15]. A semi-quantitative analysis of the lung tissue damage was performed by 
grading five random 20x fields of hematoxylin/eosin-stained sections according to the 
following criteria: alveolar wall destruction [absent (0); <25% (1),  25-75% (2), >75% (3) of 
alveoli destructed], infiltration by leukocytes [absent (0); <20 (1), 20-50 (2), >50 (3) per 
field] and hemorrhage [absent (0); mild (1); moderate (2); severe(3)]. The sum of scores 
represents the lung pathology score ranging from 0 for no pathology to 9 for severe 
pathology. 
 
Determination of inflammatory mediators 
Levels of interleukin (IL)-1β, IL-6, IL-10, IL-12p40, IL-13, IL-23, keratinocyte-derived 
chemokine (KC), macrophage inflammatory protein (MIP)-1α, MIP-2, regulated upon 
activation, normal T cell expressed and secreted (RANTES) and tumor necrosis factor 
(TNF)α in serum and lung homogenates were determined using multiplexing xMAP 
technology (Luminex Corporation Austin, USA). Multiplex kits were from Millipore 
(Millipore Corporation, USA).  
 
Statistical analysis 
Data were analyzed using the Kruskal-Wallis one-way analysis of variance and Wilcoxon 
rank sum test (SPSS 17.0). Mortality data were analyzed by Cox-regression. Spearman rank 
correlation coefficients were calculated to evaluate associations between parameters. P ≤ 





Morbidity and mortality 
Mice infected with the different A. baumannii strains and the A. junii strain (Table 1) were 
monitored daily for morbidity and mortality. Mice infected with A. baumannii RUH3023
T
 
or A. junii LUH5851 showed virtually no signs of morbidity (Table 2). In contrast, infection 
with A. baumannii clone I (RUH875) and clone II (RUH134) caused high morbidity already 
at the first day of infection, which remained high during the second day.  
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Table 2. Morbidity and lung pathology associated with Acinetobacter respiratory infection 
A. junii
2.7 ± 1.0 2.9 ± 0.9 1.9 ± 1.2 2.3 ± 0.9 0.0 ± 0.2 0.0 ± 0.2
3.2 ± 0.6 2.7 ± 1.2 2.2 ± 1.2 3.3 ± 0.5 0 0.1 ± 0.2
NA NA 1.9 ± 1.3 1.5 ± 1.7 0 0
NA NA 0.2 ± 0.4 NA 0 0
8.2 ± 0.7 8.0 ± 0.9 6.8 ± 0.5 7.2 ± 0.0 2.1 ± 0.9 3.6 ± 1.1
8.0 ± 0.9 8.3 ± 0.8 6.9 ± 1.5 7.1 ± 0.3 2.1 ± 0.6 3.0 ± 1.2
NA NA 7.3 ± 0.6 7.5 ± 1.2 2.2 ± 0.2 2.7 ± 0.6













     Day 2
     Day 3
     Day 4
Lung pathology score†
     Day 1
     Day 2
     Day 3
     Day 4
 
*Morbidity was recorded daily using a clinical score, which includes mobility, the development of 
conjunctivitis, and aspects of the hair and ranges from 0 for no clinical symptoms to 4 for maximal 
symptoms. †Sections of lungs of mice were stained with haematoxylin & eosin and lung tissue 
damage was assessed using the lung pathology score, which includes alveolar wall destruction, 
leukocyte infiltration and hemorrhage and ranges from 0 for no pathology to 9 for severe 
pathology. Values are means ± standard deviations for 8 mice except for LUH8326 at day 3, where 
n=4. Values are representative for surviving mice only. NA, not assessable, due to the high 
mortality associated with these strains. 
 
Infection with clone III (LUH5875) and sporadic isolate LUH8326 was accompanied by 
significantly (p<0.01) less morbidity at the first day of infection. For LUH8326, morbidity 
increased during the second day of infection but for LUH5875 it remained low (Table 2). 
Mice infected with RUH3023
T
 or A. junii LUH5851 did not die, whereas mortality 
was very high among mice infected with LUH8326, RUH875, and RUH134 (52%, 72% and 
86%, respectively, Fig. 1). Less animals (28%) died after infection with LUH5875 (p<0.05, 
Fig. 1). Most animals died within the first 2 days of infection with RUH875, RUH134 and 
LUH8326 and between days 3-4 of infection with LUH5875. Of note, the results described 
in the next paragraphs are representative for the surviving mice only.  
 
Persistence of Acinetobacter strains in lungs and extrapulmonary dissemination 
After 24 h of infection, RUH875, RUH134, LUH5875 and LUH8326 had multiplied in the 
lungs to approximately 1x10
9
 CFU/g of lung (Fig. 2A). These strains persisted in the lungs 
up to day 3-4 of infection (Fig. 2A). In contrast, RUH3023
T
 was cleared from the lungs 
already within the first day of infection. The levels of A. junii LUH5851 remained stable 
during the first day of infection, declined sharply thereafter with complete clearance by 
day 3.   
RUH875, RUH134, LUH5875, LUH8326 and A. junii LUH5851 were found in blood 
and spleen after the first day of infection (Fig. 2B, C). The bacterial load in the spleen after 











Figure 1. Survival associated with Acinetobacter respiratory infection. Survival of mice after 
intratracheal infection with A. baumannii clone I strain RUH875, clone II strain RUH134, clone III 
strain LUH5875, sporadic strain LUH8326 and type strain RUH3023
T
, and A. junii strain LUH5851. 
Results are expressed as percentage survival at days 1-4 of infeckon. †, all mice dead/sacrificed.  
 
 
A. junii LUH5851 disseminated into the blood and spleen to a significantly (p<0.05) lower 
extent than RUH875, RUH134, LUH5875 and LUH8326. For these A. baumannii strains, 
levels in blood and spleen remained stable up to day 3-4, whereas A. junii LUH5851 was 
cleared completely from blood and spleen already at day 2 of infection. A. baumannii 
RUH3023
T




Figure 2. Persistence of Acinetobacter strains in the lungs and extrapulmonary dissemination. Levels 
of A. baumannii clone I strain RUH875 (black circles), clone II strain RUH134 (black downward 
triangles), clone III strain LUH5875 (black squares), sporadic strain LUH8326 (black upward triangles) 
and type strain RUH3023
T
 (black crosses), and A. junii strain LUH5851 (gray circles) in the lungs (A), 
bloodstream (B) and spleen (C) of mice at 1 to 4 days after intratracheal injection. Results are 
expressed as mean CFU per g of tissue (for lung and spleen) or CFU per ml (for blood) ± standard 
errors of the mean of 8 mice except for LUH8326 at 3 days after infection, where n=4. Values are 
representative for surviving mice only. Dotted lines represent the lowest limit of detection. 
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Overall, bacterial counts in lungs correlated (p<0.01) to those in the bloodstream (r=0.85) 
and spleen (r=0.85). Furthermore, morbidity and mortality were associated (p<0.01) with 
bacterial counts in the lungs (r=0.77 and r=0.62, respectively), bloodstream (r=0.86 and 
r=0.75, respectively) and spleen (r=0.85 and r=0.82, respectively). 
 
Lung pathology 
Histologic examination of the lungs of mice at the first day of infection with RUH875, 
RUH134, LUH5875 and LUH8326 revealed hypercellularity due to increased numbers of 
lymphocytes, monocytes and macrophages, and thickened alveolar walls (Fig. 3, Table 2). 
The lungs of mice infected with these strains were highly consolidated and many areas 
had hemorrhagic lesions. The severity of tissue damage remained stable over time for all 
strains (Table 2). Alveolar wall destruction was more severe after the first day of infection 
with RUH875 and RUH134 than with LUH5875 and after the second day of infection with 
RUH875 and RUH134 than with LUH8326. Infection with RUH3023
T
 and A. junii LUH5851 
resulted in significantly (p<0.05) less lung damage (Table 2).  
 Overall, severity of tissue damage was correlated (p<0.001) to bacterial levels in 




Figure 3. Light micrographs of lungs of mice infected with Acinetobacter. Sections of the lungs of 
mice at 1 day after infection with A. baumannii clone I strain RUH875, clone II strains RUH134, clone 
III strain LUH5875, sporadic strain LUH8326, type strain RUH3023
T
 or A. junii strain LUH5851, stained 












Inflammatory response to Acinetobacter 
After the first day of infection with A. baumannii strains RUH875, RUH134, LUH5875 and 
LUH8326, levels of all chemo- and cytokines in the lungs were substantially elevated 
(p<0.05) as compared to basal levels. The levels of the chemokines KC, MIP-1α, MIP-2, and 
the pro-inflammatory cytokines IL-1β, IL-6 and TNFα further increased and peaked at day 
2 of infection (Table 3). 
 
Table 3. Inflammatory response in lungs of mice infected with four virulent A. baumannii strains 
Chemokines Day 
KC† 1 386 (38 - 700) * 311 (198 - 474) * 377 (4 - 555) * 310 (28 - 493) *
basal: 17 (3 - 57) 2 326 (150 - 749) * 236 (16 - 306) * 186 (25 - 540) * 204 (7 - 1753) *
3 NA NA 52 (8 - 224) 45 (32 - 422)
4 NA NA 41 (4 - 45) NA
MIP-1α† 1 142 (1 - 404) 114 (13 - 287) * 112 (13 - 217) * 147 (6 - 201) *
basal: 2 (1 - 5) 2 589 (118 - 888) * 319 (5 - 1076) * 760 (3 - 909) * 196 (2 - 765) *
3 NA NA 78 (12 - 654) * 124 (90 - 596) *
4 NA NA 114 (5 - 191) * NA
MIP-2† 1 171 (4 - 246) * 145 (71 - 372) * 119 (3 - 257) * 137 (6 - 220) *
basal: 5 (1 - 45) 2 400 (200 - 755) * 342 (4 - 591) * 365 (6 - 546) * 312 (3 - 406) *
3 NA NA 79 (4 - 253) * 109 (86 - 219) *
4 NA NA 97 (3 - 202) * NA
RANTES†† 1 1753 (975 - 5282) * 1682 (893 - 2708) * 2124 (1406 - 2452) * 1885 (996 - 3340) *
basal: 236 (221 - 501) 2 1229 (794 - 1760) * 1278 (671 - 1773) * 1559 (1475 - 1627) * 1000 (812 - 1381) *
3 NA NA 930 (691 - 1010) * 958 (665 - 2027) *
4 NA NA 834 (646 - 850) * NA
IL-1β† 1 20 (5 - 60) * 19 (7 - 66) * 18 (5 - 31) * 30 (5 - 48) *
basal: 1 (1 - 2) 2 51 (13 - 264) * 33 (3 - 135) * 69 (6 - 268) * 24 (2 - 81) *
3 NA NA 19 (3 - 84) * 28 (12 - 75) *
4 NA NA 14 (4 - 20) * NA
IL-6† 1 133 (3 - 217) * 67 (19 - 280) * 85 (2 - 181) * 119 (1 - 174) *
basal: 3 (2 - 11) 2 127 (43 - 670) * 76 (4 - 395) * 98 (0.4 - 376) * 72 (1 - 151) *
3 NA NA 10 (1 - 217) 6 (3 - 266)
4 NA NA 9 (1 - 14) NA
IL-12p40†† 1 1901 (1202 - 3091) * 2249 (743 - 4130) * 2824 (1818 - 5251) * 3698 (1900 - 5365) *
basal: 203 (163 - 237) 2 1730 (377 - 2380) * 1513 (976 - 2644) * 1991 (1093 - 3005) * 1031 (834 - 1282) *
3 NA NA 669 (381 - 1853) * 760 (415 - 2210) *
4 NA NA 319 (116 - 494) NA
IL-23† 1 99 (58 - 113) * 82 (48 - 122) * 150 (104 - 175) * 113 (98 - 150) *
basal: 11 (6 - 17) 2 73 (33 - 227) * 86 (59 - 108) * 79 (46 - 112) * 63 (36 - 89) *
3 NA NA 43 (19 - 135) * 59 (23 - 169) *
4 NA NA 26 (6 - 61) NA
TNFα† 1 10 (0.1 - 17) 8 (1 - 22) * 11 (1 - 30) * 12 (0.4 - 17) *
basal: 0.4 (0.2 - 5) 2 15 (3 - 28) * 11 (0.4 - 32) * 15 (1 - 32) * 6 (0.4 - 21) *
3 NA NA 2 (0.3 - 35) 2 (2 - 23)
4 NA NA 4 (1 - 9) NA
IL-10†† 1 824 (416 - 2126) * 991 (578 - 1724) * 2445 (1834 - 4053) * 2168 (1348 - 3753) *
basal: 273 (157 - 355) 2 792 (389 - 4168) * 1346 (568 - 1923) * 2016 (844 - 2741) * 876 (541 - 1837) *
3 NA NA 2923 (862 - 1234) * 1903 (862 - 3330) *
4 NA NA 3740 (1154 - 4051) * NA
IL-13†† 1 976 (678 - 2073) * 1481 (567 - 3274) * 2739 (571 - 3691) * 1628 (531 - 3958) *
basal: 215 (173 - 251) 2 1456 (565 - 4134) * 792 (275 - 1145) * 1368 (282 - 1765) * 527 (244 - 959) *
3 NA NA 262 (207 - 490) 327 (194 - 592)












Mice were intratracheally infected with A. baumannii RUH875, RUH134, LUH5875 or LUH8326 for 1-4 
days. Levels of inflammatory mediators were determined in the lung homogenates of mice directly after 
instillation (basal values), and 1-4 days after instillation. Results are medians and ranges for 8 mice, 
except for LUH8326 at 3 days after infection, where n=4. Values are representative for surviving mice 
only. NA, not assessable, due to the high mortality associated with these strains. *, significantly (p<0.05) 
different from basal level. †, results in ng/g of lung tissue; ††, results in pg/g of lung tissue. 
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The kinetics of production of the anti-inflammatory IL-10 differed significantly in animals 
infected with the four strains with a peak at day 1 in animals infected with LUH8326, at 
day 2 after infection with RUH134 and at day 3 after infection with LUH5875. At the first 
day of infection, levels of IL-10 in lungs were significantly (p<0.05) lower in mice infected 
with RUH875 and RUH134 as compared to infection with LUH5875 and LUH8326. IL-10 
levels remained lower after the second day of infection with RUH875 and RUH134 as 
compared to LUH5875. Moreover, levels of the anti-inflammatory IL-13 in lungs of mice 
infected for 1 day with RUH875 tended to be lower (p=0.1) than with LUH5875. In addition 
to these anti-inflammatory cytokines, lower (p<0.05) levels of the pro-inflammatory IL-
12p40 and IL-23 were seen in lungs of mice infected for 1 day with RUH875 and RUH134 
than with LUH5875 and LUH8326. A. baumannii RUH3023
T
 and A. junii LUH5851 did not 
induce cyto- and chemokine production (data not shown). 
In serum, all cyto- and chemokine levels were elevated 1 day after infection with 
RUH875, RUH134, LUH5875 and LUH8326, except for IL-23 that was not detectable (Table 
S1 in the online data supplement). For the majority of the cyto- and chemokines measured 
(KC, MIP-1α, MIP-2, IL-1β, IL-6 and TNFα), levels in the lungs corresponded to levels in 
serum. However, the kinetics of the innate response in lungs and serum differed, with 
some cyto- and chemokines peaking earlier (IL-1β and IL-10) and some later (MIP-1α, 
MIP-2, RANTES and TNFα) in serum than in the lungs of infected animals. No significant 
differences in levels of inflammatory mediators were seen between RUH875, RUH134, 
LUH5875 and LUH8326. Infection of mice with RUH3023
T
 and A. junii LUH5851 did not 
cause an increase in inflammatory mediators in serum, except for a 5-fold increase of 
RANTES and IL-1β levels (Table S1). 
Overall, cyto- and chemokine levels in lungs and serum correlated (p<0.05) to 
bacterial levels in lungs and blood, respectively. We determined whether there was a 
correlation between cyto- and chemokine production at day 1 and tissue pathology, 
morbidity and mortality of mice at days 1-3 after infection with A. baumannii RUH875, 
RUH134, LUH5875, and LUH8326. Results revealed that low levels of IL-10 in lungs of mice 
were associated with severe lung pathology (r=-0.70, p<0.05) at the first day of infection. 
Morbidity was associated with low IL-10 levels (r=-0.72, p<0.001), low IL-12p40 (-0.37, 
p<0.05) and IL-23 (r=-0.67, p<0.001) levels in the lungs. Moreover, low levels of IL-10 in 
lungs at day 1 correlated to mortality at days 2 (r=-0.77; p<0.05) and 3 of infection (r=-
0.72, p<0.01). A similar correlation was found between IL-12p40 and IL-23 levels at day 1 
and mortality at days 2 (r=-0.37, p<0.05 and r=-0.71, p<0.01, respectively) and 3 (r=-0.35, 












Table S1. Inflammatory response in serum of mice infected with Acinetobacter 
Chemokines  Day
KC 1 60 (7 - 256) * 57 (7 - 251) * 46 (1 - 346) * 67 (7 - 145) * 1 (0.2 - 4) 8 (0.2 - 11) *
basal: 0.1 (0.03 - 0.6) 2 21 (4 - 54) * 9 (2 - 674) * 12 (2 - 80) * 6 (0.2 - 72) * 0.2 (0.1 - 0.4) 0.4 (0.2 - 5)
3 NA NA 0.1 (0 - 93) 0.01 (0 - 0.02) 0 (0 - 0.03) 0 (0 - 0.2)
4 NA NA 0.1 (0 - 1) NA 0 0
MIP-1a 1 0.4 (0.1 - 2) * 0.3 (0.1 - 1) * 0.2 (0.1 - 0.3) * 0.1 (0.1 - 0.3) * 0.1 0.1
basal: 0.1 2 2 (1 - 11) * 2 (0.1 - 5) * 4 (0.1 - 17) * 1 (0.1 - 4) * 0.1 0.1
3 NA NA 7 (0.1 - 84) * 2 (0.4 - 82) * 0.1 0.1
4 NA NA 6 (0.1 - 23) * NA 0.1 0.1
MIP-2 1 18 (1 - 25) * 11 (2 - 23) * 5 (0.1 - 13) * 11 (2 - 19) * 0.2 (0.1 - 0.2) 0.2 (0.1 - 1)
basal: 0.1 (0.1 - 0.2) 2 10 (1 - 22) * 8 (0.1 - 18) * 10 (0.3 - 14) * 3 (0.1 - 10) 0.1 0.1
3 NA NA 0.5 (0.1 - 65) 0.1 (0.1 - 58) 0.1 0.1 (0.1 - 0.2)
4 NA NA 0.1 (0.1 - 1) NA 0.1 0.1
RANTES 1 49 (4 - 127) * 31 (12 - 101) * 19 (4 - 53) * 23 (4 - 50) * 18 (12 - 32) * 25 (9 - 46) *
basal: 4 (4 - 6) 2 27 (4 - 59) 21 (4 - 126) * 22 (4 - 50) * 16 (4 - 38) 13 (12 - 21) * 15 (12 - 19)
3 NA NA 10 (4 - 113) 6 (4 - 110) 9 (4 - 21) 8 (4 - 32) *
4 NA NA 15 (12 - 30) * NA 11 (9 - 18) * 12 (9 - 21) *
Pro-inflammatory cytokines
IL-1b 1 393 (5 - 845) * 185 234 (5 - 617) * 225 119 (119 - 223) * 62 (5 - 119)
basal: 30 (5 - 55) 2 144 (55 - 617) * 144 (5 - 584) 411 (55 - 684) * 78 (55 - 908) * 62 (5 - 119) 119 (119 - 223) *
3 NA NA 78 (5 - 1002) 30 (5 - 1495) 119 (5 - 119) 119 (5 - 119) *
4 NA NA 119 (56 - 223) * NA 119 (5 - 223) 119 (5 - 223) *
IL-6 1 33 (2 - 99) * 27 (7 - 95) * 30 (1 - 84) * 40 (1 - 105) * 0 (0 - 1) 5 (0 - 10)
basal: 0.01 (0.01 - 0.1) 2 27 (9 - 79) * 16 (0.3 - 633) * 34 (5 - 181) * 8 (0 - 158) * 0 0 (0 - 1)
3 NA NA 1 (0 - 151) * 1 (0.1 - 134) * 0 0 (0 - 0.1)
4 NA NA 0.2 (0 - 4) NA 0 0
IL-12p40 1 42 (20 - 173) * 27 (20 - 85) 25 (20 - 75) 20 (20 - 28) 20 20 (20 - 22)
basal: 20 2 20 (20 - 61) 20 (20 - 72) 20 (20 - 50) 20 (20 - 57) 20 20
3 NA NA 20 (20 - 85) 20 20 20
4 NA NA 20 (20 - 27) NA 20 20
TNFa 1 128 (3 - 285) * 84 (5 - 223) * 70 (3 - 97) * 55 (3 - 110) * 3 24 (3 - 24) *
basal: 3 2 259 (84 - 345) * 191 (3 - 446) * 185 (3 - 450) * 77 (3 - 540) * 3 (3 - 24) 3 (3 - 24)
3 NA NA 121 (3 - 3749) * 21 (3 - 2295) 3 (3 - 24) 3 (3 - 24)
4 NA NA 24 (3 - 234) * NA 3 (3 - 82) 3 (3 - 24)
Anti-inflammatory cytokines
IL-10 1 992 373 45 159 (45 - 528) * 20 (16 - 124) * 20 (20 - 92) *
basal: 16 2 620 147 (35 - 519) * 319 159 (16 - 552) * 18 (16 - 20) 20 (20 - 75) *
3 NA NA 390 305 20  * 20 (16 - 58)
4 NA NA 1475 NA 30 (20 - 92) * 20 (16 - 58) *
IL-13 1 2 (1 - 3) * 2 (1 - 2) 2 (1 - 2) 2 (1 - 3) * 2 (1 - 2) 1 (1 - 2)
basal: 1 (1 - 2) 2 1 (1 - 2) 2 (1 - 2) 2 (1 - 4) 2 (1 - 2) * 2 (1 - 2) 1 (1 - 2)
3 NA NA 1 (1 - 2) 1 (1 - 2) 1 (1 - 2) 1 (1 - 2)
4 NA NA 1 (1 - 2) NA 1 (1 - 2) 1 (1 - 2)
RUH3023T LUH5851
(102 - 550) * (55 - 1002) *
RUH875 RUH134 LUH5875 LUH8326
(16 - 1541) *
(45 - 1271) * (16 - 2127) * (16 - 1023) *
(20 - 3020) *
(237 - 1299) * (16 - 1528) *
(16 - 45053) *
 
Mice were intratracheally infected with A. baumannii RUH875, RUH134, LUH5875, LUH8326, RUH3023
T
 or 
A. junii LUH5851 for 1-4 days. Levels of inflammatory mediators were determined in the serum of mice 
directly after instillation (basal values), and 1-4 days after instillation. Results are median and ranges for 8 
mice, except for LUH8326 at 3 days after infection, where n=4. Values are representative for surviving 
mice only. NA, not assessable, due to the high mortality associated with these strains. *, significantly (p < 





The outcome of pneumonia differed strikingly among A. baumannii strains with clone I 
and II and the sporadic isolate being highly virulent and the clone III strain (a clone less 
widespread than clones I and II) being less virulent. Infection of mice with type strain 
RUH3023
T
 and A. junii LUH5851 did not result in morbidity/mortality.  
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The clone I, II, III strains and the sporadic strain survived and multiplied in the lungs and 
disseminated to the bloodstream at high levels. Difference in mortality between clone III 
versus clone I, II and the sporadic strain could not be attributed to bacterial loads in lungs 
or blood, suggesting that proliferation in lungs and extrapulmonary dissemination are not 
the only factors contributing to the virulence of these strains. 
We previously demonstrated in vitro that A. junii strains induced a stronger 
innate immune response in human cells than A. baumannii strains, implying that A. junii 
may be quickly eliminated by the host [5]. The finding that A. junii LUH5851 did not 
survive in our pneumonia model supports this presumption, although experiments 
focusing on the first hours of infection are necessary to assess the relationship between 
clearance and the innate immune response. Multiple factors play a role in clearance of 
pathogens from the lungs, including phagocytosis and killing by neutrophils and 
macrophages, by antimicrobial peptides and serum components [16]. As we used 
neutropenic mice, other factors than neutrophils contributed to the rapid clearance of the 
A. junii strain and RUH3023
T
. It is of note that RUH3023
T
 was more susceptible to killing by 
human serum in vitro than A. baumannii RUH875, RUH134, LUH5875 and LUH8326 (de 
Breij et al, unpublished).The type strain of A. baumannii (ATCC19606
T
) was used as a 
model strain in several virulence studies [9,17–21]. The finding that this strain, in contrast 
to other A. baumannii strains, did not survive in the mouse pneumonia model and in a 
mouse thigh infection model [22] (de Breij et al, unpublished), challenges the relevance of 
this strain as representative for the A. baumannii species. Altogether, noted differences in 
virulence among A. baumannii strains, as also observed by others [15,23], underscore that 
the choice of strain is a critical variable in virulence studies.  The reference strains of EU 
clones I and II that are associated with outbreaks worldwide were highly virulent in our 
study. It is important to further assess whether this is a general feature of these clones as 
this might have implications for clinical diagnostics [24,25].  
Eveillard et al [15] described a significant increase in TNFα and MIP-2 levels in 
lungs of mice after infection with five different A. baumannii strains. They showed that 
MIP-2 levels were higher in mice after the second day of infection with two virulent strains 
than with three less-virulent strains. Further to this, we found a clear association with the 
severity of infection and levels of the anti-inflammatory cytokine IL-10. The effects of IL-10  
during bacterial infections are complex. During an overwhelming infection, as in our 
mouse studies, the anti-inflammatory effects of IL-10 are most likely beneficial to the host 
by down-regulating inflammation and its unfavourable effects [26,27]. However, IL-10 also 
hampers the appropriate pro-inflammatory response to the bacteria, and then it can be 
hazardous for the host [28,29]. Indeed, we also found that low levels of IL-12p40 and IL-23 










demonstrated the critical roles of IL-12p40 and IL-23 in host survival in a murine model of 
Klebsiella pneumoniae infection [30]. Others reported that increased levels of IL-12p40 as 
well as TNFα and IL-4 in neutropenic mice infected with Cryptococcus neoformans were 
associated with survival of these mice but not with a decreased fungal burden [31]. IL-23 is 
a cytokine together with enhanced IL-1β and IL-6 production known to drive an IL-17-
producing T cell population in mice [32] that enhance epidermal defence and neutrophil 
influx. However, it is uncertain whether this cytokine plays a crucial role in host defence 
against A. baumannii as IL-17 depletion did not increase mortality in A. baumannii infected 
mice [23]. 
In conclusion, a striking difference in morbidity and mortality associated with A. 
baumannii strains was noted, with EU clone I and II strains being the most virulent. 
Furthermore, the outcome of experimental A. baumannii pneumonia is associated with IL-
10 and IL-12p40/IL-23 levels. Future studies will have to clarify whether this response 
influences the impact of A. baumannii strains in the human host. If so, levels of these 
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An understanding of why certain Acinetobacter species are more successful in causing 
nosocomial infections, transmission and epidemic spread in healthcare institutions 
compared with other species is lacking. We used genomic, metabolomic and virulence 
studies to identify differences between Acinetobacter species. Fourteen strains 
representing nine species were examined. Genomic analysis of six strains showed that the 
A. baumannii core genome contains many genes important for diverse metabolism and 
survival in the host. Few were unique compared to less clinically successful species. In 
contrast, when the accessory genome of an individual A. baumannii strain was compared 
to a less successful species (A. calcoaceticus), many unique operons with putative 
virulence function were identified, including the csu operon, the acinetobactin 
chromosomal cluster, and bacterial defence mechanisms. Metabolomic studies showed 
that compared to A. calcoaceticus (RUH2202), A. baumannii ATCC 19606
T
 was able to 
utilise nitrogen sources more effectively and was more tolerant to pH, osmotic and 
antimicrobial stress. Virulence differences were also observed, with A. baumannii ATCC 
19606
T
, A. pittii SH024, and A. nosocomialis RUH2624 persisting and forming larger 
biofilms on human skin than A. calcoaceticus. A. baumannii ATCC 19606
T
 and A. pittii 
SH024 were also able to survive in a murine thigh infection model, whereas the other two 
species were eradicated. The current study provides clues to the elucidation of differences 












In contemporary medicine, certain Acinetobacter species have proven to be highly 
successful in their ability to cause outbreaks and develop antibiotic resistance [1,2]. 
However, great diversity exists in the clinical importance of the various species, with some 
being dominant as human pathogens and others merely acting as colonizing or 
environmental organisms [2]. To date, with the recent description of the novel species 
Acinetobacter pittii (former name Acinetobacter genomic species [gen. sp.] 3) and 
Acinetobacter nosocomialis (former name Acinetobacter gen. sp. 13TU) [3], the genus 
Acinetobacter comprises 26 validly named species and 9 DNA–DNA hybridization groups 
(gen. sp.) with provisional designations. A. baumannii has long been considered the most 
clinically important species, with the greatest number of healthcare–related outbreaks 
and reports of multidrug resistance. More recently, and likely as a consequence of 
improved laboratory identification, A. pittii and A. nosocomialis have also surfaced as 
clinically significant, with increasing reports of outbreaks and antibiotic resistance 
[4,5,6,7,8,9]. Species that have less commonly been associated with human disease 
include A. lwoffii, A. junii, and A. haemolyticus, and some species have only been identified 
as colonizing human skin or very rarely described as causing human disease, such as A. 
johnsonii and A. radioresistens [2,7]. To our knowledge, A. calcoaceticus has never been 
implicated in serious human disease [2]. However, given the difficulty in phenotypically 
differentiating it from A. baumannii, A. pittii and A. nosocomialis, these species are often 
grouped together in diagnostic microbiology laboratories as the ‘A. calcoaceticus – A. 
baumannii complex’. 
Thus far, the attributes that make one Acinetobacter species more adept at 
causing human outbreaks and disease than another are poorly understood. Previous 
studies have shown that A. baumannii has the ability to survive in both wet and dry 
conditions in the hospital environment [10,11,12]. A recent clinical study showed that 
relative to A. nosocomialis, A. baumannii was an independent predictor of mortality [5]. A 
variety of virulence mechanisms have been identified in A. baumannii, including 
siderophore–mediated iron acquisition systems, biofilm formation, adherence and outer 
membrane protein function, the lipopolysaccharide (LPS), capsule formation, and 
quorum–sensing [13]. Significantly less is understood about the non–baumannii species. In 
this study, we used a systems biology approach involving genomics, phenomics and 
virulence studies, to identify species characteristics that may explain why some 
Acinetobacter species are successful as human pathogens and others are not. This work 
deepens our understanding of Acinetobacter biology, which is critical to develop improved 
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diagnostic, preventative and therapeutic strategies against this troublesome human 
pathogen.    
 
 
Materials and Methods 
 
Bacterial strains and culture conditions 
The 14 strains included in this study are shown in Table 1. The genomes of eight strains 
were sequenced in the present investigation, while for six strains, the publicly available 
genomes were used (Table 1). Cultures were performed at 30°C or 37°C on sheep blood 
agar plates (bioMérieux, Boxtel, The Netherlands) or in Luria–Bertani (LB) broth. 
 
Whole genome sequencing 
Genomic DNA was extracted using the Invitrogen Easy–DNA kit (Invitrogen, CA, USA) or as 
described by Boom et al. [32]. Genomes were sequenced using 454 FLX pyrosequencing 
(Roche) with DNA standard fragment and 3 kb jumping libraries according to the 
manufacturer’s recommendations [33]. Genomes were assembled using Newbler and the 
runAssembly script was then used to assemble reads into contigs. Final assemblies were 
BLASTed to the NCBI non-redundant database and UniVecCore was used to remove any 
contaminating sequence. For annotation, ab initio gene models were predicted using 
GeneMark, Glimmer3, MetaGene, and Zcurveb (Delcher et al, Nucleic Acids Res 27, 1999; 
Guo et al, Nucleic Acids Res 27, 2003; Noguchi et al, Nucleic Acids Res 34, 2006). An 
evidence-based approach constructed open reading frames (ORFs) from BLASTX hits with 
the NCBI non–redundant protein database; all BLAST hits with e–values better than 1 x  
10
–10
 were used as BLAST evidence. A summary of gene finding data for each locus can be 




Phylogenetic analysis and comparative genomics 
Predicted proteins from each Acinetobacter genome were compared using an all–against–
all BLAST search and Pseudomonas aeruginosa PAO1 was used as the outgroup. Reciprocal 
best blast matches (RBM), regardless of percent identity, were stored in a custom MySQL 
relational database to facilitate identification of orthologous groups shared by selected 
phylogenetic and phenotypic groups of organisms. RBM matching proteins were clustered 
using the Markov clustering algorithm implemented in MCL [34], and clusters with one 










present as a single copy in each genome. The protein sequences for each cluster were 
aligned using CLUSTALW [35] and the resulting multiple sequence alignments were 
concatenated for tree building. A neighbour joining (NJ) tree was made using MEGA4 [36] 
and evaluated using 100 bootstrap replicates. The criteria used to define an operon were 
(i) genes were consecutive, (ii) genes were transcribed in the same orientation, (iii) the 
intergenic distance between the genes was no longer than 150 bp, and (iv) gene length 
was at least 450 bp [37,38].  
 






Unknown, before 1949 Urine 3.97 3766 This study ACQB0000000
A. baumannii ATCC 17978 Unknown, ~1951 Unknown 3.98 3791 [45] CP000521
A. baumannii AB0057 Washington, D.C., USA, Blood 4.05 3853 [46] CP001182
A. baumannii AB307–0294 Buffalo, NY, USA, 1994 Blood 3.76 3458 [46] CP001172
A. baumannii AYE Le Cremlin–Bicêtre, FR, 2001 Urine 3.94 3607 [47] CU459141
A. baumannii ACICU Rome, IT, 2005 CSF 3.90 3667 [48] CP000863
A. calcoaceticus
1
RUH2202 Malmoe, SE, 1980–82 Wound 3.88 3566 This study ACPK00000000
A. pittii
1
SH024 Cologne, DE, 1993 Skin 3.97 3689 This study ADCH0000000
A. nosocomialis
1
RUH2624 Rotterdam, NL, 1987 Skin 3.87 3631 This study ACQF00000000
A. lwoffii SH145 Cologne, DE, 1994 Skin 3.48 3134 This study ACPN0000000
A. junii SH205 Cologne, DE, 1994 Skin 3.46 3186 This study ACPM0000000
A. radioresistens SH164 Cologne, DE, 1994 Skin 3.16 2874 This study ACPO0000000
A. johnsonii SH046 Cologne, DE, 1994 Skin 3.69 3363 This study ACPL00000000









DE, Germany; FR, France; IT, Italy, NL, The Netherlands; SE, Sweden; US, United States 
1




To assess for metabolic differences between Acinetobacter species, we used Phenotype 
Microarrays (PM) as described previously by Biolog Inc. (Hayward, CA, USA) [39]. This 
technology uses tetrazolium violet irreversible reduction to formazan as a reporter of 
active metabolism. Twenty 96–well microarray plates were used (PM 1-20) comprising 
1920 different metabolic and toxic compound conditions, including 192 assays of C-source 
metabolism (PM 1–2), 384 assays of N–source metabolism (PM 3, 6 – 8), 96 assays of P-
source and S–source metabolism (PM 4), 96 assays of biosynthetic pathways (PM 5), 96 
assays of ion effects and osmolarity (PM 9), 96 assays of pH effects (PM 10), and sensitivity 
to 240 chemicals (PM 11–20) (Bochner, FEMS Microbiol Rev 33, 2009). In brief, a 
standardized bacterial cell density suspension containing a tetrazolium redox dye 
(measures cell respiration) was transferred into wells of the microplates, which contained 
dried nutrients or chemicals to create the unique culture conditions. Plates were 
incubated at 37°C and metabolic activity was measured colorimetrically using the redox 
dye (Bochner, FEMS Microbiol Rev 33, 2009). Bioinformatic software (OmniLog V. 1.5) 
quantified metabolism as a color–coded kinetic graph. Two independent experiments 
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were performed for all analyses. A best blast hit approach was used to map all the 
proteins in the four genomes to the KEGG reactions database using the KEGG proteome 
database (http://www.genome.jp/kegg/, release 54.1); an E–value threshold of 1x10
–50
 
was applied. Phenotype microarray data was analyzed using GenoPhenomicon: the 
activity of each well was predicted as active/not active using a support vector machine 
(SVM) predictor built using SVMpython v.2 (http://www.tfinley.net 
/software/svmpython2/), using a training dataset of 800 manually validated samples. 
Relationships between genome content and phenotype microarray data were then 
inspected. 
The analysis of PM data was carried out on the raw data–set provided by Biolog 
Inc., obtained by three replicates of each substrate. Binary coefficients (1/0) for positive 
metabolism (1) or no metabolic activity (0) were attributed to each PM well and a matrix 
of binary vectors, each representing a single Acinetobacter species, was prepared as 
previously described [40]. Binary data were then used to compute a similarity matrix by 
using Jaccard coefficient with the software PAST [41].  
          
Growth on human skin equivalents 
Human keratinocytes were isolated from fresh mamma reduction surplus skin as 
previously described [42]. Human epidermal skin constructs were generated as described 
previously [51]. In brief, human epidermal skin constructs were incubated with 300 µl of a 
mid–logarithmic bacterial suspension (3x10
5 
colony forming units [CFU]/ml) at 37ºC (7.3% 
CO2). After 1 h, skin constructs were washed with phosphate buffered saline (PBS) to 
remove non–adherent bacteria and were incubated for an additional 23 h and 47 h. Two 
circular biopsies (4 mm in diameter) were taken from the skin, homogenized in PBS and 
serially diluted to determine the number of CFU. A third biopsy of each skin construct was 
fixed in 4% formaldehyde, dehydrated and embedded in paraffin for subsequent staining 
with Alcian–blue PAS (Merck, Darmstadt, Germany) for morphological analysis. Three 
independent experiments were performed. 
 
Bronchial epithelial cell adhesion and cytokine production 
Adherence of bacteria to human bronchial epithelial cells (H292 cells, ATCC CRL–1848, 
Manassas, VA, USA) and cytokine production by these cells was determined as described 
previously [30,43]. In brief, H292 cells were incubated for 1 h at 37°C with 1x10
8
 CFU of an 
overnight bacterial culture on blood agar. Bacterial adherence to H292 cells was quantified 
by light microscopy and the average number of bacteria per 100 epithelial cells was 
recorded. Two independent experiments were performed in duplicate. For cytokine 










above) with prewarmed PBS, and fresh RPMI medium was added. After 23 h incubation at 
37°C, supernatants were collected and stored at –20°C until determination of cytokine 
levels. RPMI medium alone was used as a control. Interleukin (IL)–6 and IL–8 were 
determined by enzyme–linked immunosorbent assays (ELISA, Biosource, CA, USA) 
according to the manufacturer’s instructions. The lower limit of detection was 15 pg/ml 
for IL–6 and 7 pg/ml for IL–8. Three independent experiments were performed. 
 
Murine thigh infection model 
The survival of Acinetobacter strains in a mouse thigh muscle infection model was 
assessed as previously described [44], with modifications. Female Swiss mice (Charles 
River Nederland, Maastricht, The Netherlands) were made transiently neutropenic by 
intraperitoneal injection with cyclophosphamide (150 mg/kg body weight in 150 µl) on day 
4 and 3 prior to infection. Approximately 1x10
4
 CFU (in 50 µl of saline) of a mid–
logarithmic culture was injected in the right thigh muscle (three animals per strain). At 48 
h after infection, mice were sacrificed and infected thigh muscles were removed and 
homogenized in 1 ml PBS and viable counts were performed. The animal studies were 
approved by the Leiden Experimental Animal Committee (Permit number: 10038) and 
were performed in compliance with Dutch laws related to the conduct of animal 
experiments. All efforts were undertaken to minimize suffering. 
 
Statistical analysis 
All data were analysed for statistical significance using the Wilcoxon rank sum test. P 





Genome characteristics of the Acinetobacter species 
As shown in Table 1, 14 genomes were included in this analysis, covering nine different 
Acinetobacter species (species names will be used for non–baumannii species 
throughout). Eight strains were sequenced as part of this study with mean coverage of 22–
fold. Overall, the species that make up the A. calcoaceticus – A. baumannii complex had 
the largest genomes, with A. radioresistens having the smallest (3.16 Mb). Genome sizes 
of strains within the A. baumannii species varied by up to 289 Kb. The number of genes 
corresponded to genome size, ranging from 3,690 in A. baumannii to 2,874 in A. 
radioresistens. Phylogenetic analysis showed that the species that make up the A. 
calcoaceticus – A. baumannii complex were most closely related, with A. nosocomialis 
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being closest to A. baumannii, followed by A. pittii and A. calcoaceticus (Figure S1). The 
other species formed distinct phylogenetic branches (Figure S1). 
 
Analysis of the A. baumannii core genome 
To understand the genetic core of A. baumannii, we first analysed the orthologous genes 
found in all six A. baumannii genomes. This analysis yielded 2,800 genes, indicating that 
the accessory genome varied between 658 – 1,053 genes depending on the strain. A 
distribution of the A. baumannii core genome based on functional gene categories is 
shown in Figure 1. Apart from genes of general or unknown function, genes related to 
molecule transport and metabolism were most abundant (35%), including amino acid 
(11%), carbohydrate (5%), lipid (5%), nucleotide (3%), coenzyme (4%) and inorganic ion 
(7%) processing. 
        
 
 
Figure S1. Phylogenetic analysis of the eight sequenced strains of Acinetobacter species from this 
study.  
 
Interestingly, despite Acinetobacter deriving its name from akineto meaning non–motile, 
A. baumannii has several core cell motility genes. These include a type IV pilus apparatus 
and pilus assembly genes (pilB, pilW, pilL, pilJ, pilI, pilY1, pilQ, pilO, pilN, pilM), fimbrial 
biogenesis genes (fimT, pilZ), and twitching motility genes (pilU, pilT, which are important 
for pilus retraction). In fact, it has recently been shown that A. baumannii is motile under 
certain conditions [14,15], and this may play an important role in its ability to colonize and 
spread on surfaces, and to form biofilms [16]. We also identified 24 genes that appear to 
determine A. baumannii cell shape and division, including the cell division genes (ftsA, 
ftsZ, ftsW, ftsK), the rod shape determining genes (mreB, rodA) and the min operon (minE, 










Given that cell division biosynthetic machinery has been targeted in other successful 




Figure 1. A. baumannii core genome. Functional distribution of the genes found in all six A. baumannii 
strains included in this study.   
 
Comparison of A. baumannii genome with other Acinetobacter species 
To begin to decipher the genetic attributes that may help explain why some Acinetobacter 
species are clinically more significant than others, we assessed for genes observed 
uniquely in pathogenic species of Acinetobacter (the six A. baumannii genomes, and the A. 
pittii and A. nosocomialis genome). This analysis identified 51 genes, including 12 operons, 
shared among these eight genomes that were not present in the other species (Table S1). 
Importantly, one of these operons was the csu operon, which includes six genes, and 
codes for proteins involved in a chaperone – usher pili assembly system [18]. This operon 
appears important for pili assembly, adherence to abiotic surfaces and biofilm formation 
[18]. The presence of this operon only in pathogenic species of Acinetobacter highlights its 
potential role in determining the clinical success of these species. The predominant 
functional categorization of the remaining genes was in molecule transport and 
metabolism, and transcription (Table S1).  
 
Comparison of specific strains of the A. calcoaceticus – A. baumannii complex       
The data presented thus far provide some evidence that a small number of core genes 
may partly explain the clinical success of certain Acinetobacter species; however the 
number of genes that differed was few, suggesting that additional genetic characteristics 
that distinguish pathogenic from less pathogenic strains may be found among the 
accessory genomes.                     
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Table S1. Unique genes found in pathogenic species of Acinetobacter (A. baumannii [six strains], A. pittii 
and A. nosocomialis) and not in other less or non-pathogenic species 
A. pittii A. nosocomialis
ACIB1v1_040004 transcriptional regulator, TetR family Transcription No 89.6 90.1
ACIB1v1_050001 CsuA/B Cell motility 99.4 99.4
ACIB1v1_050002 CsuA Cell motility 84.1 85.2
ACIB1v1_050003 CsuB Cell motility Yes 89.5 87.4
ACIB1v1_050004 CsuC Cell motility 96.3 94.5
ACIB1v1_050005 CsuD Cell motility 95.8 95.3
ACIB1v1_050006 CsuE Cell motility 95.7 99.3
ACIB1v1_050012 transcriptional regulator, TetR family Transcription No 72.2 72.2
ACIB1v1_050037 acetyltransferase, gnat family General function prediction only No 96.0 99.3
ACIB1v1_090011 transcriptional regulator, AsnC family Transcription No 95.3 97.3
ACIB1v1_090012 kynureninase Amino acid transport and metabolism 90.6 95.9
ACIB1v1_090013 proline-specific permease ProY Amino acid transport and metabolism Yes 90.2 96.8
ACIB1v1_090014 conserved hypothetical protein Lipid transport and metabolism 72.0 83.8
ACIB1v1_090017 conserved hypothetical protein Function unknown No 79.6 89.0
ACIB1v1_150007 transcriptional regulator, GntR family Transcription Yes 99.2 100.0
ACIB1v1_150008 dihydroxy-acid dehydratase Carbohydrate transport and metabolism 99.5 99.5
ACIB1v1_150009 MFS family permease General function prediction only Yes 99.8 99.0
ACIB1v1_150010 hypothetical protein Function unknown 97.3 99.1
ACIB1v1_150012 conserved hypothetical protein No COG annotation No 92.9 97.7
ACIB1v1_150014 oxidoreductase FMN-binding Energy production and conversion Yes 97.8 97.6
ACIB1v1_150015 saccharopine dehydrogenase Function unknown 95.8 96.6
ACIB1v1_150017 transcriptional regulator, MerR family Transcription No 91.3 97.8
ACIB1v1_150046 transcriptional regulator, LysR family Transcription No 97.1 97.7
ACIB1v1_150047 hypothetical protein Function unknown Yes 97.9 95.1
ACIB1v1_150048 hypothetical protein Function unknown 97.4 96.0
ACIB1v1_150094 putative acid phosphatase General function prediction only Yes 97.8 97.2
ACIB1v1_150095 conserved hypothetical protein No COG annotation 93.0 94.4
ACIB1v1_230050 transcriptional regulator, LysR family Transcription No 96.7 95.8
ACIB1v1_230051 3-oxoacyl-[acyl-carrier-protein] reductase Lipid transport and metabolism No 95.1 95.1
ACIB1v1_240001 conserved hypothetical protein General function prediction only No 87.5 93.6
ACIB1v1_240049 FAD dependent oxidoreductase Amino acid transport and metabolism Yes 94.8 92.5
ACIB1v1_240050 ABC transporter, permease Inorganic ion transport and metabolism 97.7 98.8
ACIB1v1_240051 ABC transporter, ATP binding protein Amino acid transport and metabolism 95.5 97.6
ACIB1v1_240052 2-aminoethylphosphonate ABC transport Inorganic ion transport and metabolism Yes 98.3 98.8
system, 1-amino-ethylphosphonate-binding
protein component
ACIB1v1_240053 transcriptional regulator, GntR family Transcription 97.9 99.6
ACIB1v1_240056 acyl carrier protein phosphodiesterase Lipid transport and metabolism No 96.0 97.5
ACIB1v1_240122 cyanate transport protein CynX Inorganic ion transport and metabolism Yes 78.8 90.0
ACIB1v1_240123 guanine deaminase Nucleotide transport and metabolism 80.6 91.3
ACIB1v1_240159 glutathione-dependent formaldehyde Amino acid transport and metabolism No 97.7 96.9
dehydrogenase
ACIB1v1_240186 4-hydroxybenzoate transporter Amino acid transport and metabolism No 94.5 94.5
ACIB1v1_250041 cis,cis-muconate transport protein Amino acid transport and metabolism No 98.9 98.6
ACIB1v1_250167 conserved hypothetical protein No COG annotation No 96.2 94.2
ACIB1v1_250168 transcriptional regulator, LysR family Transcription No 98.2 98.6
ACIB1v1_250169 tartrate dehydrogenase Energy production and conversion Yes 98.9 98.7
ACIB1v1_250170 betaine/choline/glycine transport protein Cell wall/membrane/envelope biogenesis 99.3 99.5
ACIB1v1_250174 putative dioxygenase subunit beta Energy production and conversion 95.6 97.3
ACIB1v1_430020 transcriptional regulator, TetR family Transcription No 93.1 93.6
ACIB1v1_460007 Peptidase M20D, amidohydrolase General function prediction only No 93.2 92.1
ACIB1v1_490004 TonB-dependent receptor Inorganic ion transport and metabolism Yes 96.2 96.8
ACIB1v1_490005 aminopeptidase N Amino acid transport and metabolism 97.6 97.4
ACIB1v1_820017 haloacid dehydrogenase General function prediction only No 93.9 90.6
Homologues (nt ID %)
ATCC19606 Description COG Description Operon
 
To interrogate the accessory genome in more detail, we analysed representative strains 
from the four species that make up the A. calcoaceticus – A. baumannii complex (Table 1). 
A distribution of genes is shown in Figure 2A. A total of 2505 genes were common to all 
four species, with the greatest number of unique genes observed in A. baumannii ATCC 
19606
T
. Based on category of gene (COG) functional classification, the distribution of 
genes unique to A. baumannii ATCC 19606
T










strains was similar, with the greatest number of unique genes having a role in amino acid, 
carbohydrate and lipid transport and metabolism, and transcription (Figure 2B). 
 
 
Figure 2. Distribution of genes in individual strains of the A. calcoaceticus – A. baumannii complex. (A) 
Venn diagram showing the number of overlapping genes between the four strains that make up the A. 
calcoaceticus – A. baumannii complex. (B) The number of genes present in A. baumannii ATCC 19606
T
 
but absent in each of A. calcoaceticus, A. pittii and A. nosocomialis. 
 
 
Of most interest was the comparison between A. baumannii ATCC 19606
T
 and A. 
calcoaceticus. This comparison identified 759 unique genes in A. baumannii ATCC 19606
T
. 
Of these, only 169 were found in the other five A. baumannii genomes analysed in this 
study, indicating that the majority of the unique genes (78%) were part of the accessory 
genome of A. baumannii ATCC 19606
T
. Of the 759 unique genes, 333 had a COG 
classification, and they were significantly overrepresented in several functions necessary 
for basic bacterial growth and survival, including transcription (56 genes), DNA replication, 
recombination, and repair (33 genes), amino acid, inorganic ion and carbohydrate 
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transport and metabolism (66 genes), and cell envelope biogenesis and outer membrane 
function (19 genes). 
Of the 333 genes, there were 69 unique operons that were enriched in virulence–
related genes, including those involved in siderophore transport and biosynthesis, LPS 
biosynthesis, pili and biofilm formation, Curli fimbriae assembly, and bacterial defence 
mechanisms (Table 2). Several operons responsible for iron handling were identified, 
including the acinetobactin chromosomal locus (operons 36 – 39, Table 2), encoding a key 
Acinetobacter siderophore [19,20]. The genetic organisation of this locus and homologues 
in A. pittii, A. nosocomialis and A. calcoaceticus are shown in Figure 3A. A. calcoaceticus 
and A. nosocomialis lacked the full complement of genes that make this locus (Table 2 and 
Figure 3A). We also identified a more recently described siderophore operon (operon 17, 
Table 2 and Figure 3B) [14], made up of eight genes, with A. baumannii ATCC 19606
T
 being 
the only strain with the full complement of genes, and A. nosocomialis and A. 
calcoaceticus being deficient in most of them.  
 
Table 2. Select operons with putative virulence function found in A. baumannii ATCC 19606
T 







A . pittii A. nosocomialis
2 Pili assembly and biofilm form. csuAB/ABCDE ACIB1v1_50001–6 91.8 ± 7.1 91.8 ± 7.1
17 Siderophore transp. bios. cirA , menG , iucA/C, araJ , rhbE/C ACIB1v1_160094–101
3
46.2 ± 17.9 31.1 ± 3.7
29 Defense mechanism cas1, csy1, csy2, csy3, csy4 ACIB1v1_260071–75 – –
36 Siderophore transp. bios. bauD , bauC , bauE , bauB and bauA ACIB1v1_480066–70 97.8 ± 1.0 –
37 Siderophore transp. bios. basC and basD ACIB1v1_480071–72 97.4 ± 1.0 –
38 Siderophore transp. bios. basE, basF, basG ACIB1v1_480073–75 97.6 ± 0.3 47.8 ± 0.4
39 Siderophore transp. bios. barA, barB, basH, basI, basJ ACIB1v1_480076–80 95.1 ± 6.3 32.8 ± 0.8
40 Siderophore transp. bios. tonB , PEPN ACIB1v1_490004–5 97.0 ± 0.3 97.5 ± 0.3
46 Cell motility and secretion pilA ACIB1v1_560044–45 60.2 ± 14.5 73.3 ± 0.3
47 LPS biosynthesis lpsC and lpsE ACIB1v1_600015–16
4
33.9 68.2 ± 29.8
50 Curli fimbriae assembly csgG ACIB1v1_700078–80 94.8 ± 1.1 –
56 LPS biosynthesis wzx , degT , wbbJ , mviM and vipA ACIB1v1_740018–22
6
42.6 ± 23.8 48.3 ± 17.2
Homologues average similarity
Operon ID Function Genes
 (ID% ± SD)
2
 
Bios., Biosynthesis; Form., Formation; ID, Identity; SD, Standard Deviation; Transp., Transport. 
1
Based on Microbial Genome Annotation Platform (www.cns.fr/agc/mage) [50]. 
2
Expressed as the average 
identity at the nucleotide level ± standard deviation. 
3
Only three, two and two genes (out of eight) are 
found in A. pittii, A. nosocomialis and A. calcoaceticus, respectively. The homologues identified exhibited 
low similarity. 
4
Both genes belong to an LPS operon that spans from ORF ACIB1v1_600009 to 16, and 
which is only partially present within A. calcoaceticus (three of eight genes are absent). 
5
lpsC is absent 
from A. pittii genome. 
6
Only vipA is present in A. calcoaceticus and exhibited moderate similarity. The 
operon is poorly conserved and partially present also in A. pittii and A. nosocomialis. 
 
Unique genes related to bacterial defence mechanisms were also observed in A. 
baumannii ATCC 19606
T
, including those coding for ABC transporters, and CRISPR – (Cas) 
and phage–related proteins. Clustered regularly interspaced short palindromic repeats 
(CRISPRs) are recently described adaptive bacterial immune mechanisms that protect 
bacteria from invading foreign genetic elements such as bacteriophages [21,22]. Such 










phage resistance mechanisms, may provide a survival benefit to the bacterial host [21]. 
The A. baumannii ATCC 19606
T
 CRISPR system includes cas1 and cas3; however we could 
not locate cas2, which is thought to be required with cas1 to form a functional CRISPR 





Figure 3. Genetic organisation and conservation of the siderophore clusters found in A. baumannii 
ATCC 19606
T
 and not in A. calcoaceticus. (A) Siderophore cluster 1 (operons 36 – 39) is known as the 
acinetobactin chromosomal cluster, and (B) siderophore cluster 2 (operon 17) (See Table 2 for details 
about the operons). The presence of homologues for each gene in A. pittii, A. nosocomialis, and A. 
calcoaceticus is shown.  
 
 
Comparison of the metabolic versatility of specific strains of the A. calcoaceticus – A. 
baumannii complex  
Given the predominance of metabolism genes differentiating pathogenic and less 
pathogenic strains, we analyzed the metabolic profile of the four species of the A. 
calcoaceticus – A. baumannii complex using phenotype microarrays. Of the 1920 
conditions tested, the four species shared 1356 metabolic responses (70.6%), of which 795 
compounds or conditions could be utilized by all the species and 561 by none of them. A 
summary of the entire metabolic profile of the four species is shown in Figure 4. A. 
baumannii ATCC 19606
T
 appeared to utilize peptide nitrogen sources (PM 6–8) more 
effectively and to be more tolerant to pH stress (PM 10) than the other three species. A. 
baumannii ATCC 19606
T
 and A. pittii had a reduced ability to utilise most of the 
phosphorus and sulfur sources (PM 4) (Figure 4).  
We then focused on the most clinically disparate of the species, and compared A. 
baumannii ATCC 19606
T
 with A. calcoaceticus in more detail. In 195 conditions, A. 
baumannii ATCC 19606
T
 was significantly more metabolically active than A. calcoaceticus. 
These conditions comprised 10 carbon sources, 105 nitrogen sources (of which 98 were 
di– and tri–peptides) and 80 stress conditions, of which 26 related to osmotic and pH 
stress and 54 related to the presence of antimicrobials and other cytotoxic compounds. 
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Figure 4. Metabolic diversity of specific strains of the A. calcoaceticus – A. baumannii complex. 
Phenotype Microarray (PM) comparative results showing the number of compounds used (green) or 
not used (red) by A. baumannii ATCC 19606
T
 [A], A. nosocomialis [B], A. pittii [C] and A. calcoaceticus 
[D]. The external circle and PM number represent the Biolog plate number.  
 
 
Apart from the likely survival advantage inferred by the greater ability of A. baumannii 
ATCC 19606
T
 to metabolise in the presence of osmotic, pH and antimicrobial exposure, 
one of the carbon sources utilized by this strain was D–glucarate. D–glucarate is found in 
the human body and has been shown to be a carbon source utilized by a range of gram–
negative bacteria [23,24]. D–glucarate catabolism generates α–ketoglutarate, which 
enhances the citric acid cycle. Recently, over–expression of the citric acid cycle was shown 
to occur in an A. baumannii strain with increased virulence in the presence of ethanol [25]. 
 
Virulence differences between strains of the A. calcoaceticus – A. baumannii complex 
Given the differences in the number of operons with putative virulence function that were 
observed between the four species of the A. calcoaceticus – A. baumannii complex, we 
performed a range of in vitro and in vivo virulence studies to characterise further the 
functional significance of their genetic differences. Given the predilection of A. baumannii 
to colonise or infect the respiratory tract, we first analysed the interaction of the four 
species with human bronchial epithelial cells. Cell adherence and pro–inflammatory 
cytokine response (IL–8) was most pronounced with A. pittii (P < 0.05) (Figure 5, A, B and 













Figure 5. Virulence attributes of individual strains belonging to the A. calcoaceticus – A. baumannii 
complex. (A) Adherence of A. baumannii ATCC 19606
T
, A. pittii, A. nosocomialis and A. calcoaceticus to 
human bronchial epithelial cells after 1 h. Results are expressed as mean number of bacteria per 100 
epithelial cells ± standard deviation (SD) of two independent experiments performed in duplicate. (B) 
Levels of IL–6 and (C) IL–8 in the culture medium of human bronchial epithelial cells after 24 hour 
stimulation with specific strains of the A. calcoaceticus – A. baumannii complex. Results are expressed 
as mean levels of IL–6 and IL–8 (in ng/ml) ± SD of three independent experiments. Asterisk signifies 
statistical significance (P < 0.05). (D) Persistence and biofilm formation of A. baumannii ATCC 19606
T
 
(squares), A. pittii (upward triangles), A. nosocomialis (downward triangles) and A. calcoaceticus 
(diamonds) on three–dimensional human skin constructs. Results are expressed as mean CFU per skin 
construct ± SD of three independent experiments. Dotted line represents the lower limit of detection. 
(E) Alcian–blue PAS staining shows biofilm formation (black arrow) on human skin constructs by A. 
baumannii ATCC 19606
T
 but not by (F) A. calcoaceticus. Scale bar is equivalent to 20 µm. (G) 
Approximately 1x10
4
 CFU were injected in the thigh muscles of neutropenic mice and the number of 
viable bacteria was determined after 48 h. Results are expressed as mean number of bacteria (in 
CFU/muscle) ± SD from three animals. Dotted line represents lower limit of detection. Asterisk 
signifies statistical significance (P < 0.05). 
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Given the likely importance of biofilm formation to the success of Acinetobacter in 
hospitals, we next tested the four species in a unique biofilm assay. Thus far, the 
correlation between biofilm formation on abiotic surfaces and clinical significance has 
been poor [26]. Therefore, we used a novel assay that may predict the ability of 
Acinetobacter to colonise and form a biofilm on human skin. Using a three–dimensional 
human skin construct [51], we observed that A. baumannii ATCC 19606
T
, A. pittii and A. 
nosocomialis were able to multiply rapidly and persist on human skin, whereas A. 
calcoaceticus grew to a significantly lower density (Figure 5D). In addition, biofilms of the 
former three species were visible on the stratum corneum, whereas no such bacterial 
structures were seen for A. calcoaceticus (Figure 5, E and F). Finally, we assessed the 
survival of the four strains in a neutropenic mouse thigh muscle infection model. A. 
baumannii ATCC 19606
T
 and A. pittii were able to survive in the thigh muscle at least up to 





This study provides a combined genomic, phenomic and virulence assessment of a range 
of Acinetobacter species that have been variably associated with humans. From a genomic 
analysis of nine different Acinetobacter species, we identified a small number of genes 
unique to pathogenic species. The majority of these genes are predicted to be important 
for molecule transport and metabolism but also included the putative virulence csu 
operon. Investigating the accessory genome of individual strains of the four species of the 
A. calcoaceticus – A. baumannii complex, we found a range of unique operons with 
putative functions relating to host survival and virulence in A. baumannii ATCC 19606
T
 but 
not in A. calcoaceticus. A. pittii appeared most similar to A. baumannii ATCC 19606
T
, 
whereas A. nosocomialis lacked several of these important operons, particularly the full 
repertoire of genes of the acinetobactin chromosomal locus. Global metabolomic studies 
supported the genomic analysis in that A. baumannii ATCC 19606
T
 was able to utilise more 
carbon and nitrogen sources, and was more tolerant to a range of cellular stresses than A. 
calcoaceticus. Moreover, the pathogenic species were able to multiply and form biofilms 
on human skin significantly more than A. calcoaceticus. Only A. baumannii and A. pittii 
were able to survive in a mammalian thigh infection model.       
As a consequence of improved laboratory speciation, it is becoming apparent that 
non–baumannii species, particularly A. nosocomialis and A. pittii, are clinically significant 
human pathogens. For example, in a recent study from Norway, A. nosocomialis was the 










followed by A. pittii (20%) [27]. With regard to their clinical impact, a more contemporary 
study has  shown that relative to A. nosocomialis, bacteremia with A. baumannii was an 
independent predictor of mortality [5]. Interestingly, and consistent with our study 
findings, there was no significant difference between A. baumannii and A. pittii, however 
the number of patients in the A. pittii group was small [5]. Genetically and metabolically, 
we showed that A. pittii appeared similar to A. baumannii, and they also behaved similarly 
in the mammalian infection model. A. nosocomialis lacked several of the virulence related 
operons, particularly the acinetobactin siderophore cluster, and its metabolome was more 
closely aligned to A. calcoaceticus, both of which may explain its failure to survive in the 
murine model and its reduced virulence in clinical studies [5].  
Within mammalian hosts, free iron is often a scarce resource and for pathogenic 
organisms to survive in vivo they often utilize a range of iron scavenging systems. Such 
systems have been analysed across different A. baumannii strains [14,29] however this is 
the first analysis, to our knowledge, of such genes in non–baumannii species. In addition 
to the acinetobactin chromosomal locus, we observed another siderophore cluster and a 
putative iron uptake receptor in A. baumannii ATCC 19606
T
 that was not present in A. 
calcoaceticus. This second cluster (operon 17 in Table 2) is a recently described 
siderophore cluster made up of eight genes that is well conserved across A. baumannii 
strains [14]. The full repertoire of genes from this cluster was not found in A. pittii, A. 
nosocomialis, and A. calcoaceticus, and the few homologues identified exhibited low 
similarity (Table 2). Such genetic differences between Acinetobacter species in key 
virulence attributes may help explain why some species have greater clinical impact. 
Apart from genes involved in metabolism and transcription, we identified the csu 
operon as an operon found in pathogenic species of Acinetobacter (six A. baumannii 
strains, A. pittii and A. nosocomialis) but not in non–pathogenic species. Loss of function 
of this operon leads to a lack of pili–like structures on the surface of A. baumannii and to 
loss of cell attachment and biofilms on abiotic surfaces [18]. Interestingly, this operon was 
not shown to be important for attachment to and cytokine production by human 
bronchial epithelial cells [30]. We hypothesize that this operon may aid in Acinetobacter 
attachment and colonization of plastic medical devices such as ventilator tubing and 
catheters, with a subsequent increased risk of invasive infection. The definitive role of this 
operon in mammalian virulence requires further evaluation.    
  We observed a diverse repertoire of core metabolic genes in A. baumannii, which 
is likely to be important for its ability to survive in vivo, as well as in unique ecological 
niches of healthcare institutions. To assess the global metabolic capabilities of the 
Acinetobacter species, we used phenotype microarrays, which enabled us to assess nearly 
2000 metabolic and toxic compound conditions. Overall, A. baumannii ATCC 19606
T
 was 
Genetic, metabolic and virulence attributes of Acinetobacter 
 98 
able to utilize nitrogen sources more effectively and was more tolerant to pH stress than 
A. nosocomialis, A. pittii and A. calcoaceticus. The differences were more marked when A. 
baumannii ATCC 19606
T
 was compared to A. calcoaceticus. Interestingly, A. baumannii 
and A. pittii were unable to utilize most of the phosphorus sources despite both strains 
having the necessary genetic composition for phosphate metabolism. Several studies have 
highlighted the key role of the Pho regulon in phosphate management, virulence and 
stress response [31]. Whether the inability of A. baumannii and A. pittii to utilize 
phosphorus is linked to expression of the Pho regulon remains a question that needs 
further evaluation. 
Taken together, these data provide a systems biology approach to understanding 
the potential differences between important species of the Acinetobacter genus. We 
provide genetic and metabolic insights into why some species may be more clinically 
important than others, and also highlight the functional significance of these differences in 
various virulence models. A limitation of our study is that we only analysed one strain for 
each of the non-baumannii species, and our results need confirmation using a larger set of 
strains. Furthermore, confirmation of our findings using targeted gene deletion and 
complementation is required to define the significance and role of the unique operons 
found in pathogenic versus non-pathogenic species. Overall, these data provide useful 
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Acinetobacter baumannii is an important nosocomial pathogen responsible for 
colonization and infection of critically ill patients. The effect of the bacterium on the host 
follows from the interplay between virulence attributes of the micro-organism and the 
condition of the host. As some virulence attributes can be delivered to the host by 
membrane vesicles, this study aimed at characterization of the formation and morphology 
of membrane vesicles formed by A. baumannii ATCC19606
T
 in vitro using cryo-electron 
tomography. Results revealed that different membrane vesicles were formed by A. 
baumannii during the various stages of its life cycle: (i) small outer membrane vesicles 
(OMVs; ±30 nm in diameter) formed at distal ends in the log-phase; (ii) larger OMVs (200-
500 nm) formed at septa during cell division; (iii) inner and outer membrane vesicles 
(IOMVs; 100-300 nm) formed in the stationary phase, and (iv) OMVs with a rough surface 
formed in the late stationary phase. Exposure of A. baumannii to a sub-inhibitory 
concentration of the antibiotic ceftazidime resulted in filamentous forms that produced 
large numbers of OMVs. We argue that the different types of membrane vesicles formed 
during the various stages of the life cycle of A. baumannii play distinct roles in infection.  
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Acinetobacter baumannii is a Gram-negative bacterium that can colonize and infect 
severely ill, hospitalized patients. Multidrug-resistant strains of A. baumannii have the 
propensity to spread among patients and numerous endemic and epidemic episodes 
caused by this species have been reported [13,32]. Although colonization is far more 
common than infection, severe A. baumannii-associated infections, including ventilator-
associated pneumonia and catheter-related bloodstream infections, do occur [32]. Several 
virulence attributes are thought to play a role in A. baumannii infections, including its 
ability to adhere to and invade host cells [7,10,11,25], form a biofilm, induce host cell 
death [6], resist the killing actions of serum [20] and produce siderophores [15].  
It has been reported that virulence factors of Gram-negative bacteria can be 
delivered to host cells by outer membrane vesicles (OMVs) [18,22,23]. OMVs are 
nanovesicles composed of outer membrane and periplasm components, such as 
phospholipids, proteins, and lipopolysaccharides (LPS) [1,26]. However, OMVs produced 
by a clinical A. baumannii isolate were found to contain not only proteins from the outer 
membrane, including the potent cytotoxic outer membrane protein A (OmpA), and the 
periplasm, but also components from the inner membrane and cytoplasm [23]. OmpA 
present on OMVs of A. baumannii can contribute directly to host cell death [18], indicating 
that OMVs from A. baumannii are an important vehicle to deliver bacterial effector 
molecules to host cells. Moreover, it has been suggested that A. baumannii release OMVs 
as a mechanism of horizontal gene transfer whereby carbapenem resistance genes can be 
delivered to surrounding A. baumannii isolates [34]. It is of note that these studies on the 
composition and function of OMVs of A. baumannii all used extensive purification 
methods for the isolation of OMVs, including (ultra)-filtration and centrifugation. A 
disadvantage of this isolation procedure could be the presence of inner membrane and 
cytoplasmic proteins in OMVs resulting from random capture by membrane fragments. 
Thus, these preparations may not represent the naturally occurring OMVs [22]. The aim of 
the present study was to characterize the formation and morphology of naturally formed 
membrane vesicles by A. baumannii ATCC19606
T
 during the various stages of its life cycle 
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Material and Methods 
 
Bacterial strain and culture conditions 
A. baumannii ATCC19606
T
 was used in the present study. Bacteria were preserved for 
prolonged periods in nutrient broth supplemented with 20% (v/v) glycerol at -80°C. For 
experiments, inocula from fresh overnight cultures on sheep blood agar plates were 
grown overnight in Luria Bertani (LB) medium at 37°C under shaking. One hundred 
microliters of the overnight culture were added to 15 ml of prewarmed LB medium in an 
Erlenmeyer flask and incubated at 37°C under vigorous shaking. Where indicated, bacteria 
were cultured for 2.5 h at 37°C under vigorous shaking in the presence of 4 mg/L 
ceftazidime (Sigma-Aldrich, Zwijndrecht, The Netherlands), i.e. below the MIC level of 16 




Isolation of vesicles 
Bacterial suspensions were cultured for 1, 2.5, 6, 20, and 48 h in LB medium at 37°C. 
Thereafter the bacteria were centrifuged for 10 min at 3,000 g and the supernatants were 
centrifuged for 1 h at 17,000 g to remove remaining cells and debris. Next, the pellets 
were resuspended in 1 to 2 ml phosphate buffered saline (PBS; pH 7.4) and these 
preparations were used for analysis by cryo electron microscopy.  
 
Cryo electron microscopy 
Cryo sample preparation 
A few microliters of vesicle preparation were applied to glow-discharged lacey carbon EM 
grids. For cryo electron tomography, 5 or 10 nm protein A - gold particles were added as 
fiducial markers to the sample. Excess medium was automatically blotted onto Whatman 
no. 4 filter paper for 1 to 2 sec in a controlled environment operated at room temperature 
and 100% humidity. Subsequently, the specimen was vitrified by plunging into liquid 
ethane in a Vitrobot Mark IV (FEI Company, Eindhoven, The Netherlands). Samples were 
stored in liquid nitrogen until use. Grids were mounted in a Gatan 626 cryo holder (Gatan, 
Pleasanton, Germany) for cryo electron microscopy imaging. 
 
Cryo electron microscopy 
Cryo electron microscopy (cryo EM) was performed on several microscopes. For large 
scale automated data collection we used custom written software (unpublished) that was 
able to automatically scan and image large areas. These images were recorded on a Tecnai 
12 electron microscope with a LaB6 source and operated at 120 keV using a 4k x 4k Eagle 
camera (FEI Company). Cryo electron tomography (cryo ET) was performed on a Tecnai 20 
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FEG operated at 200 keV and a Tecnai G2 Polara operated at 300 keV (FEI Company). 
Images were recorded using Explore 3D software on a 2k x 2k camera mounted behind a 
GIF energy filter (Gatan) operated at a slit width of 20 eV. Cryo ETs of membrane vesicles 
were recorded with 2° tilt steps between -70° to +70° at a defocus of -5 micron, while 
tomograms of whole bacteria were recorded between -60° to +60° at a defocus between -
6 and -8 micron and a magnification between 13,500 and 19,000 corresponding with a 
pixel size of 1.02 resp. 0.69 nm.  
 
Image analysis and visualization 
Tomographic tilt series were processed using IMOD version 3.9 [21]. Projection images 
were roughly aligned by cross-correlation and fine alignment was done using fiducial 
markers. The tomograms were reconstructed using weighted back-projection. Cryo 
electron tomograms were denoised using non-linear anisotropic diffusion. The number of 
OMVs and their size were measured using ImageJ [33]. Image segmentation and 3D 







We investigated the general morphology of logarithmic phase A. baumannii ATCC19606
T
 
using cryo EM/ET (Figure 1). The bacteria did not form aggregates and readily attached to 
the carbon surface of the electron microscopy grid (Figure 1A). The size of (visibly 
classified) non-dividing bacteria was 1.54 ± 0.07 micron in length and 0.77 ± 0.04 micron in 
width (n=9). The bacterial outer membrane was smooth (Figure 1B) with occasional small 
ripples, predominantly at the distal ends. The distance between the outer and inner 
membrane layers was 33.4 ± 1.48 nm and the peptidoglycan layer measured about 7 ± 0.7 
nm in width and was centered between the inner and outer membrane (Figure 1C, D).  
The bacterial cell surface was covered by a ~150 nm thick layer with very low 
contrast and a radial appearance (data not shown). Also long filaments, bacterial fimbriae 
or pili, were extending from the surface of the bacteria as was observed earlier by others 
(11). The bacteria regularly contained 50-500 nm dark inclusions (Figure 1B) possibly 
containing phosphor, magnesium and potassium [3,16]. 
 




Figure 1. Cryo electron microscopic overview of A. baumannii ATCC19606
T
 morphology and 
membrane structure. A, A. baumannii ATCC19606
T
 (white arrow) on a lacey carbon support. B, 
Typical morphology of a single bacterium. In many cells a dark inclusion is present (white arrow). C, 
Detailed image of the bacterial membrane, showing the inner membrane (IM), the peptidoglycan 
layer (PG) and the outer membrane (OM). D, Density profile of the bacterial membrane showing the 
inner membrane, peptidoglycan and outer membrane. Scale bars are 2 μm (A) and 200 nm (B).  
 
 
Formation and structure of membrane vesicles during logarithmic phase 
In order to investigate whether the morphology and formation of membrane vesicles 
depends on the stage of the bacterial life cycle we imaged the vesicles from A. baumannii 
ATCC19606
T
 cultured for 1 and 2.5 h (early and mid-logarithmic phase), 6 h (late 
logarithmic phase), and 20 and 48 h (early and late stationary phase, respectively).  
Cryo ET recordings from 1 and 2.5 h cultured A. baumannii revealed the presence 
of ~30 nm vesicles budding off from the outer membrane (Figure 2B - G). These outer 
membrane vesicles (OMVs) were rarely observed possibly due to their small size and/or 
their limited occurrence. The formation of OMVs mainly occurred at the bacterial distal 
ends. At these sites we noted that the peptidoglycan layer was thickened and less dense, 
and the distance between inner and outer membrane was increased (Figure 2 A-F). In 
addition, large OMVs - typically 200-500 nm in diameter - were formed predominantly at 
sites of bacterial cell division (Figure 3A, B). Cryo ET on large OMVs showed that these 
vesicles lacked internal structures and displayed a smooth appearance (Figure 3C, D). 
These OMVs lacked fimbriae and the previously noted 150 nm thick low contrast layer 
that is present on the whole bacterium. Cryo electron microscopic images of OMV 
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formation indicated that these OMVs are connected to septa via a small outer membrane 
tubal structure (Figure 3B, E). 
 
Figure 2. Formation of small outer membrane vesicles during logarithmic growth phase. A, Cryo 
electron tomographic slice of A. baumannii. B-F, Tomographic slices through the tomogram from the 
area that is outlined in (A) with white arrows indicating budding of outer membrane vesicles (OMVs). 
G, Surface representation of part of the bacterium that is outlined in (A) with colored in blue the 
bacterial outer membrane and in red to purple the formed OMVs. H, Schematic representation of the 





Figure 3. Formation of large outer membrane vesicles during logarithmic growth phase. A, Outer 
membrane vesicles (OMVs; white arrow) are often formed at or in the vicinity of bacterial septa 
during cell division. B, Sometimes OMVs are attached to the cell wall of dividing bacteria via a long 
tube (white arrow). C, Slice from a cryo electron tomogram through a large OMV reveal a smooth 
surface. D, 3D reconstruction of the tomogram in C. E, Schematic representation of the various stages 
of formation of large OMV at septa. Scale bars are 300 nm (A and B) and 50 nm (C). 
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Formation and structure of membrane vesicles during stationary phase 
While in early (<6 h) bacterial cultures the number of vesicles was low, it dramatically 
increased during stationary phase (>6 h) cultures (Figure 4). The number of membrane 
vesicles did not linearly increase with the number of viable bacteria in the culture 
medium, suggesting that membrane vesicles are primarily formed from stationary bacteria 




Figure 4. A. baumannii growth curve and membrane vesicle formation. The growth curve of A. 
baumannii ATCC19606
T
 is plotted (round dots and black line) and the number of outer membrane 
vesicles (squares and dark grey striped line) and inner and outer membrane vesicles (triangles and 
light grey striped line) are plotted in time.  
 
 
Also from cryo EM it appeared that the majority of membrane vesicles was formed by 
cellular degradation. While logarithmic phase A. baumannii exhibited a very regular shape, 
stationary bacteria often displayed anomalous shapes, such as bulges of the outer 
membrane (Figure 5A - C). It seemed that these deviating bacterial shapes are 
intermediates of bacterial fragmentation (Figure 5C, D) possibly associated with the 
process of bacterial cell death. Vesicles pinched off from dying bacteria, resulted in the 
formation of vesicles containing both inner and outer membranes (IOMV; Figure 5C, E - G, 
left panel), as demonstrated by tomographic reconstruction (Figure 5E, F). Probably 
IOMVs contain all components that are present in the periplasmic space and the 
cytoplasm (e.g. DNA). Almost all IOMVs contained a 150 nm low dense layer and fimbriae 
on their surface. These were occasionally observed in OMVs in stationary phase bacteria. 
It appeared that in several IOMVs the inner membrane was dissociated or totally 
detached from the peptidoglycan layer, while this peptidoglycan layer remained 
associated with the outer membrane (compare Figure 5E and Figure 1C). Additionally, we 
observed intermediate structures with evidence of gradual breakdown of the inner 
membrane (Figure 5G) and secondary vesicle formation, i.e. membrane vesicle formation 
from IOMVs (Figure 5G, right panel). This breakdown of IOMVs and the formation of 
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membrane vesicles from IOMVs could explain the decrease in the relative numbers of 
IOMVs compared to the numbers of OMVs in later growth stages (Figure 4). The size of the 
membrane vesicles increased with the development from early logarithmic phase towards 
late stationary phase; OMVs being 72.3 ± 68.4 nm, while IOMVs were about 2 to 3 times 




Figure 5. Formation of inner and outer membrane vesicles during late stationary phase. A, B, Bacteria 
deform and exhibit bulges that result in the (C) formation of membrane vesicles comprising both 
inner and outer membranes and peptidoglycan. D, Schematic representation of the stages of the 
formation of inner and outer membrane vesicles (IOMVs). E, Slice from a tomogram of an IOMV, with 
arrows showing the inner membrane (IM) and outer membrane (OM). F, 3D reconstruction of the 
tomogram in E, with in green the outer membrane and in purple the inner membrane. G, Once the 
IOMVs have been released from the bacteria they can have different shapes and the peptidoglycan 
and the inner membrane seem to degrade. Additionally, it appeared that MVs can arise from larger 
MVs. Scale bars are 300 nm (A, B and C) and 100 nm (E and G). 
 
 
In A. baumannii cultures occasionally bacterial remnants were observed. In the most 
extreme case the bacterial remnants were transformed into a branched arrangement 
from which at the end OMVs were released (Figure 6A, B). These OMVs (Figure 6C - E) 
were rather uniform in size measuring roughly 75 nm. Cryo ET showed that the surface of 
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these vesicles had a rough appearance, being covered with small and large densities, most 
probable representing membrane (-associated) proteins (Figure 6E). On almost all these 
OMVs a large (10 nm) density was present (Figure 6D, E) that, judged by its shape and size, 
could be hemolysin (37). Large numbers of these rough OMVs were observed in the 
vicinity of bacterial remnants and given the surface area of an A. baumannii and the 





Figure 6. Formation of outer membrane vesicles from late stationary phase bacteria. A, outer 
membrane vesicles (OMVs) were formed form bacteria in their late stationary phase. B, From 
branching membrane structures OMVs are released (area from large white box in A). C, These OMVs 
are round and have a rough surface (area from large white box in A). D, Cryo electron tomography 
showed that these OMVs have many small densities on their surface and regularly contain a large 
cylindrical density. E, 3D reconstruction of the tomogram from D more clearly shows the rough 
surface and the densities that are suggestive for proteins (blue), the lipid membrane (green) and the 




Effect of ceftazidime on vesicle formation 
A sub-inhibitory concentration of the cephalosporin ceftazidime, which interferes with 
peptidoglycan synthesis, was added to A. baumannii cultures to investigate the effects of 
this antibiotic on the formation of OMVs. As expected in 2.5 h exposed cultures many 
filaments had been formed; in most extreme cases reaching lengths up to several tens of 
microns (Figure 7A). Membrane ruffling was observed along the whole outer membrane 
of ceftazidime-exposed bacteria instead of being localized solely to the distal ends of 
control bacteria. Additionally, deformations of the peptidoglycan layer and the outer 
membrane of antibiotic-exposed bacteria were observed frequently. In the presence of 
ceftazidime, membrane vesicle formation was more abundant than in the absence of the 
antibiotic. Especially at sites of potential septum formation (Figure 7B, C) and at distal 
ends (Figure 7D - F) membrane vesicle formation was more frequent than in control A. 
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baumannii. Cryo ET showed that these membrane vesicles often contained peptidoglycan 




Figure 7. Formation of outer membrane vesicles by ceftazidime-treated bacteria. A, Ceftazidime 
inhibits bacterial division resulting in the formation of long bacterial structures. B, C, The formation of 
outer membrane vesicles (OMVs) was observed at potential sites of cell division with membrane 
roughing and peptidoglycan expansion (the white box in B depicts the position of C). D, At the 
bacterial distal ends, broadening of the peptidoglycan layer and formation of OMVs was regularly 
observed (white arrow). E, A large extension of the outer membrane. F, 3D reconstruction of the area 
in D shows OMVs (yellow) with attached fimbriae (orange), the formation of OMVs by bulging of the 
outer membrane (blue) and the inner bacterial membrane (purple). Scale bars are 2 μm (A and B), 





The main finding of the present study is that A. baumannii ATCC19606
T
 forms 
morphologically diverse types of membrane vesicles during different stages of its life 
cycle. In exponentially growing bacterial cultures outer membrane vesicles (OMVs) were 
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formed mainly at distal ends of the bacteria and at septa of dividing cells. Stationary phase 
and dying bacteria released large numbers of vesicles, i.e. rough OMVs and inner and 
outer membrane vesicles (IOMVs), the latter were formed by partial fragmentation and 
budding off the cells. The timing of IOMV formation suggests that they are mainly derived 
from dying bacteria. These OMVs and IOMVs were abundant and it appeared that their 
surfaces were covered with low contrast material with a radial appearance, fimbriae and 
protein complexes. This is in accordance with the mass spectrometry measurements on 
purified membrane vesicles from A. baumannii [24]. It is conceivable that the biogenesis 
of membrane vesicle formation by A. baumannii in the present in vitro cultures may also 
occur in vivo. For example, Jin et al demonstrated that A. baumannii ATCC19606
T 
secreted 
membrane vesicles during pneumonia in a mouse model of infection [18]. Others reported 
that A. baumannii present in alveolar macrophages in a patient with fatal A. baumannii 
pneumonia secreted multiple pleomorphic vesicles [28], suggesting the possibility of 
secretion of different types of vesicles during infection.  
What are the functions of the various types of membrane vesicles in A. 
baumannii infection? It has been reported that pathogenic Gram-negative bacteria, 
including A. baumannii, deliver toxins and other virulence attributes to host cells via OMVs 
[2,17-19]. So far, proteomic studies on OMVs from A. baumannii including the ATCC19606
T
 
strain have indicated that inner membrane and cytosolic proteins as well as some 
virulence factors were present in these vesicles [19,23]. In addition, IOMVs of A. 
baumannii contain cytoplasmic material, including genetic material, and therefore they 
could be involved in gene transfer among bacteria. It should be noted that knowledge of 
the transfer of genetic material among clinical A. baumannii strains is still very limited. 
Together, further studies are clearly needed to identify the virulence attributes present in 
the various membrane vesicles formed by A. baumannii during its life cycle. 
Other important findings pertain to the main mechanisms underlying the 
biogenesis of membrane vesicles in A. baumannii. Several genetic, biochemical, proteomic 
and microscopic observations have indicated that disruption of peptidoglycan synthesis 
genes and the removal of proteins that interconnect peptidoglycan-outer membrane 
interactions can lead to increased formation of OMVs [12,27]. Our cryo electron 
tomographic data showed that OMVs were formed primarily at sites where reorganization 
of peptidoglycan occurred, i.e. the peptidoglycan layer increased in thickness and was 
deformed, thus supporting the current models for OMV formation.  
We found that sub-inhibitory concentrations of ceftazidime, which interferes 
with peptidoglycan synthesis by inhibiting the penicillin-binding-proteins (PBPs) in the 
cytoplasmic membrane of Gram-negative bacteria [9], resulted in filament formation, as 
described before [4]. These strands of non-dividing bacteria contain enhanced quantities 
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of LPS conferring the risk of delayed, higher release of LPS during treatment of infections 
[14]. Moreover, these sub-inhibitory concentrations of ceftazidime enhanced OMV 
production at distal and septal sites. It is conceivable that these OMVs carry LPS on their 
surface. Therefore, the possibility that inadequate dosing of antibiotics, such as penicillins 
and cephalosporins, has serious adverse effects in patients suffering from A. baumannii 
infection should be considered. 
In this study we investigated both the formation and three-dimensional structure 
of naturally occurring membrane vesicles from A. baumannii using cryo electron 
tomography. To ensure optimal preservation of membrane vesicles from A. baumannii 
ATCC19606
T
, we isolated the membrane vesicles from bacterial cultures by centrifugation 
steps only. This lenient isolation procedure limits rupture of cells and vesicles, stripping 
proteins from the surface and induction of vesicle fusion [22] resulting from harsh 
purification methods, that are regularly used in other studies. Furthermore, we employed 
cryo fixation of the samples using vitrification to preserve the membrane vesicles with 
high integrity. Cryo electron tomography has been used since this method is able to 
resolve cellular structures with high accuracy and resolution in three dimensions. In earlier 
investigations on the structure and formation of membrane vesicles either negative 
staining of purified MVs was employed or fixation, dehydration, staining and sectioning 
techniques were used [18,29-31,35]. In line with the above considerations, cryo electron 
tomography is increasingly used to study bacteria [5,36,38].  
Our findings show that several types of membrane vesicles are formed by A. 
baumannii ATCC19606
T
 during the different stages of the bacterial life cycle and we 
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Acinetobacter baumannii can colonize body surfaces of hospitalized patients. From these 
sites, invasion into the host and spread to other patients and the hospital environment 
may occur. Eradication of the organism from the patient’s skin is an important infection 
control strategy during epidemic and endemic episodes. In this study, a three-
dimensional, air-exposed human epidermal skin equivalent was exploited to study 
Acinetobacter skin colonization. We characterized the adherence of A. baumannii 
ATCC19606
T
 and A. junii RUH2228
T
 to and biofilm formation on the skin equivalent and 
the responses to these bacteria. Furthermore, we assessed the ability of the disinfectant 
chlorhexidine to decolonize the skin equivalents. Results revealed that both strains 
replicated on the stratum corneum up to 72 h, but did not invade the epidermis. A. 
baumannii, in contrast to A. junii, formed large biofilms on the stratum corneum. Bacterial 
colonization did not affect keratinocyte activation, proliferation or differentiation nor did 
it induce a strong inflammatory response. Disinfection with chlorhexidine solution 
resulted in complete eradication of A. baumannii from the skin without detrimental 
effects. This 3D model is a promising tool to study skin colonization and to evaluate the 
effects of novel disinfectant and antimicrobial strategies.  
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Multidrug resistant (MDR) strains of Acinetobacter baumannii are notorious for their 
association with outbreaks of colonization and infection worldwide [6,23]. During such 
outbreaks, A. baumannii can colonize body surfaces of severely ill patients from which the 
organisms may invade the patient causing infection and/or spread to other patients and 
their environment. Thus, the skin is thought to constitute an important reservoir for A. 
baumannii during outbreaks and endemic episodes [1,17]. Insight into Acinetobacter skin 
colonization and the microbial ecology of the skin may result in novel strategies to prevent 
or interfere with skin colonization and thus contribute to eradication of the organisms 
from a ward. 
Adherence and biofilm formation on plastic and adherence to human cells are 
widely used systems to study interactions of bacteria with abiotic and biotic surfaces. 
However, these systems may not adequately reflect the association of bacteria with the 
human skin, a process that takes place under relatively dry conditions [20]. Moreover, 
adherence and subsequent replication is strongly influenced by environmental conditions 
[19], including the physico-chemical barrier properties of the skin surface and its nutrient 
availability. Once bacteria have adhered to the skin, they may invade the epidermis and 
trigger an inflammatory response. To our knowledge little is known about the possible 
response of human skin cells to Acinetobacter.  
Tissue-engineered, air-exposed human skin models are 3D systems that mimic 
the native skin to a high degree [10,11]. Such epidermal skin equivalents are generated by 
culturing primary keratinocytes at the air–liquid interface on cell-free matrices (e.g., inert 
filters or de-epidermized dermis). The keratinocytes will proliferate, migrate and 
differentiate during epidermal development resulting in skin equivalents that contain all 
layers of the native epidermis [11]. The skin equivalents also have barrier properties that 
show high similarities with the human skin [21].  These systems are interesting models for 
studying pathogen-skin interactions. 
In the present study, we exploited a 3D human epidermal skin equivalent to 
study the adherence of an A. baumannii and an A. junii strain to the skin, subsequent 
biofilm formation and the skin’s response to these bacteria. Furthermore, we explored the 
usefulness of this model to investigate the effects of a disinfectant on the bacteria and the 
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Materials and methods 
 
Generation of epidermal skin equivalents 
Human keratinocytes were isolated from fresh plastic surgery surplus skin as previously 
described [10]. Briefly, the epidermis and dermis were enzymatically and mechanically 
separated and each layer subsequently digested to obtain single cell suspensions. 
Keratinocytes were cultured in Dermalife medium (Lifeline cell technology) supplemented 
with penicillin (10000 U) and streptomycin (10 mg/ml). Epidermal skin models were 
generated as described [11,21]. In short, approximately 2x10
5
 keratinocytes from a 
secondary culture were seeded onto a filter insert (12 mm in diameter, Costar, Corning) in 
12-wells plates in Dermalife medium. Three days after seeding, cells were put air-exposed 
by aspirating the apical medium. The basal medium was replaced with CnT-02-3D medium 
(CellTec) supplemented with 2.4×10
-2
 μM bovine serum albumin, 25 µM palmitic acid, 15 
µM linoleic acid and 7 µM arachidonic acid. Prior to bacterial inoculation, the medium was 
replaced by keratinocyte medium without penicillin and streptomycin. Experiments were 
performed using 7 days air-exposed cultures. 
 
Preparation of bacterial inoculum 
A. baumannii type strain ATCC19606
T





were used. Bacteria were preserved for prolonged periods in nutrient broth supplemented 
with 20% (v/v) glycerol at -80°C. Inocula from frozen cultures were grown overnight at 
37°C on sheep blood agar plates (BioMerieux). Bacteria were cultured for 2.5 h at 37°C in 
Luria Bertani (LB) medium [10 g of Bactotryptone, 5 g of Yeast extract (both from BD, 
Sparks) and 5 g of sodium chloride (Merck) in 1 l of distilled water] under vigorous shaking. 
This suspension was diluted in phosphate buffered saline (PBS; pH 7.4) to a concentration 
of approximately 3x10
5 
colony forming units (CFU)/ml as calculated from the absorbance 
of the suspension at 600 nm, and verified afterwards using standard vital counts.  
 
Colonization of epidermal skin equivalents 
Skin equivalents were incubated with 300 µl of the bacterial suspension at 37°C / 7.3% 
CO2. After 1 h, the bacterial suspension was aspirated to remove non-adherent bacteria. 
At different intervals after inoculation, the number of viable detachable and adherent 
bacteria was assessed microbiologically. Briefly, 600 µl of PBS were applied to the skin and 
the detachable bacteria were collected, serially diluted and plated onto diagnostic 
sensitivity test (DST) agar plates to determine the number of CFU. To assess the number of 
adherent bacteria, two biopsies (each 4 mm in diameter) were taken from the skin, 
homogenized in PBS using a glass Potter-Elvehjem tissue homogenizer and the 
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homogenates were subsequently serially diluted. The lower limit of detection of 
detachable and adherent bacteria was 12 and 115 CFU/skin equivalent, respectively. The 
number of adherent bacteria per skin equivalent (113.04 mm
2
) was calculated by 
multiplying the number of adherent bacteria in two biopsies (25.12 mm
2
) by 4.5. The total 
number of bacteria per skin equivalent was calculated by adding up the number of 
detachable bacteria per skin equivalent and the number of adherent bacteria per skin 
equivalent.  
 
Microscopic analysis of bacterial replication on skin equivalents 
To visualize bacterial colonization of the skin equivalents, one biopsy of each skin 
equivalent was fixed in 4% formaldehyde, dehydrated and embedded in paraffin. Next, 
paraffin blocks were cut into 5 µm sections, deparaffinized and rehydrated and then 
stained with Alcian-blue in combination with Periodic acid-Schiff (PAS, both from Merck) 
to detect polysaccharides.  
 
Immunohistochemical analysis of keratinocyte response  
For analysis of the effects of colonization of the skin equivalents, the levels of keratin (K) 
16, a marker for keratinocyte activation or stress; Ki67, a marker for keratinocyte 
proliferation; and K10, a marker for early keratinocyte differentiation were determined by 
immunohistochemical analysis. In short, standard antigen retrieval of deparaffinised and 
rehydrated paraffin sections was performed by immersing sections in 0.01 M citrate buffer 
(pH 6.0) for 30 min at 90°C followed by slow cooling down to room temperature for at 
least three h prior to staining of the sections. Sections were incubated overnight at 4°C 
with the primary mouse antibodies directed against human K16 (AbD serotec, clone LL025, 
5x diluted), Ki67 (DAKO, clone MIB-1, 75x diluted), and K10 (Abcam, clone DE-k10, 50x 
diluted). Thereafter, sections were incubated for 60 min with secondary biotinylated goat-
anti-mouse antibodies (DAKO) and subsequently 30 min with streptavidin-biotinylated 
horseradish peroxidase (DAKO). Chromogen 3-amino-9-ethyl-carbozole (AEC) solution was 
used as substrate solution. Sections were washed three times with PBS between 
subsequent incubations and finally counterstained with haematoxylin.  
To determine the proliferation index, the number of Ki67 positive nuclei from the 
total number of basal cells was used. A minimum of 100 basal cells was counted in 
sections of three different samples at a magnification of 200x.  
 
Determination of cytokine and chemokine levels  
The levels of IL-1α, IL-1β, IL-6, IL-8, IL-10, and TNFα in culture media were determined by 
ELISA (all from Biosource, Invitrogen) according to manufacturer’s instructions. The lower 
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limit of detection was 1 pg/ml for IL-1α and IL-1β, 15 pg/ml for IL-6, 7 pg/ml for IL-8 and 25 
pg/ml for IL-10 and TNFα. 
 
Determination of gene expression levels  
Total RNA was extracted from homogenized skin biopsies using the RNeasy Mini kit 
(Qiagen), followed by a treatment with DNase I (Qiagen). cDNA synthesis was performed 
on 300 ng of total RNA using the iScript cDNA synthesis kit (Bio-RAD) following 
manufacturer’s instructions. For each sample, a control for genomic DNA contamination 
was included by adding sterile water instead of reverse transcriptase. Real-time 
quantitative PCR was performed in an ICycler IQ (Bio-RAD) in a final volume of 25 µl 
comprising 1x IQ SYBR Green Supermix (Bio-RAD), 10 pmol of each primer (Table 1) and 5 
µl of 10x diluted cDNA. PCR conditions consisted of an initial denaturation step at 95°C for 
10 min followed by 40 cycles of denaturation at 95°C for 15 s, annealing at 56.5°C (for 
Ki67), 57.8°C (for LL-37), 60.8°C (for GAPDH and IL-1β), 61.7°C (for TNFα) or 62°C (for β2M, 
IL-1α, IL-6, IL-8, hBD-2, hBD-3, K16 and K10) for 15 s, and elongation
 
at 72°C for 20 s. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and beta-2 microglobulin (β2M) 
were used for standardization. Experiments were performed in duplicate. Data were 
acquired and analyzed using ICycler IQ Optical System software (Bio-RAD) with automatic 
adjustment of the baseline and threshold parameters.  
 

















Decontamination of colonized skin equivalents 
Two days after inoculation with A. baumannii ATCC19606
T
, 0.5% chlorhexidine solution in 
70% ethanol or as a control PBS was applied to the skin equivalents using a sterile cotton 
swab. The numbers of detachable and adherent bacteria were assessed as described 













Results are expressed as mean ± standard errors of the mean unless stated otherwise. 
Data were analyzed for statistical significance using the Wilcoxon rank sum test (SPSS 





Replication of Acinetobacter on skin equivalents 
To compare the persistence of A. baumannii ATCC19606
T
 and A. junii RUH2228
T
 on the 
skin, human epidermal skin equivalents were inoculated with approximately 1x10
5
 CFU 
suspended in 300 μl of PBS. The suspensions were aspirated from the skin equivalents 
after 1 h to allow air-exposure again. The total number of bacteria on the skin equivalent 








 CFU for the A. baumannii 








 CFU for the A. junii strain and thereafter 
remained stable for the duration of the experiment (Figure 1).  
 
Figure 1. A. baumannii and A. junii replication on skin equivalents. Human epidermal skin equivalents 
were inoculated with approximately 1x10
5
 CFU of A. baumannii ATCC19606
T
 (triangles) or A. junii 
RUH2228
T
 (circles). After 1 h, the non-adhered bacteria were removed. At different intervals 
thereafter, the numbers of detachable and adherent bacteria were determined microbiologically. 
Results are expressed as mean number of adherent (dotted lines) and total (solid lines) colony 




At 48 and 72 h after infection, the number of adhered A. baumannii ATCC19606
T
 was 
significantly greater than the number of detachable bacteria, indicating that the 
proportion of bacteria that adhered increased over time (Figure 1). For the A. junii strain, 
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the number of adherent bacteria exceeded that of detachable bacteria at 72 h after 
infection.  
 
Acinetobacter biofilm formation on skin equivalents 
Microscopic analysis revealed that bacteria of both strains persisted on the stratum 
corneum and did not invade the epidermis (Figure 2). Although there was no significant 
difference in the number of adherent bacteria between A. baumannii ATCC19606
T
 and A. 
junii RUH2228
T
  (Figure 1), Alcian blue-PAS staining revealed large biofilm structures by the 




Figure 2. Biofilm formation on skin equivalents. Skin equivalents were exposed to A. baumannii 
ATCC19606
T
 and A. junii RUH2228
T
 up to 72 h. Thereafter, 5 µm sections of paraffin-embedded skin 
were stained with Alcian blue PAS and biofilm formation was analysed by light microscopy. Small 




Response of skin equivalents to Acinetobacter 
Subsequently, the effect of bacterial colonization on keratinocyte differentiation, 
proliferation and cytokine and antimicrobial peptide production was evaluated. Results 
revealed that exposure of the skin equivalents to A. baumannii ATCC19606
T
 and A. junii 
RUH2228
T
 did not affect the mRNA expression of Ki67, K10 and K16 in keratinocytes 
(Figure 3A). In agreement, no difference was seen in protein expression of the 
activation/stress marker K16 between colonized and PBS-exposed skin equivalents (Figure 
3B). 
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Figure 3. Response of keratinocytes to Acinetobacter. Skin equivalents were exposed to A. baumannii 
ATCC19606
T
 (triangles), A. junii RUH2228
T
 (circles) or as a control PBS (crosses). At various intervals 
thereafter, mRNA expression (A) and at 48 h thereafter, protein levels (B) of keratinocyte 
activation/stress marker K16, proliferation marker Ki67 and differentiation marker K10 were 
determined using qPCR and immunohistochemistry, respectively. Scale bars, 20 μm. In addition, the 
mRNA expression (C) and protein (D) levels of the chemokine IL-8 and the pro-inflammatory cytokine 
interleukin (IL)-1α and IL-1β at different intervals were determined using qPCR and ELISA, 
respectively. Results are expressed as mean fold change in mRNA expression relative to PBS-exposed 
skin equivalents (A and C) or mean cytokine level in pg/ml (D) ± standard errors of the mean of three 
independent experiments. *, significantly different from PBS. 
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Moreover, the expression of K10 in the suprabasal viable cell layers of the exposed and 
non-exposed skin equivalents confirms that the early differentiation program was not 
altered by the Acinetobacter strains. In addition, the number of proliferating cells in the 
basal layers was not influenced by the bacteria, i.e. 20±2 versus 18±1 cells positive for 
Ki67/100 basal cells in A. baumannii-colonized skin versus PBS-exposed skin.  
 Furthermore, we assessed the production of the pro-inflammatory cytokines 
TNFα, IL-1α, IL-1β, IL-6, and IL-8 and that of the anti-inflammatory cytokine IL-10 by the 
skin equivalent in response to both Acinetobacter strains. During the first 48 h of infection, 
skin equivalents expressed similar levels of IL-1α and IL-8 after exposure to the two 
Acinetobacter strains as to PBS. However, after 72 h mRNA and protein expression levels 
of IL-8, but not of IL-1α, were slightly but significantly (p<0.05) higher in skin equivalents 
colonized by the A. baumannii strain as compared to those colonized by the A. junii strain 
and/or exposed to PBS (Figure 3C,D). In addition to IL-8 and IL-1α, IL-1β mRNA expression 
levels were significantly (p<0.05) higher in skin equivalents exposed to the Acinetobacter 
strains as compared to PBS-exposed skin equivalents, but only at 12 h of infection (Figure 
3C). IL-1β protein was, however, not detectable. Moreover, TNFα, IL-6 and IL-10 mRNA 
and proteins were not detectable in skin equivalents. 
 The skin equivalents constitutively expressed the antimicrobial peptides human 
beta-defensin (hBD)-2 and -3, but no LL-37. Infection of skin equivalents with the 
Acinetobacter strains did not induce enhanced expression of these peptides (data not 
shown). 
 
Eradication of A. baumannii from skin equivalent 
Finally, we examined the effect of chlorhexidine on A. baumannii ATCC19606
T
 colonization 
and on the epidermis. Swapping of skin equivalents colonized by the A. baumannii strain 
for 48 h with 0.5% chlorhexidine solution in 70% ethanol resulted in undetectable levels of 
A. baumannii on the skin (Figure 4A). In addition, this chlorhexidine solution did not affect 
skin morphology (Figure 4B) and mRNA expression levels of K16, IL-1α and IL-8, but 
enhanced the expression levels of Ki67 and K10 11-fold and 4-fold, respectively (Figure 
4C). This indicates that chlorhexidine enhanced keratinocyte proliferation and 















Figure 4. Treatment of infected skin equivalents with chlorhexidine. Skin equivalents were infected 
with A. baumannii ATCC19606
T
 for 48 h. Thereafter, chlorhexidine or PBS was applied to the skin 
equivalents. A, Twenty-four hours after treatment, the numbers of detachable and adherent bacteria 
were determined microbiologically. Results are expressed as mean number of adherent (white bars) 
and total (gray bars) colony forming units (CFU) per skin equivalent ± standard errors of the mean of 
three independent experiments. The dotted line represents the lower limit of detection. nd, not 
detectable; *, significant (p<0.05) difference. B, Light micrograph of section of chlorhexidine-treated 
skin stained with Alcian blue PAS. Scale bar, 20 μm. C, Twenty-four hours after treatment, mRNA 
expression levels of the keratinocyte activation/stress (K16), proliferation (Ki67) and differentiation 
(K10) markers as well as the inflammatory mediators IL-8 and IL-1α were determined using qPCR. 
Results are expressed as mean mRNA expression levels relative to PBS-treated skin ± standard 






The main conclusion from the present findings is that the 3D human skin equivalent is a 
promising model to study skin colonization by Acinetobacter strains and to evaluate the 
effects of disinfectants and other antimicrobial agents. This is of importance as A. 
baumannii is able to colonize the skin [2,7,8,17,24], which can be a source for infection 
and spread to other patients and the environment. Recent papers have emphasized the 
benefits of skin disinfection as a tool to reduce colonization pressure in a ward [2,12,22]. 





, which belongs to A. junii, a species that occurs on the human 
skin,
 
adhered to and replicated on the stratum corneum up to 72 h without invading the 
epidermis. An important difference between these two strains was the ability of the A. 
baumannii strain, but not the A. junii strain, to form a large biofilm on the skin 
equivalents. Secondly, bacterial colonization did not affect keratinocyte activation, 
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proliferation or differentiation nor did it induce a strong inflammatory response. Thirdly, 
disinfection with chlorhexidine solution resulted in complete eradication of the A. 
baumannii strain from the skin without detrimental effects. 
We have previously shown that both A. baumannii ATCC19606
T
 and A. junii 
RUH2228
T
 were able to form large biofilms on plastic [5]. On the present human skin 
model, however, only A. baumannii ATCC19606
T
 formed large biofilms. A possible 
explanation for the latter observation could be that A. baumannii, but not A. junii, can 
utilize the nutrients of the stratum corneum for biofilm formation. In agreement with this 
suggestion it has been shown that the metabolic versatility of A. baumannii is considerably 
greater than that of A. junii [3,18]. The ability of Acinetobacter to form biofilms appears to 
depend on the surface to which the bacteria adhere, as suggested earlier by Gaddy et al 
[13]. Although more strains should be examined before a definitive conclusion can be 
drawn, we hypothesize that the ability of A. baumannii to form a biofilm on human skin 
plays an important role in its persistence on the skin.  
We have previously shown that human bronchial epithelial cells and cultured 
human macrophages produce considerable amounts of inflammatory mediators in 
response to these Acinetobacter strains [5]. Using this skin equivalent model, however, A. 
baumannii ATCC19606
T
 and A. junii RUH2228
T
 induced a poor inflammatory response. This 
may be explained as follows. In our previous study, the cells were cultured in monolayers 
and infected with bacteria, enabling direct contact between the bacteria and the cells. 
However, in the current experiments the bacteria did not invade the epidermis, and thus, 
did not come in direct contact with live keratinocytes. These results underline the 
importance of the stratum corneum as a protective barrier against infections, as also 
shown by Duckney et al, who demonstrated that Staphylococcus epidermidis and 
Propionibacterium acnes induced an inflammatory response in a reconstructed human 
epidermis model only when applied subcutaneously in the culture medium and not when 
applied topically on the stratum corneum [9]. Moreover, it emphasizes that results from 
studies into pathogen-host interactions using keratinocyte monolayers (lacking a stratum 
corneum) will not reflect the in vivo situation.  
With the emergence of antibiotic resistance, there has been a re-appraisal of the 
use of antiseptics for skin disinfection [12,15]. Chlorhexidine is widely used as an 
antiseptic against many microorganisms, including A. baumannii [12]. However, several 
studies have shown that chlorhexidine may have toxic effects on human fibroblasts [14] 
and be detrimental to wound healing [14,16], making its use controversial in particular 
situations. Although the A. baumannii type strain used in this study was fully susceptible 
to treatment with chlorhexidine, a MDR A. baumannii isolate that was resistant to 
chlorhexidine concentrations up to 1% has already been reported [4]. In this light, it is 
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necessary to develop novel disinfectant strategies to eradicate A. baumannii from the 
colonized skin.  
In summary, we have described a novel model for Acinetobacter skin colonization 
using 3D human epidermal skin equivalents. This model will be beneficial in characterizing 
bacterial growth kinetics and the interactions of different bacterial species on a biotic 
surface. Moreover, this model may also be advantageous for identifying and evaluating 
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During the last decades, A. baumannii has emerged as an important nosocomial pathogen 
responsible for outbreaks of infection worldwide. The spectrum of A. baumannii-host 
interactions is complex; ranging from a quiescent colonizer of the human skin to a 
dangerous invader of the bloodstream causing bacteremia and septic shock. The outcome 
of its interaction with the host depends on the balance between the virulence factors 
displayed by the bacterium and the condition of the host and the quality of its immune 
response (Figure 1).  
 The studies presented in this thesis aimed to gain further insight into the 
bacterial and host factors associated with the pathogenesis of A. baumannii to seek an 




Figure 1. The pathogen-host balance. The outcome of colonization or infection by A. baumannii 
depends both on the virulence of the pathogen (in red) and on the condition of the host (in green).  
 
 
Adherence to and biofilm formation on abiotic and biotic surfaces 
As adherence to host cells is the first step in colonization and infection (chapter 1), we 
asked the question whether adherence to biotic surfaces differed between A. baumannii 
and less virulent Acinetobacter species. Results showed that strains of A. junii, which is a 
common skin colonizer, adhered equally well to human bronchial epithelial cells as A. 
baumannii strains (chapter 2). However, within each species there was a wide variation in 
quantitative adherence, expressed as the percentage infected epithelial cells (chapter 2). 
Strain variation within A. baumannii was previously also shown by Lee et al, who 
quantified the adherence of a large set of A. baumannii strains to human bronchial 
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epithelial cells [1]. They did not observe a difference in the percentage of infected cells 
between outbreak-associated strains and strains not associated with outbreaks. However, 
we found a correlation between the clonal lineage and the percentage of infected cells, 
with strains of EU clone II being more adherent than strains belonging to EU clone I [1]. 
Together, these data indicate that adherence to human mucosal cells is a general feature 
of Acinetobacter strains. In the next paragraph, the mechanisms that are thought to play a 
role in adherence of Acinetobacter to human cells are discussed. 
 Once bacteria have attached to an abiotic or biotic surface, they can multiply and 
form a biofilm, which protects them against environmental stresses, such as desiccation 
and exposure to antibiotics. The ability to form a biofilm may contribute to the survival of 
bacteria on environmental surfaces and medical devices like catheters and respiratory 
tubes (chapter 1). In this thesis, we first investigated whether A. baumannii strains can 
form biofilms on an abiotic surface. A wide variation in biofilm formation among A. 
baumannii strains was found (chapter 2). Although epidemic strains did not form larger 
biofilms than sporadic strains, it appeared that strains of EU clone II formed larger biofilms 
than strains of clone I. The finding that strains of EU clone II seemed to adhere better to 
epithelial cells [1] and form larger biofilms than strains of clone I raises the question 
whether there is a difference in clinical impact between these clones. Up to date however, 
both EU clone I and II strains are involved in outbreaks worldwide [2–5] and, although 
there are temporal and geographical shifts in their occurrence, there is, to our knowledge, 
no clear distinction in clinical-epidemiological behaviour. Therefore, differences in 
adherence to human cells [1] and biofilm formation on plastic cannot be directly linked to 
the clinical-epidemiological significance of the clones. 
As there was no association between biofilm formation on plastic and clinical 
significance among A. baumannii strains, we next investigated the capacity of other 
Acinetobacter species to form a biofilm. It was found that some strains of A. pittii and A. 
nosocomialis and of the less virulent species A. calcoaceticus and A. junii were also able to 
form biofilm on plastic. As for A. baumannii, intraspecies variation was considerable 
among these species. This led us to conclude that biofilm formation on plastic is strain- 
and not species-specific and does not explain the success of A. baumannii in the 
susceptible host. The poor correlation between the adherence to bronchial epithelial cells 
and biofilm formation on plastic (chapter 2) may be explained by the fact that different 
mechanisms are involved in these processes as will be described in the next section. 
 Biofilm formation on plastic and adherence to human cells are widely used 
systems to study interactions of bacteria with abiotic and biotic surfaces, respectively. 
However, these systems do not adequately reflect the real-life association of bacteria with 
its host. Moreover, it is known that biofilm formation is strongly influenced by 
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environmental conditions [6], such as the physical properties of the surface and nutrient 
availability. The colonized skin is thought to constitute an important reservoir for A. 
baumannii during outbreaks and endemic episodes [7,8]. In chapter 5 and 7, adherence 
and biofilm formation of Acinetobacter was investigated on this biologically relevant 
surface using a 3D human epidermal skin equivalent that mimics the native skin to a high 
degree [9,10]. The A. baumannii type strain ATCC19606
T
 and the A. junii type strain 
RUH2228
T
 both colonized the epidermis and persisted up to 72 h, but did not invade the 
epidermis (chapter 7). Moreover, strains of A. pittii (SH024) and A. nosocomialis 
(RUH2624) also survived and persisted on the skin equivalent, whereas a strain of the 
environmental species A. calcoaceticus (RUH2202) did not (chapter 5). Although both A. 
baumannii ATCC19606
T
 and A. junii RUH2228
T
 were able to form a large biofilm on plastic 
(chapter 2), only A. baumannii ATCC19606
T
 formed a biofilm on the human skin 
equivalent, as demonstrated using the polysaccharide stain Alcian blue-PAS (chapter 7). 
Together, these data demonstrate that the ability of Acinetobacter to form biofilms 
depends on the substrate with which the bacteria are interacting, as was also found by 
Gaddy et al [11].   
 
Mechanisms underlying adherence and biofilm formation 
The differences in adherence and biofilm formation among Acinetobacter strains triggered 
us to study the possible mechanisms underlying these colonization processes. It was 
previously shown that the ability of A. baumannii ATCC19606
T
 to form pili and to adhere 
to and form biofilms on abiotic surfaces depends on the expression of csuE, which is part 
of the CsuA/BABCDE chaperone-usher pili assembly system [12]. The involvement of these 
CsuA/BABCDE-mediated pili in adherence to human epithelial cells was investigated 
(chapter 3). Compared to A. baumannii ATCC19606
T
, the isogenic csuE-mutant did not 
show impaired adherence to human bronchial epithelial cells. Strikingly, the mutant could 
adhere even better to these cells than the parental strain. These results were later 
confirmed by Gaddy et al using human alveolar epithelial cells [13]. This indicates that the 
csuE-mediated pili are not required for adherence to human cells, although they are 
important attributes for the A. baumannii type strain to form microcolonies and biofilm on 
inanimate surfaces.  
As part of a multicenter study, the genome, metabolome and virulence of a range 
of Acinetobacter species that differ in success in the clinical setting was assessed (chapter 
5). It was found that the csu operon was present in pathogenic species of Acinetobacter 
(six A. baumannii strains, A. pittii and A. nosocomialis) but not in non-pathogenic species, 
suggesting that this operon is a putative virulence factor. CsuE-mediated adherence to 
indwelling medical devices like lines and respiratory tubes, may allow for multiplication of 
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the organism on these abiotic surfaces, which contributes to an increased risk of infection 
for the patient. 
Using scanning electron microscopy, we showed that ATCC19606
T
 expressed 
short fimbrial-like structures as well as thick cell extensions connecting bacteria (chapter 
3). The csuE-mutant appeared to densely express short fimbriae on its surface but no thick 
cell extensions. These thick cell extensions resemble the polysaccharide poly-β-1-6-N-
acetylglucosamine (PNAG) described recently by Choi et al, that was associated with A. 
baumannii biofilm formation on abiotic surfaces under shaking conditions [14]. As the 
csuE-mutant expressed more short fimbrial-like extensions on its surface than the parental 
strain, we hypothesized that these CsuA/BABCDE-independent short fimbrial-like 
extensions play a role in adherence to biotic surfaces as was shown previously for the 
acuA-encoded short fimbriae of A. baylyi strain ADP1 [15]. To test this hypothesis, the 
surface morphology of additional A. baumannii strains that differed in their ability to 
adhere to human cells was examined (chapter 2). There was a wide variation in the 
presence of cell surface extensions between these strains and we did not find a clear 
association between the presence of either the thick cell extensions or the short fimbriae 
and biofilm formation or adherence to human cells. To investigate the involvement of cell 
extensions in these colonization processes in more detail the presence of cell extensions 
should be examined at different growth conditions as it has been shown that pilus 
assembly is influenced e.g. by the presence of a substratum [16]. Moreover, biochemical 
approaches are necessary to elucidate the structure of these extensions. 
 
Host response to Acinetobacter 
On the other side of the pathogen-host balance (Figure 1), the host has several innate 
defense mechanisms to prevent infection. In chapter 2, we describe that human bronchial 
epithelial cells respond to infection with A. baumannii and A. junii strains by the 
production of the inflammatory cytokine IL-6 and the chemokine IL-8. Interestingly, A. junii 
strains induced higher levels of these inflammatory mediators than A. baumannii strains 
did. This difference was even more pronounced in cultured human macrophages, where 
A. junii induced higher levels of the pro-inflammatory TNFα and IL-12p40, the chemokine 
IL-8 and the anti-inflammatory IL-10 than A. baumannii strains did. Thus, strains of A. 
baumannii induced a limited TNFα, IL-12p40, IL-6, IL-8 and IL-10 response in human cells 
as compared to A. junii strains, despite the finding that they adhered equally well to these 
cells. Different studies have demonstrated the importance of inflammatory cytokines for 
clearing of A. baumannii in vivo [17–20]. Therefore, we hypothesized that A. baumannii 
may survive and persist in the airways of patients and cause disease at least in part by 
inducing a weak inflammatory response that poorly mediates the clearance of bacteria by 
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the host. To investigate this possibility, the persistence of and host response to different 
well-characterized Acinetobacter strains was determined using a mouse infection model 
(chapter 4). MDR A. baumannii reference strains of EU clone I (RUH875), II (RUH134) and 
III (LUH5875) as well as a susceptible sporadic A. baumannii isolate (LUH8326) had a 
dramatic effect on the neutropenic host as they survived and multiplied in the lungs of 
mice and disseminated into the bloodstream. As might be expected from the rare 
prevalence of A. junii in infection, the strain of this species did not persist in the lungs of 
mice, which might be explained by a strong inflammatory response to this strain, as we 
have shown in vitro (chapter 2). Surprisingly, the type strain of A. baumannii ATCC19606
T
 
was also cleared from the lungs rapidly without causing disease. This type strain, an urine 
isolate from the 1960s of which the clinical epidemiological significance is unknown, is a 
widely used model strain to study the pathogenesis of A. baumannii. The findings of our 
studies challenge the relevance of this A. baumannii strain in virulence studies.  
A striking difference in the outcome of pneumonia among the A. baumannii 
strains was observed with the clone I and II strains being most virulent (chapter 4). These 
findings emphasize that there are great differences in virulence among A. baumannii 
strains, and stress the need for rapid identification tools of high risk strains [21,22].  
 The mouse model studies also revealed that the host responded differently to the 
various A. baumannii strains, with higher levels of the pro-inflammatory IL-12p40 and IL-
23 and the anti-inflammatory IL-10 after infection with the less virulent EU clone III strain 
and the susceptible sporadic isolate as compared to the clone I and II strains (chapter 4). 
One possible explanation for the association between high levels of IL-10 and low 
mortality could be that this anti-inflammatory cytokine down-regulates inflammation and 
its unfavourable effects. In agreement with others, who described a role for IL-12p40 and 
IL-23 in mice survival after infection with other pathogens [23,24], we found that high 
levels of these cytokines in A. baumannii infected mice were associated with better 
outcomes. IL-23 is a cytokine that together with IL-1β and IL-6 in mice drives the 
development of an IL-17-producing T cell population [25], which plays a role in host 
defense against extracellular pathogens by mediating the recruitment of neutrophils and 
monocytes to infected tissues. However, it is uncertain whether this cytokine plays a 
crucial role in host defence against A. baumannii as IL-17 depletion did not increase 
mortality in A. baumannii infected mice [17]. Future studies will have to clarify the precise 
roles of these cytokines in the outcome of A. baumannii infection. If these cytokines also 
influence the impact of A. baumannii strains on the human host, these mediators could 





Mechanisms underlying host innate immune response during Acinetobacter infection 
Several mechanisms can play a role in the observed inflammatory responses induced by 
the different Acinetobacter strains. The lipid A part of the LPS of A. baumannii was 
suggested to have a high cytokine-inducing capacity [26]. In line with this, it was shown 
that LPS of A. baumannii strain RUH2037 and of A. nosocomialis strains induced a pro-
inflammatory cytokine response in mice [18] and human cells in vitro [27], respectively. 
Using three-dimensional human skin equivalents, we demonstrated that A. baumannii 
ATCC19606
T
 and A. junii RUH2228
T
 both induced a very weak inflammatory response 
(chapter 7). This observation may be related to the barrier function of the stratum 
corneum but also by the low expression of TLR4, which serves as a LPS pattern recognition 
receptor, in keratinocytes, as also reported by others [28]. These studies underline the 
role of LPS and TLR4 in Acinetobacter signaling.  
It has been demonstrated for Pseudomonas aeruginosa that adaptive and 
dynamic changes can occur in the chemical composition of lipid A resulting in different 
potencies to activate the host innate immunity via binding to TLR4 [29]. Unpublished 
results showed that there are structural differences in the lipid A part of the LPS of several 
Acinetobacter species (personal communication with L. Dijkshoorn). Future studies 
investigating the host response to the LPS of different Acinetobacter strains are necessary 
to determine to what extent lipid A diversity contributes to the differences in host 
response among species. 
It has been suggested that the coupling of pili to host cell receptors induces 
inflammation through the production of inflammatory mediators [30]. We found that A. 
baumannii type strain ATCC19606
T
 and its csuE-mutant induced similar levels of 
inflammatory cytokines IL-6 and IL-8 in bronchial epithelial cells (chapter 3), suggesting 
that CsuA/BABCDE-mediated pili are not involved in induction of inflammatory responses 
in human bronchial epithelial cells interacting with this bacterial pathogen. 
 
Membrane vesicles 
For several Gram-negative bacterial species outer membrane vesicles (OMVs) were shown 
to transfer virulence factors into host cells, thereby inducing an immune response [31]. A. 
baumannii ATCC19606
T
 has been shown to excrete membrane vesicles in vitro that were 
proposed to play a role in the delivery of virulence factors, including the cytotoxic OmpA, 
to host cells [32]. These studies used extensive purification methods for the isolation of 
OMV, including (ultra)-filtration and centrifugation. A disadvantage of this harsh isolation 
procedure could be the presence of inner membrane and cytoplasmic proteins in OMV 
resulting from random capture by membrane fragments. Since it is not known whether 
these OMVs represent the naturally occurring OMVs or are artefacts [33], we examined 
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the formation and structure of membrane vesicles by A. baumannii in different growth 
phases without the use of extensive purification methods (chapter 6). Our results showed 
that A. baumannii ATCC19606
T
 forms structurally different MVs depending on its growth 
phase: (i) small OMVs and (ii) large OMVs, both formed during early growth phases; and 
(iii) vesicles containing both inner and outer membrane (IOMVs) formed during late 
stationary growth phases. Stationary phase or dying bacteria appeared to form the most 
MVs. Moreover, it was found that sub-lethal concentrations of the antibiotic ceftazidime, 
which interferes with peptidoglycan synthesis [34] and structure, enhanced the formation 
of OMVs at distal and septal sites of the bacterial cells. It is conceivable that these OMVs 
carry LPS on their surface. Therefore, the possibility that inadequate dosing of antibiotics, 
such as penicillins and cephalosporins, has serious adverse effects in patients suffering 
from A. baumannii infection should be considered [35].  
Jin et al demonstrated that A. baumannii ATCC19606
T
 secreted MVs during 
pneumonia in a mouse model of infection [32]. Moreover, it was reported that A. 
baumannii present in alveolar macrophages in a patient with fatal A. baumannii 
pneumonia secreted multiple pleomorphic vesicles [36], suggesting the possibility of 
secretion of different types of vesicles during in vivo infection. We argue that these 
differences in structure may have implications for their function. Obviously, future studies 
are needed to identify the virulence attributes present in the various membrane vesicles 
formed by A. baumannii and the interaction of these vesicles with the host. 
 
Metabolic versatility 
In addition to its ability to adhere to surfaces and form a biofilm, the capacity to utilize a 
wide range of different carbon sources and to replicate at room temperature and up to 
44⁰C [37,38] are likely to contribute to the persistence of A. baumannii in the hospital 
environment and the human host. In this connection, the multicenter study (chapter 5) 
identified a diverse repertoire of core metabolic genes in A. baumannii. Moreover, using 
phenotype microarrays, it was shown that A. baumannii ATCC19606
T
 was able to utilize 
nitrogen sources more effectively and was more tolerant to pH stress than A. nosocomialis 
(RUH2624), A. pittii (SH024) and A. calcoaceticus (RUH2202). Interestingly, A. baumannii 
and A. pittii were unable to utilize most of the phosphorus sources despite both strains 
having the necessary genetic composition for phosphate metabolism. These two species 
were also able to survive in the mouse thigh muscle infection model, in contrast to A. 
nosocomialis and A. calcoaceticus (chapter 5), suggesting that there may be a link 
between phosphate metabolism and virulence. Several studies have highlighted the key 
role of the Pho regulon in phosphate management, virulence and stress response [39]. 
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Whether the inability of A. baumannii and A. pittii to utilize phosphorus is linked to 
expression of the Pho regulon remains a question that needs further evaluation.  
The metabolic versatility of A. baumannii enables strains of this species to flourish 
in a variety of niches, from the hospital environment to the febrile patient.  
 
 
Summary and main conclusions 
 
The study of the pathogenesis of A. baumannii is still in its early phase. In the studies 
presented in this thesis, we compared possible virulence attributes among strains that 
differ in their behavior in the clinical setting, i.e., MDR A. baumannii strains known to be 
involved in outbreaks of infection, susceptible sporadic A. baumannii strains and strains of 
other, less virulent Acinetobacter species. We demonstrated that both A. baumannii and 
less virulent Acinetobacter species can adhere to surfaces and form a biofilm, albeit with a 
wide variation among strains of each species. These results first of all show that a single 
strain is not representative for the species. Secondly, the presence of many virulence 
attributes in both clinically relevant and less-relevant strains indicates that the clinical 
success of A. baumannii cannot be explained by these virulence factors alone. Moreover, 
our results suggest that the outcome of infection depends mainly on the host. In this 
respect, a specific host innate immune response induced by different A. baumannii strains 
was associated with the outcome of A. baumannii pneumonia. Thus, the ability of certain 
A. baumannii strains to induce specific immune responses in susceptible hosts in 
combination with their metabolic versatility and a MDR phenotype are likely to be 
important features associated with the clinical success of this pathogen.  
To date, the genomes of different Acinetobacter strains have been sequenced. In 
this post-genomic era, studies have shifted towards gene expression and function [40]. 
Integrating the wealth of information from genomics, transcriptomics, proteomics and 
metabolomics with bacterial behavior and host responses will provide us more insight into 
the pathogenesis of A. baumannii. The work described in this thesis is a first step to 
unravel the factors that play a role in the pathogenesis of A. baumannii, which is critical in 
our efforts to develop improved diagnostic and therapeutic strategies against this 
pathogen. 
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Acinetobacter baumannii is een belangrijke ziekenhuisbacterie die vooral bij ernstig zieke 
patiënten, zoals patiënten op intensive care afdelingen, aanleiding kan geven tot 
kolonisatie en infecties. Infecties veroorzaakt door deze bacterie variëren van pneumonie, 
urineweg-, huid- en wondinfecties tot bacteriëmie met sepsis. Behandeling kan problemen 
geven omdat stammen dikwijls resistent zijn voor meerdere of zelfs alle bruikbare 
antibiotica. Het zijn vooral de antibiotica-resistente stammen die zich epidemisch onder 
patiënten kunnen verspreiden. Er zijn drie groepen van genetisch verwante A. baumannii 
stammen, de zogenaamde Europese klonen I, II en III, die verantwoordelijk zijn voor 
epidemieën in ziekenhuizen wereldwijd. 
Naast A. baumannii zijn er twee nauw verwante species, A. pittii en A. 
nosocomialis, die relatief vaak in klinische materialen kunnen voorkomen en soms ook 
antibiotica-resistent zijn. Sommige van de overige Acinetobacter species kunnen ook bij de 
mens voorkomen en infecties geven, maar het beloop van zulke infecties is vaak mild en 
goed behandelbaar. Of de aanwezigheid van acinetobacters bij een patiënt tot ziekte leidt, 
wordt bepaald door de balans tussen de weerstand van de gastheer en de virulentie van 
de bacterie. Er is vooralsnog weinig bekend over de factoren die geassocieerd zijn met de 
pathogenese van A. baumannii infecties. De studies beschreven in dit proefschrift hadden 





Aangezien hechting een cruciale eerste stap is in het kolonisatieproces, hebben wij 
onderzocht of er verschil bestaat in het vermogen van diverse Acinetobacter stammen en 
species om te hechten aan humaan luchtwegepitheel. De resultaten in hoofdstuk 2 tonen 
dat zowel A. baumannii stammen als stammen van de klinisch minder relevante species A. 
junii kunnen hechten aan luchtwegepitheel. De mate van hechting varieerde sterk tussen 
de stammen binnen de twee species. Nadat bacteriën gehecht zijn aan een biotisch of 
abiotisch oppervlak kunnen zij zich vermenigvuldigen, microkolonies vormen en een 
beschermende slijmlaag (bestaande uit o.a. exopolysacchariden) produceren. Dit kan 
leiden tot een gestructureerd netwerk van bacteriën ingebed in een polysaccharidenlaag: 
een biofilm. Bacteriën in een biofilm zijn resistenter voor factoren van buitenaf, zoals 
antibiotica en effectorcellen van het immuunsysteem. Het vermogen van een groot aantal 
Acinetobacter stammen en species om biofilm te vormen op een abiotisch oppervlak is 
vergeleken in hoofdstuk 2. Ondanks het verschil in de mate van biofilmvorming tussen 
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individuele stammen was er geen verschil tussen de klinisch relevante species A. 
baumannii, A. pittii en A. nosocomialis en de klinisch minder relevante species A. junii en 
A. calcoaceticus. Deze studie toont dat hechting aan slijmvlies en biofilmvorming op een 
abiotisch oppervlak een algemeen kenmerk is van Acinetobacter stammen, ongeacht de 
species.  
 Tijdens epidemieën vormt de gekoloniseerde huid een belangrijk reservoir van A. 
baumannii. In hoofdstuk 5 en 7 is een driedimensionaal humaan huidmodel gebruikt om 
de hechting aan en biofilmvorming op een fysiologisch relevant biotisch oppervlak nader 
te bestuderen. Zowel stammen van A. baumannii, A. pittii, A. nosocomialis als de klinisch 
minder relevante A. junii konden hechten aan de huidcellen en zich vermenigvuldigen. 
Opvallend was dat een stam van de klinisch niet-relevante A. calcoaceticus niet kon 
persisteren op het huidmodel. Hoewel al deze stammen een biofilm vormden op plastic, 
ontwikkelden uitsluitend de drie klinisch relevante species een biofilm op de 
huidmodellen. Dit suggereert dat biofilmvorming ook afhankelijk is van het oppervlak 
waaraan de bacteriën gehecht zijn. 
 Om de verschillen in de mate van hechting en biofilmvorming tussen 
Acinetobacter stammen te kunnen verklaren, onderzochten we mogelijke mechanismen 
die een rol spelen bij deze kolonisatieprocessen. Pili, haarachtige structuren op het 
oppervlak van de bacterie, maken hechting van bacteriën aan (a)biotische oppervlakken 
en aan andere bacteriën mogelijk. In hoofdstuk 3 is beschreven dat de zogenaamde 
CsuA/BABCDE-pili, waarvan bekend is dat zij noodzakelijk zijn voor hechting en biofilm 
vorming van de A. baumannii typestam op plastic, geen rol spelen in de hechting van deze 
stam aan luchtwegepitheel. Ook voor een grotere set A. baumannii stammen was er geen 
relatie tussen de aanwezigheid van pili en de mate van hechting aan epitheel of biofilm 
vorming op plastic (hoofdstuk 2).  
 Hechting van bacteriën aan de huid of slijmvliezen van de gastheer kan een 
ontstekingsreactie opwekken, gekenmerkt door de productie van ontstekingsmediatoren 
zoals chemokines en cytokines en de recrutering van ontstekingcellen naar het 
geïnfecteerde weefsel. Deze ontstekingscellen spelen in het algemeen een belangrijke rol 
in het verwijderen van de bacteriën. In hoofdstuk 2 is de productie vergeleken van 
specifieke ontstekingsmediatoren door luchtwegepitheelcellen in reactie op A. baumannii 
en A. junii. Hoewel stammen van beide species even goed konden hechten aan deze 
cellen, wekten A. baumannii stammen significant minder ontstekingsmediatoren 
(interleukine (IL)-6) en chemokines (IL-8) op dan A. junii stammen. Dit verschil was nog 
groter in humane macrofagen, die behoren tot de eerste ontstekingscellen waar bacteriën 
mee in aanraking komen in het weefsel. Aangezien de productie van 
ontstekingsmediatoren cruciaal wordt geacht voor het verwijderen van de bacteriën, 
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veronderstelden wij dat A. baumannii stammen mogelijk kunnen overleven en persisteren 
in de luchtwegen van patiënten en ziekte kunnen veroorzaken doordat zij een zwakke 
ontstekingsreactie opwekken. Deze hypothese hebben wij in hoofdstuk 4 getoetst met 
behulp van een muismodel voor pneumonie. Binnen A. baumannii was er een duidelijk 
verschil in het beloop van de luchtweginfectie te zien: A. baumannii stammen behorend 
tot Europese kloon I en II waren zeer virulent, en veroorzaakten hoge morbiditeit en 
mortaliteit. Een Europese kloon III stam en een sporadische, antibiotica-gevoelige stam 
vermenigvuldigden zich in dezelfde mate in de longen en verspreidden zich in de 
bloedbaan van de muis. Echter, deze laatste twee stammen veroorzaakten minder 
symptomen. De stam behorend tot de laag-virulente species A. junii werd snel verwijderd 
uit de longen en veroorzaakte geen ziekte. Dit zou verklaard kunnen worden door de 
effecten van een sterke ontstekingsreactie opgewekt door deze stam zoals in vitro het 
geval was. De typestam van A. baumannii, een stam die veelvuldig gebruikt wordt in 
virulentiestudies, overleefde ook niet in de muis en veroorzaakte geen ziekte. Deze 
bevindingen benadrukken dat er een groot verschil is in virulentie tussen A. baumannii 
stammen. Met behulp van dit muismodel konden we ook vaststellen dat het aangeboren 
immuunsysteem van de gastheer verschillend reageert op A. baumannii stammen. Zo 
wekten de minder virulente A. baumannii stammen meer specifieke 
ontstekingsmediatoren (de ontstekingsstimulerende IL-12p40 en IL-23 en het 
ontstekingsremmende IL-10) op dan de virulente stammen. Verdere studies zullen de rol 
van deze ontstekingsmediatoren in het beloop van A. baumannii infecties moeten 
ophelderen. 
 Ook zonder direct contact kunnen bacteriën de gastheercel beïnvloeden, namelijk 
door middel van blaasjes afgesnoerd van hun buitenmembraan (vesicles), die door de 
gastheercel kunnen worden opgenomen. Deze vesicles kunnen virulentiefactoren 
bevatten die langs deze weg in de gastheercel terecht komen. In hoofdstuk 6 is de 
productie van membraanvesicles door de typestam van A. baumannii onderzocht met 
behulp van electronen-microscopische technieken. Deze A. baumannii stam vormde 
verschillende typen membraanvesicles, afhankelijk van de groeifase van de bacterie. 
Vervolgstudies moeten uitwijzen of deze verschillende membraanvesicles 
virulentiefactoren bevatten en de gastheer beïnvloeden. 
 Om mogelijke species-specifieke kenmerken te identificeren die het verschil in 
klinisch gedrag tussen Acinetobacter species kunnen verklaren, is een zogenaamde 
systeemstudie uitgevoerd, waarbij genomische, metabolische en virulentiestudies werden 
gecombineerd binnen een internationaal samenwerkingsproject (hoofdstuk 5). Een divers 
repertoire aan genen die een rol spelen in het metabolisme werden geïdentificeerd in alle 
zes geteste A. baumannii stammen. Slechts enkele van deze genen waren uniek voor A. 
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baumannii in vergelijking met klinisch minder relevante Acinetobacter species. Echter, 
wanneer het genoom van één A. baumannii stam vergeleken werd met dat van een A. 
calcoaceticus stam, werden meerdere unieke genclusters geïdentificeerd, waaronder het 
csu operon (dat codeert voor de hierboven beschreven CsuA/BABCDE-pili) en een 
gencluster dat een rol speelt bij ijzeropname. Daarnaast lieten de metabolische studies 
zien dat de A. baumannii stam efficiënter stikstofbronnen kon gebruiken en resistenter 
was voor pH, osmotische en antibiotica stress dan A. pittii, A. nosocomialis en A. 
calcoaceticus stammen. A. baumannii en A. pittii konden minder goed fosfaatbronnen 
gebruiken om te groeien dan A. nosocomialis en A. calcoaceticus. Juist deze 
laatstgenoemde species konden niet overleven in een muismodel van een 
dijbeenspierinfectie. Deze resultaten suggereren dat het klinische succes van 
Acinetobacter species afhankelijk is van genetische verschillen die een functionele impact 





De aanwezigheid van meerdere virulentiefactoren in zowel A. baumannii als klinisch 
minder relevante Acinetobacter species, toont aan dat het klinische succes van A. 
baumannii niet alleen verklaard kan worden door deze virulentiefactoren. Het vermogen 
van bepaalde A. baumannii stammen om een specifieke gastheerrespons op te wekken in 
combinatie met hun genetische flexibiliteit, metabolische verscheidenheid en antibiotica-
resistentie zijn waarschijnlijk alle belangrijke factoren die geassocieerd zijn met het 
klinische succes van deze bacterie. Het werk beschreven in dit proefschrift is een stap naar 
het ophelderen van de factoren die een rol spelen in de pathogenese van A. baumannii, 
wat essentieel is voor de ontwikkeling van nieuwe diagnostische en therapeutische 
strategieën ten aanzien van infecties door deze bacterie. 
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